Omega Healthcare Investors (OHI) 10-K 24 Feb 17 2016 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2016	Feb. 17, 2017	Jun. 30, 2016
Document and Entity Information [Abstract]
Entity Registrant Name	OMEGA HEALTHCARE INVESTORS INC
Entity Central Index Key	888,491
Trading Symbol	ohi
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Well-Known Seasoned Issuer	Yes
Entity Common Stock Shares Outstanding		196,743,251
Entity Public Float			$ 6,465,433,450.70
Document Type	10-K
Document Period End Date	Dec. 31, 2016
Amendment Flag	false
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	FY

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Real estate properties
Real estate investments (see Note 3)	$ 7,566,358	$ 6,743,958
Less accumulated depreciation	(1,240,336)	(1,019,150)
Real estate investments - net	6,326,022	5,724,808
Investments in direct financing leases - net	601,938	587,701
Mortgage notes receivable - net	639,343	679,795
Real estate properties, total	7,567,303	6,992,304
Other investments	256,846	89,299
Investment in unconsolidated joint venture	48,776
Assets held for sale - net	52,868	6,599
Total investments	7,925,793	7,088,202
Cash and cash equivalents	93,687	5,424
Restricted cash	13,589	14,607
Accounts receivable - net	240,035	203,862
Goodwill	643,474	645,683
Other assets	32,682	32,158
Total assets	8,949,260	7,989,936
LIABILITIES AND EQUITY
Revolving line of credit	190,000	230,000
Term loans - net	1,094,343	745,693
Secured borrowings - net	54,365	235,593
Unsecured borrowings - net	3,028,146	2,328,727
Accrued expenses and other liabilities	360,514	333,706
Deferred income taxes	9,906	15,352
Total liabilities	4,737,274	3,889,071
Equity:
Common stock $.10 par value authorized - 350,000 shares, issued and outstanding - 196,142 shares as of December 31, 2016 and 187,399 as of December 31, 2015	19,614	18,740
Common stock - additional paid-in capital	4,861,408	4,609,474
Cumulative net earnings	1,738,937	1,372,522
Cumulative dividends paid	(2,707,387)	(2,254,038)
Accumulated other comprehensive loss	(53,827)	(8,712)
Total stockholders' equity	3,858,745	3,737,986
Noncontrolling interest	353,241	362,879
Total equity	4,211,986	4,100,865
Total liabilities and equity	$ 8,949,260	$ 7,989,936

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parentheticals) - $ / shares shares in Thousands	Dec. 31, 2016	Dec. 31, 2015
Statement Of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.10	$ 0.10
Common stock, shares authorized	350,000	350,000
Common stock, shares issued	196,142	187,399
Common stock, shares outstanding	196,142	187,399

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Revenue
Rental income									$ 743,885	$ 605,991	$ 388,443
Income from direct financing leases									62,298	59,936	56,719
Mortgage interest income									69,811	68,910	53,007
Other investment income - net									21,852	7,534	6,369
Miscellaneous income									2,981	1,246	249
Total operating revenues	$ 234,486	$ 224,638	$ 228,824	$ 212,879	$ 210,512	$ 201,974	$ 197,711	$ 133,420	900,827	743,617	504,787
Expenses
Depreciation and amortization									267,062	210,703	123,257
General and administrative									45,867	38,568	25,888
Acquisition and merger related costs									9,582	57,525	3,948
Impairment loss on real estate properties									58,726	17,681	3,660
Provisions for uncollectible mortgages, notes and accounts receivable									9,845	7,871	2,723
Total operating expenses									391,082	332,348	159,476
Income before other income and expense									509,745	411,269	345,311
Other income (expense)
Interest income									173	285	44
Interest expense									(164,103)	(147,381)	(119,369)
Interest - amortization of deferred financing costs									(9,345)	(6,990)	(4,459)
Interest - refinancing costs									(2,113)	(28,837)	(3,041)
Realized loss on foreign exchange									(232)	(173)
Total other expense									(175,620)	(183,096)	(126,825)
Income before gain on assets sold									334,125	228,173	218,486
Gain on assets sold - net									50,208	6,353	2,863
Income from continuing operations									384,333	234,526	221,349
Income tax expense									(1,405)	(1,211)
Income from unconsolidated joint venture									439
Net income	129,883	82,134	113,154	58,196	63,543	83,254	43,466	43,052	383,367	233,315	221,349
Net income attributable to noncontrolling interest									(16,952)	(8,791)
Net income available to common stockholders	$ 124,259	$ 78,549	$ 108,052	$ 55,555	$ 60,642	$ 79,402	$ 41,428	$ 43,052	$ 366,415	$ 224,524	$ 221,349
Basic:
Net income available to common stockholders (in dollars per share)	$ 0.63	$ 0.40	$ 0.57	$ 0.30	$ 0.32	$ 0.43	$ 0.23	$ 0.32	$ 1.91	$ 1.30	$ 1.75
Diluted:
Net income (in dollars per share)	$ 0.63	$ 0.40	$ 0.57	$ 0.29	$ 0.32	$ 0.43	$ 0.22	$ 0.32	$ 1.90	$ 1.29	$ 1.74
Weighted-average shares outstanding, basic (in shares)									191,781	172,242	126,550
Weighted-average shares outstanding, diluted (in shares)									201,635	180,508	127,294

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Statement of Comprehensive Income [Abstract]
Net income		$ 383,367	$ 233,315	$ 221,349
Other comprehensive income (loss)
Foreign currency translation		(46,535)	(8,413)
Cash flow hedges		(702)	(718)
Total other comprehensive income (loss)		(47,237)	(9,131)
Comprehensive income		336,130	224,184	221,349
Comprehensive income attributable to noncontrolling interest	[1]	(14,830)	(8,373)
Comprehensive income attributable to common stockholders	[1]	$ 321,300	$ 215,811	$ 221,349
[1]	The 2015 amount has been adjusted to increase the comprehensive income attributable to the noncontrolling interest and decrease the comprehensive income attributable to common stockholders by $8.8 million.

CONSOLIDATED STATEMENTS OF COM6

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parentheticals) $ in Millions	12 Months Ended
	Dec. 31, 2015USD ($)
Statement of Comprehensive Income [Abstract]
Adjustments made in comprehensive income attributable to noncontrolling interest and comprehensive income attributable to common stockholders	$ 8.8

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Thousands	Common Stock Par Value	Additional Paid-in Capital	Cumulative Net Earnings	Cumulative Dividends Paid	Accumulated Other Comprehensive Loss	Total Stockholders' Equity	Noncontrolling Interest	Total
Balance (123,530 common shares, 127,606 common shares, 187,399 shares and 196,142 shares for 2013, 2014, 2015, 2016 respectively and OP Units 8,956 and 8,862 for 2015 and 2016 respectively.) at Dec. 31, 2013	$ 12,353	$ 1,998,169	$ 926,649	$ (1,637,068)		$ 1,300,103		$ 1,300,103
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Grant of restricted stock to company directors ( 12 shares at $35.79, 21 shares at $35.70 per share and 18 shares at $33.09 per share to company directors for 2014, 2015 and 2016 respectively)	1	(1)
Stock-based compensation expense		8,382				8,382		8,382
Vesting of restricted stock, net of tax withholdings (126 shares)	13	(3,590)				(3,577)		(3,577)
Dividend reinvestment plan (2,084 shares at $34.32 per share, 4,184 shares at $36.06 per share and 7,215 shares at $33.27 per share for 2014, 2015, 2016 respectively)	208	71,279				71,487		71,487
Grant of stock as payment of directors fees (6 shares at an average of $35.52 per share, 9 shares at an average of $35.94 per share, 10 shares at an average of $31.27 per share for 2014, 2015, 2016 respectively)	1	199				200		200
Equity Shelf Program (1,848 shares at $34.33 per share, net of issuance costs and 656 shares at $29.97per share, net of issuance costs for 2014 and 2016, respectively)	185	61,796				61,981		61,981
Common dividends declared ($2.02 per share, $2.18 per share and $2.36 per share for 2014, 2015, 2016 respectively)				(258,598)		(258,598)		(258,598)
Net income			221,349			221,349		221,349
Balance (123,530 common shares, 127,606 common shares, 187,399 shares and 196,142 shares for 2013, 2014, 2015, 2016 respectively and OP Units 8,956 and 8,862 for 2015 and 2016 respectively.) at Dec. 31, 2014	12,761	2,136,234	1,147,998	(1,895,666)		1,401,327		1,401,327
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Grant of restricted stock to company directors ( 12 shares at $35.79, 21 shares at $35.70 per share and 18 shares at $33.09 per share to company directors for 2014, 2015 and 2016 respectively)	2	(2)
Stock-based compensation expense		11,133				11,133		11,133
Vesting/exercising of equity compensation, net of tax withholdings (941 shares and 773 shares for 2015 and 2016 respectively)	94	(26,800)				(26,706)		(26,706)
Dividend reinvestment plan (2,084 shares at $34.32 per share, 4,184 shares at $36.06 per share and 7,215 shares at $33.27 per share for 2014, 2015, 2016 respectively)	418	150,429				150,847		150,847
Value of assumed options in Aviv Merger		109,346				109,346		109,346
Value of assumed other equity compensation plan in Aviv Merger		12,644				12,644		12,644
Grant of stock as payment of directors fees (6 shares at an average of $35.52 per share, 9 shares at an average of $35.94 per share, 10 shares at an average of $31.27 per share for 2014, 2015, 2016 respectively)	1	312				313		313
Deferred compensation directors		1,444				1,444		1,444
Issuance of common stock (10,925 shares at an average of $40.32 per share)	1,093	438,229				439,322		439,322
Issuance of common stock - Aviv Merger - related (43,713 shares)	4,371	1,776,505				1,780,876		1,780,876
Common dividends declared ($2.02 per share, $2.18 per share and $2.36 per share for 2014, 2015, 2016 respectively)				(358,372)		(358,372)		(358,372)
OP units issuance (9,165 units)							373,394	373,394
Conversion of OP units (209 units)							(7,251)	(7,251)
OP units distributions							(11,636)	(11,636)
Foreign currency translation					(8,027)	(8,027)	(386)	(8,413)
Cash flow hedges					(685)	(685)	(33)	(718)
Net income			224,524			224,524	8,791	233,315
Balance (123,530 common shares, 127,606 common shares, 187,399 shares and 196,142 shares for 2013, 2014, 2015, 2016 respectively and OP Units 8,956 and 8,862 for 2015 and 2016 respectively.) at Dec. 31, 2015	18,740	4,609,474	1,372,522	(2,254,038)	(8,712)	3,737,986	362,879	4,100,865
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Grant of restricted stock to company directors ( 12 shares at $35.79, 21 shares at $35.70 per share and 18 shares at $33.09 per share to company directors for 2014, 2015 and 2016 respectively)	2	(2)
Stock-based compensation expense		13,790				13,790		13,790
Vesting/exercising of equity compensation, net of tax withholdings (941 shares and 773 shares for 2015 and 2016 respectively)	77	(23,503)				(23,426)		(23,426)
Dividend reinvestment plan (2,084 shares at $34.32 per share, 4,184 shares at $36.06 per share and 7,215 shares at $33.27 per share for 2014, 2015, 2016 respectively)	721	239,320				240,041		240,041
Grant of stock as payment of directors fees (6 shares at an average of $35.52 per share, 9 shares at an average of $35.94 per share, 10 shares at an average of $31.27 per share for 2014, 2015, 2016 respectively)	1	324				325		325
Deferred compensation directors		(129)				(129)		(129)
Equity Shelf Program (1,848 shares at $34.33 per share, net of issuance costs and 656 shares at $29.97per share, net of issuance costs for 2014 and 2016, respectively)	66	19,585				19,651		19,651
Common dividends declared ($2.02 per share, $2.18 per share and $2.36 per share for 2014, 2015, 2016 respectively)				(453,349)		(453,349)		(453,349)
Conversion of OP units to common stock (72shares at $35.68 per share)	7	2,559				2,566		2,566
Redemption of OP units (94 units)		(10)				(10)	(3,289)	(3,299)
OP units distributions							(21,179)	(21,179)
Foreign currency translation					(44,468)	(44,468)	(2,067)	(46,535)
Cash flow hedges					(647)	(647)	(55)	(702)
Net income			366,415			366,415	16,952	383,367
Balance (123,530 common shares, 127,606 common shares, 187,399 shares and 196,142 shares for 2013, 2014, 2015, 2016 respectively and OP Units 8,956 and 8,862 for 2015 and 2016 respectively.) at Dec. 31, 2016	$ 19,614	$ 4,861,408	$ 1,738,937	$ (2,707,387)	$ (53,827)	$ 3,858,745	$ 353,241	$ 4,211,986

CONSOLIDATED STATEMENTS OF CHA8

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parentheticals) - $ / shares shares in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Increase (Decrease) In Stockholders' Equity [Roll Forward]
Balance (in shares)	187,399	127,606	123,530
Grant of restricted stock (in shares)	18	21	12
Grant of restricted stock (in dollars per share)	$ 33.09	$ 35.70	$ 35.79
Payments for exercising restricted stock to company executives, net of tax withholdings (in shares)			126
Payments for exercising equity compensation, net of tax withholdings	773	941
Dividend reinvestment plan (in shares)	7,215	4,184	2,084
Dividend reinvestment plan (in dollars per share)	$ 33.27	$ 36.06	$ 34.32
Grant of stock as payment of directors fees (in shares)	10	9	6
Grant of stock as payment of directors fees (in dollars per share)	$ 31.27	$ 35.94	$ 35.52
Equity shelf program (in shares)	656		1,848
Equity Shelf Program, (in dollars per share)	$ 29.97		$ 34.33
Issuance of common stock (in shares)		10,925
Issuance of common stock, (in dollars per share)		$ 40.32
Issuance of common stock - Aviv Merger - related (in shares)		43,713
OP units issuance		9,165
Cash conversion of OP units		209
Conversion of OP Units to Common stock (in shares)	72
Conversion of OP Units to Common stock (in dollars per share)	$ 35.68
Redemption of OP units (in shares)	94
Common dividends (in dollars per share)	$ 2.36	$ 2.18	$ 2.02
Balance (in shares)	196,142	187,399	127,606
Balance (in units)	8,862	8,956

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities
Net income	$ 383,367	$ 233,315	$ 221,349
Adjustment to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	267,062	210,703	123,257
Impairment loss on real estate properties	58,726	17,681	3,660
Provision for uncollectible mortgages, notes and accounts receivable	9,845	7,871	2,723
Refinancing costs and amortization of deferred financing costs	11,458	35,827	7,500
Accretion of direct financing leases	(12,157)	(11,007)	(9,787)
Stock-based compensation expense	13,790	11,133	8,592
Gain on assets sold - net	(50,208)	(6,353)	(2,863)
Amortization of acquired in-place leases - net	(13,991)	(13,846)	(4,986)
Change in operating assets and liabilities - net of amounts assumed/acquired:
Accounts receivable, net	(4,876)	248	(2,264)
Straight-line rent receivables	(42,091)	(36,057)	(20,956)
Lease inducements	2,589	994	2,656
Effective yield receivable on mortgage notes	(721)	(4,065)	(2,878)
Other operating assets and liabilities	2,998	17,441	11,537
Net cash provided by operating activities	625,791	463,885	337,540
Cash flows from investing activities
Acquisition of real estate - net of liabilities assumed and escrows acquired	(959,748)	(294,182)	(131,689)
Cash acquired in merger		84,858
Investments in construction in progress	(68,983)	(164,226)
Investments in direct financing leases	(2,080)	(6,793)
Placement of mortgage loans	(48,722)	(14,042)	(529,548)
Investments in unconsolidated joint venture	(50,032)
Distributions from unconsolidated joint venture	1,318
Proceeds from sale of real estate investments	169,603	41,543	4,077
Capital improvements to real estate investments	(40,471)	(26,397)	(17,917)
Proceeds from other investments	96,789	45,871	13,589
Investments in other investments	(271,557)	(65,402)	(9,441)
Collection of mortgage principal	59,975	1,359	122,984
Net cash used in investing activities	(1,113,908)	(397,411)	(547,945)
Cash flows from financing activities
Proceeds from credit facility borrowings	1,304,000	1,826,000	900,000
Payments on credit facility borrowings	(1,344,000)	(1,681,000)	(1,141,000)
Receipts of other long-term borrowings	1,048,173	1,838,124	842,148
Payments of other long-term borrowings	(181,249)	(2,187,314)	(242,544)
Payments of financing related costs	(11,830)	(54,721)	(17,716)
Receipts from dividend reinvestment plan	240,041	150,847	71,487
Payments for exercised options and restricted stock	(23,426)	(26,706)	(3,577)
Net proceeds from issuance of common stock	19,651	439,322	61,981
Dividends paid	(453,152)	(358,232)	(258,501)
Redemption of OP Units	(733)
Distributions to OP Unit Holders	(21,179)	(11,636)
Net cash provided by (used in) financing activities	576,296	(65,316)	212,278
Effect of foreign currency translation on cash and cash equivalents	84	(223)
Increase in cash and cash equivalents	88,263	935	1,873
Cash and cash equivalents at beginning of year	5,424	4,489	2,616
Cash and cash equivalents at end of year	93,687	5,424	4,489
Interest paid during the year, net of amounts capitalized	148,326	145,929	$ 110,919
Taxes paid during the year	4,922	1,016
Non- cash investing activities
Non-cash acquisition of businesses (see Note 3 and Note 5 for details)	(60,079)	(3,602,040)
Non-cash surrender of mortgage (see Note 5 for details)	25,000
Non-cash surrender of other investment (see Note 3 for details)	5,500
Total	(29,579)	(3,602,040)
Non-cash financing activities
Assumed Aviv debt		1,410,637
Stock exchanged in merger		1,902,866
OP Units exchanged in merger		373,394
Purchase option buyout obligation (see Note 3 for details)	29,579
Change in fair value of cash flow hedges	764	718
Other unsecured long term borrowing (see Note 3 and Note 12 for details)	3,000
Total	$ 33,343	$ 3,687,615

ORGANIZATION AND BASIS OF PRESE

ORGANIZATION AND BASIS OF PRESENTATION	12 Months Ended
	Dec. 31, 2016
Organization, Consolidation and Presentation Of Financial Statements [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	NOTE 1 - ORGANIZATION AND BASIS OF PRESENTATION Organization Omega Healthcare Investors, Inc. (“Omega,” “we,” “our” or the “Company”) has one reportable segment consisting of investments in healthcare-related real estate properties located in the United States (“U.S.”) and the United Kingdom (“U.K.”). Our core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (“SNFs”). Our core portfolio consists of long-term leases and mortgage agreements. All of our leases are “triple-net” leases, which require the tenants to pay all property-related expenses. Our mortgage revenue derives from fixed rate mortgage loans, which are secured by first mortgage liens on the underlying real estate and personal property of the mortgagor. Omega was formed as a real estate investment trust (“REIT”) and incorporated in the State of Maryland on March 31, 1992. In April 2015, Aviv REIT, Inc., a Maryland corporation (“Aviv”), merged (the “Aviv Merger”) with and into a wholly-owned subsidiary of Omega, pursuant to the terms of that certain Agreement and Plan of Merger, dated as of October 30, 2014 (the “Merger Agreement”), by and among the Company, Aviv, OHI Healthcare Properties Holdco, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Omega (“Merger Sub”), OHI Healthcare Properties Limited Partnership, a Delaware limited partnership (“Omega OP”), and Aviv Healthcare Properties Limited Partnership, a Delaware limited partnership (the “Aviv OP”). Prior to April 1, 2015 and in accordance with the Merger Agreement, Omega restructured the manner in which it holds its assets by converting to an umbrella partnership real estate investment trust structure (the “UPREIT Conversion”). As a result of the UPREIT Conversion and following the consummation of the Aviv Merger, substantially all of the Company’s assets are held by Omega OP. Omega OP is governed by the Second Amended and Restated Agreement of Limited Partnership of OHI Healthcare Properties Limited Partnership, dated as of April 1, 2015 (the “Partnership Agreement”). Pursuant to the Partnership Agreement, the Company and Merger Sub are the general partners of Omega OP, and have exclusive control over Omega OP’s day-to-day management. As of December 31, 2016, the Company owned approximately 96% of the issued and outstanding units of partnership interest in Omega OP (“Omega OP Units”), and other investors owned approximately 4% of the Omega OP Units. Consolidation Our consolidated financial statements include the accounts of (i) Omega, (ii) Omega OP and (iii) all direct and indirect wholly-owned subsidiaries of Omega. All inter-company transactions and balances have been eliminated in consolidation, and our net earnings are reduced by the portion of net earnings attributable to noncontrolling interests.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Accounting Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Fair Value Measurement The Company measures and discloses the fair value of nonfinancial and financial assets and liabilities utilizing a hierarchy of valuation techniques based on whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy: · Level 1 - quoted prices for identical instruments in active markets; · Level 2 - quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and · Level 3 - fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The Company measures fair value using a set of standardized procedures that are outlined herein for all assets and liabilities which are required to be measured at fair value. When available, the Company utilizes quoted market prices from an independent third party source to determine fair value and classifies such items in Level 1. In some instances where a market price is available, but the instrument is in an inactive or over-the-counter market, the Company consistently applies the dealer (market maker) pricing estimate and classifies such items in Level 2. If quoted market prices or inputs are not available, fair value measurements are based upon valuation models that utilize current market or independently sourced market inputs, such as interest rates, option volatilities, credit spreads and/or market capitalization rates. Items valued using such internally-generated valuation techniques are classified according to the lowest level input that is significant to the fair value measurement. As a result, these items could be classified in either Level 2 or Level 3 even though there may be some significant inputs that are readily observable. Internal fair value models and techniques used by the Company include discounted cash flow and Monte Carlo valuation models. Risks and Uncertainties Our Company is subject to certain risks and uncertainties affecting the healthcare industry as a result of healthcare legislation and growing regulation by federal, state and local governments. Additionally, we are subject to risks and uncertainties as a result of changes affecting operators of nursing home facilities due to the actions of governmental agencies and insurers to limit the rising cost of healthcare services (see Note 10 – Concentration of Risk). Business Combinations We record the purchase of properties to net tangible and identified intangible assets acquired and liabilities assumed at fair value. Transaction costs are expensed as incurred as part of a business combination. In making estimates of fair value for purposes of recording the purchase, we utilize a number of sources, including independent appraisals that may be obtained in connection with the acquisition or financing of the respective property and other market data. We also consider information obtained about each property as a result of our pre-acquisition due diligence, marketing and leasing activities as well as other critical valuation metrics such as current capitalization rates and discount rates used to estimate the fair value of the tangible and intangible assets acquired (Level 3). When liabilities are assumed as part of a transaction, we consider information obtained about the liabilities and use similar valuation metrics (Level 3). In some instances when debt is assumed and an identifiable active market for similar debt is present, we use market interest rates for similar debt to estimate the fair value of the debt assumed (Level 2). The Company determines fair value as follows: · Land is determined based on third party appraisals which typically include market comparables. · Buildings and site improvements acquired are valued using a combination of discounted cash flow projections that assume certain future revenues and costs and consider capitalization and discount rates using current market conditions as well as replacement cost analysis. · Furniture and fixtures are determined based on third party appraisals which typically utilize a replacement cost approach. · Intangible assets and liabilities acquired are valued using a combination of discounted cash flow projections as well as other valuation techniques based on current market conditions for the intangible asset or liability being acquired. When evaluating below market leases we consider extension options controlled by the lessee in our evaluation. For additional information regarding above and below market leases assumed as part of an acquisition see “In-Place Leases" below. · Other assets acquired and liabilities assumed are typically valued at stated amounts, which approximate fair value on the date of the acquisition. · Assumed debt balances are valued by discounting the remaining contractual cash flows using a current market rate of interest. · Stock based compensation and noncontrolling interests are valued using a stock price on the acquisition date. · Goodwill represents the purchase price in excess of the fair value of assets acquired and liabilities assumed and the cost associated with expanding our investment portfolio. Goodwill is not amortized. Asset Acquisitions For acquisitions not accounted for as a business combination, assets and liabilities are recognized based on their cost to the Company which generally includes transaction costs. The costs of the acquisition are allocated to the assets and liabilities acquired on a relative fair value basis. Real Estate Investments and Depreciation The costs of significant improvements, renovations and replacements, including interest are capitalized. In addition, we capitalize leasehold improvements when certain criteria are met, including when we supervise construction and will own the improvement. Expenditures for maintenance and repairs are charged to operations as they are incurred. Depreciation is computed on a straight-line basis over the estimated useful lives ranging from 20 to 40 years for buildings, eight to 15 years for site improvements, and three to ten years for furniture, fixtures and equipment. Leasehold interests are amortized over the shorter of the estimated useful life or term of the lease. As of December 31, 2016 and 2015, we had identified conditional asset retirement obligations primarily related to the future removal and disposal of asbestos that is contained within certain of our real estate investment properties. The asbestos is appropriately contained, and we believe we are compliant with current environmental regulations. If these properties undergo major renovations or are demolished, certain environmental regulations are in place, which specify the manner in which asbestos must be handled and disposed. We are required to record the fair value of these conditional liabilities if they can be reasonably estimated. As of December 31, 2016 and 2015, sufficient information was not available to estimate our liability for conditional asset retirement obligations as the obligations to remove the asbestos from these properties have indeterminable settlement dates. As such, no liability for conditional asset retirement obligations was recorded on our accompanying Consolidated Balance Sheets as of December 31, 2016 and 2015. Lease Accounting At the inception of the lease and during the amendment process, we evaluate each lease to determine if the lease should be considered an operating lease, sales-type lease, or direct financing lease. We have determined that all but seven of our leases should be accounted for as operating leases. The other seven leases are accounted for as direct financing leases. For leases accounted for as operating leases, we retain ownership of the asset and record depreciation expense, see “Business Combinations” and “Real Estate Investments and Depreciation” above for additional information regarding our investment in real estate leased under operating lease agreements. We also record lease revenue based on the contractual terms of the operating lease agreement which often includes annual rent escalators, see “Revenue Recognition” below for further discussion regarding the recordation of revenue on our operating leases. For leases accounted for as , we record the present value of the future minimum lease payments (utilizing a constant interest rate over the term of the lease agreement) as a receivable and record In-Place Leases In-place lease assets and liabilities result when we assume a lease as part of a facility purchase or business combination. The fair value of in-place leases consists of the following components, as applicable (1) the estimated cost to replace the leases, and (2) the above or below market cash flow of the leases, determined by comparing the projected cash flows of the leases in place at the time of acquisition to projected cash flows of comparable market-rate leases (referred to as Lease Intangibles). Lease Intangible assets and liabilities are classified as lease contracts above and below market value, respectively, in other assets and accrued expenses and other liabilities on our Consolidated Balance Sheets, and amortized on a straight-line basis as decreases and increases, respectively, to rental income over the estimated remaining term of the underlying leases. Should a tenant terminate the lease, the unamortized portion of the lease intangible is recognized immediately as income or expense. For additional information, see Note 9 – Intangibles. Asset Impairment Management evaluates our real estate investments for impairment indicators at each reporting period, including the evaluation of our assets’ useful lives. The judgment regarding the existence of impairment indicators is based on factors such as, but not limited to, market conditions, operator performance, legal structure, as well as our intent with respect to holding or disposing of the asset. If indicators of impairment are present, management evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows based on our intended use of the property are determined to be less than the carrying values of the assets. An adjustment is made to the net carrying value of the real estate investments for the excess of carrying value over fair value. The fair value of the real estate investment is determined by market research, which includes valuing the property as a nursing home as well as other alternative uses. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset. Management’s impairment evaluation process, and when applicable, impairment calculations involve estimation of the future cash flows from management’s intended use of the property. Changes in the facts and circumstances that drive management’s assumptions may result in an impairment of the Company’s assets in a future period that could be material to the Company’s results of operations. If we decide to sell real estate properties or land holdings, we evaluate the recoverability of the carrying amounts of the assets. If the evaluation indicates that the carrying value is not recoverable from estimated net sales proceeds, the property is written down to estimated fair value less costs to sell. Our estimates of cash flows and fair values of the properties are based on current market conditions and consider matters such as rental rates and occupancies for comparable properties, recent sales data for comparable properties, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers. For the years ended December 31, 2016, 2015 and 2014, we recognized impairment losses of $58.7 million, $17.7 million and $3.7 million, respectively. For additional information, see Note 3 – Properties and Note 8 – Assets Held For Sale. Loan and Direct Financing Lease Impairment Management evaluates our outstanding mortgage notes, direct financing leases and other notes receivable for impairment. When management identifies potential loan or direct financing lease impairment indicators, such as non-payment under the loan documents, impairment of the underlying collateral, financial difficulty of the operator or other circumstances that may impair full execution of the loan documents or direct financing leases, and management believes it is probable that all amounts will not be collected under the contractual terms of the loan or direct financing lease, the loan or direct financing lease is written down to the present value of the expected future cash flows. In cases where expected future cash flows are not readily determinable, the loan or direct financing lease is written down to the fair value of the collateral. The fair value of the loan or direct financing lease is determined by market research, which includes valuing the property as a nursing home as well as other alternative uses. We account for impaired loans and direct financing leases using (a) the cost-recovery method, and/or (b) the cash basis method. We generally utilize the cost-recovery method for impaired loans or direct financing leases for which impairment reserves were recorded. We utilize the cash basis method for impaired loans or direct financing leases for which no impairment reserves were recorded because the net present value of the discounted cash flows expected under the loan or direct financing lease and/or the underlying collateral supporting the loan or direct financing lease were equal to or exceeded the book value of the loans or direct financing leases. Under the cost-recovery method, we apply cash received against the outstanding loan balance or direct financing lease prior to recording interest income. Under the cash basis method, we apply cash received to principal or interest income based on the terms of the agreement. As of December 31, 2016 and 2015, we had $8.7 million and $3.0 million, respectively, of reserves on our mortgages and other investments and no reserves on our direct financing leases. For additional information, see Note 4 – Direct Financing Leases, Note 5 – Mortgage Notes Receivable and Note 6 – Other Investments. Investment in Unconsolidated Joint Venture We account for our investment in an unconsolidated joint venture using the equity method of accounting as we exercise significant influence, but do not control the entity. Under the equity method of accounting, the net equity investment of the Company is reflected in the accompanying Consolidated Balance Sheets and the Company's share of net income and comprehensive income from the joint venture is included in the accompanying Consolidated Statements of Operations and Consolidated Statements of Comprehensive Income, respectively. On a periodic basis, management assesses whether there are any indicators that the value of the Company's investment in the unconsolidated joint venture may be other-than-temporarily-impaired. An investment is impaired only if management's estimate of the value of the investment is less than the carrying value of the investment, and such a decline in value is deemed to be other than-temporary. To the extent impairment has occurred, the loss is measured as the excess of the carrying amount of the investment over the estimated fair value of the investment. The estimated fair value of the investment is determined using a discounted cash flow model which is a Level 3 valuation. We consider a number of assumptions that are subject to economic and market uncertainties including, among others, rental rates, operating costs, capitalization rates, holding periods and discount rates. No impairment loss on our investment in unconsolidated joint venture was recognized during the year ended December 31, 2016. Assets Held for Sale We consider properties to be assets held for sale when (1) management commits to a plan to sell the property; (2) it is unlikely that the disposal plan will be significantly modified or discontinued; (3) the property is available for immediate sale in its present condition; (4) actions required to complete the sale of the property have been initiated; (5) sale of the property is probable and we expect the completed sale will occur within one year; and (6) the property is actively being marketed for sale at a price that is reasonable given our estimate of current market value. Upon designation of a property as an asset held for sale, we record the property's value at the lower of its carrying value or its estimated fair value, less estimated costs to sell, and we cease depreciation. For additional information, see Note 8 – Assets Held for Sale. Cash and Cash Equivalents Cash and cash equivalents consist of cash on hand and highly liquid investments with a maturity date of three months or less when purchased. These investments are stated at cost, which approximates fair value. The majority of our cash and cash equivalents are held at major commercial banks. Restricted Cash Restricted cash consists primarily of funds escrowed for tenants’ security deposits required by us pursuant to certain contractual terms (see Note 11 – Lease and Mortgage Deposits). Accounts Receivable Accounts receivable includes: contractual receivables, effective yield interest receivables, straight-line rent receivables and lease inducements, net of an estimated provision for losses related to uncollectible and disputed accounts. Contractual receivables relate to the amounts currently owed to us under the terms of our lease and loan agreements. Effective yield interest receivables relate to the difference between the interest income recognized on an effective yield basis over the term of the loan agreement and the interest currently due to us according to the contractual agreement. Straight-line rent receivables relate to the difference between the rental revenue recognized on a straight-line basis and the amounts currently due to us according to the contractual agreement. Lease inducements result from value provided by us to the lessee, at the inception or renewal of the lease, and are amortized as a reduction of rental revenue over the non-cancellable lease term. On a quarterly basis, we review our accounts receivable to determine their collectability. The determination of collectability of these assets requires significant judgment and is affected by several factors relating to the credit quality of our operators that we regularly monitor, including (i) payment history, (ii) the age of the contractual receivables, (iii) the current economic conditions and reimbursement environment, (iv) the ability of the tenant to perform under the terms of their lease and/or contractual loan agreements and (v) the value of the underlying collateral of the agreement. If we determine collectability of any of our contractual receivables is at risk, we estimate the potential uncollectible amounts and provide an allowance. In the case of a lease recognized on a straight-line basis, a mortgage recognized on an effective yield basis or the existence of lease inducements, we generally provide an allowance for straight-line, effective interest, and or lease inducement accounts receivable when certain conditions or indicators of adverse collectability are present. If the accounts receivable balance is subsequently deemed uncollectible, the receivable and allowance for doubtful account balance are written off. A summary of our net receivables by type is as follows: December 31, 2016 2015 (in thousands) Contractual receivables $ 13,376 $ 8,452 Effective yield interest receivables 9,749 9,028 Straight-line rent receivables 208,874 175,709 Lease inducements 8,393 10,982 Allowance (357 ) (309 ) Accounts receivable – net $ 240,035 $ 203,862 In 2016, we wrote-off approximately $4.3 million of straight-line rent receivable. The write-off primarily related to the transition of facilities from a former operator to a current operator. In 2015, we wrote-off $3.2 million of straight-line rent receivables and $1.5 million of effective yield interest receivables associated with four facilities that were transitioned to a new operator and three mortgages that were repaid prior to their maturity. This transaction closed in 2016. In 2014, we wrote-off $0.8 million of straight-line rent receivables associated with a lease amendment to an existing operator for two facilities that were transitioned to a new operator and $2.0 million of effective yield interest receivables associated with the termination of a mortgage note that was due November 2021. Goodwill Impairment We assess goodwill for potential impairment during the fourth quarter of each fiscal year, or during the year if an event or other circumstance indicates that we may not be able to recover the carrying amount of the net assets of the reporting unit. In evaluating goodwill for impairment on an interim basis, we assess qualitative factors such as a current macroeconomic conditions, state of the equity and capital markets and our overall financial and operating performance In the first step of the two-step goodwill impairment test (“Step 1”), we compare the fair value of the reporting unit to its net book value, including goodwill. As the Company has only one reporting unit, the fair value of the reporting unit is determined by reference to the market capitalization of the Company as determined through quoted market prices and adjusted for other relevant factors. A potential impairment exists if the fair value of the reporting unit is lower than its net book value. The second step (“Step 2”) of the process is only performed if a potential impairment exists, and it involves determining the difference between the fair value of the reporting unit's net assets other than goodwill and the fair value of the reporting unit. If the difference is less than the net book value of goodwill, impairment exists and is recorded. The Company has not been required to perform Step 2 of the process because the fair value of the reporting unit has significantly exceeded its book value at the measurement date. There was no impairment of goodwill during 2016 and 2015. Income Taxes We were organized to qualify for taxation as a REIT under Section 856 through 860 of the Internal Revenue Code (“Code”). As long as we qualify as a REIT; we will not be subject to federal income taxes on the REIT taxable income that we distributed to stockholders, subject to certain exceptions. However, with respect to certain of our subsidiaries that have elected to be treated as taxable REIT subsidiaries (“TRSs”), we record income tax expense or benefit, as those entities are subject to federal income tax similar to regular corporations. We account for deferred income taxes using the asset and liability method and recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in our financial statements or tax returns. Under this method, we determine deferred tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in the deferred tax liability that results from a change in circumstances, and that causes us to change our judgment about expected future tax consequences of events, is included in the tax provision when such changes occur. Deferred income taxes also reflect the impact of operating loss and tax credit carryforwards. A valuation allowance is provided if we believe it is more likely than not that all or some portion of the deferred tax asset will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes us to change our judgment about the realizability of the related deferred tax asset, is included in the tax provision when such changes occur. For additional information on income taxes, see Note 14 – Taxes. Revenue Recognition We have various different investments that generate revenue, including leased and mortgaged properties, as well as other investments, including working capital loans. We recognize rental income and other investment income as earned over the terms of the related leases and notes, respectively. Interest income is recorded on an accrual basis to the extent that such amounts are expected to be collected using the effective interest method. In applying the effective interest method, the effective yield on a loan is determined based on its contractual payment terms, adjusted for prepayment terms. Substantially all of our operating leases contain provisions for specified annual increases over the rents of the prior year and are generally computed in one of three methods depending on specific provisions of each lease as follows: (i) a specific annual increase over the prior year’s rent, generally between 2.0% and 3.0%; (ii) an increase based on the change in pre-determined formulas from year to year (e.g. increases in the Consumer Price Index); or (iii) specific dollar increases over prior years. Revenue under lease arrangements with minimum fixed and determinable increases is recognized over the non-cancellable term of the lease on a straight-line basis. The authoritative guidance does not provide for the recognition of contingent revenue until all possible contingencies have been eliminated. We consider the operating history of the lessee, the payment history, the general condition of the industry and various other factors when evaluating whether all possible contingencies have been eliminated. We do not recognize contingent rents as income until the contingencies have been resolved. In the case of rental revenue recognized on a straight-line basis, we generally record reserves against earned revenues from leases when collection becomes questionable or when negotiations for restructurings of troubled operators result in significant uncertainty regarding ultimate collection. The amount of the reserve is estimated based on what management believes will likely be collected. We continually evaluate the collectability of our straight-line rent assets. If it appears that we will not collect future rent due under our leases, we will record a provision for loss related to the straight-line rent asset. We record direct financing lease income on a constant interest rate basis over the term of the lease. The costs related to originating the direct financing leases have been deferred and are being amortized on a straight-line basis as a reduction to income from direct financing leases over the term of the direct financing leases. Mortgage interest income is recognized as earned over the terms of the related mortgage notes, using the effective yield method. Allowances are provided against earned revenues from mortgage interest when collection of amounts due becomes questionable or when negotiations for restructurings of troubled operators lead to lower expectations regarding ultimate collection. When collection is uncertain, mortgage interest income on impaired mortgage loans is recognized as received after taking into account the application of security deposits. Gains on sales of real estate assets are recognized in accordance with the authoritative guidance for sales of real estate. The specific timing of the recognition of the sale and the related gain is measured against the various criteria in the guidance related to the terms of the transactions and any continuing involvement associated with the assets sold. To the extent the sales criteria are not met, we defer gain recognition until the sales criteria are met. Stock-Based Compensation We recognize stock-based compensation expense adjusted for estimated forfeitures to employees and directors, in general and administrative in our Consolidated Statements of Operations on a straight-line basis over the requisite service period of the awards, see Note 17 – Stock-Based Compensation for additional details. Deferred Financing Costs and Original Issuance Premium and/or Discounts for Debt Issuance In April 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2015-03, Simplifying the Presentation of Debt Issuance Costs Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements External costs incurred from the placement of our debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings which approximates the effective interest method. Deferred financing costs related to our revolving line of credit are included in other assets on our Consolidated Balance Sheets and deferred financing costs related to our other borrowings are included as a direct deduction from the carrying amount of the related debt liability on our Consolidated Balance Sheets. Original issuance premium or discounts reflect the difference between the face amount of the debt issued and the cash proceeds received and are amortized on a straight-line basis over the term of the related borrowings. All premiums and discounts are recorded as an addition to or reduction from debt on our Consolidated Balance Sheets. Amortization of deferred financing costs and original issuance premiums or discounts totaled $9.3 million, $7.0 million and $4.5 million in 2016, 2015 and 2014, respectively, and are classified as interest - amortization of deferred financing costs on our Consolidated Statements of Operations. When financings are terminated, unamortized deferred financing costs and unamortized premiums or discounts, as well as charges incurred for the termination, are recognized as expense or income at the time the termination is made. Gains and losses from the extinguishment of debt are presented in interest-refinancing costs on our Consolidated Statements of Operations. Earnings Per Share Basic earnings per common share (“EPS”) is computed by dividing net income available to common stockholders by the weighted-average number of shares of common stock outstanding during the year. Diluted EPS is computed using the treasury stock method, which is net income divided by the total weighted-average number of common outstanding shares plus the effect of dilutive common equivalent shares during the respective period. Dilutive common shares reflect the assumed issuance of additional common shares pursuant to certain of our share-based compensation plans, including stock options, restricted stock and performance restricted stock units and the assumed issuance of additional shares related to Omega OP Units held by outside investors. All outstanding unvested share-based payment awards that contain rights to non-forfeitable dividends or dividend equivalents that participate in undistributed earnings with common stockholders are considered participating securities that shall be included in the two-class method of computing basic EPS. The impact of the two class method is immaterial. For additional information, see Note 21 – Earnings Per Share. Redeemable Limited Partnership Unitholder Interests and Noncontrolling Interests As of April 1, 2015 and after giving effect to the Aviv Merger, the Company owned approximately 138.8 million Omega OP Units and Aviv OP owned approximately 52.9 million Omega OP Units. Each of the Omega OP Units (other than the Omega OP Units owned by Omega) is redeemable at the election of the Omega OP Unit holder for cash equal to the then-fair market value of one share of Omega co

PROPERTIES

PROPERTIES	12 Months Ended
	Dec. 31, 2016
Real Estate [Abstract]
PROPERTIES	NOTE 3 - PROPERTIES Leased Property Our leased real estate properties, represented by 809 SNFs, 101 assisted living facilities (“ALFs”), 16 specialty facilities and one medical office building at December 31, 2016, are leased under provisions of single leases and master leases with initial terms typically ranging from 5 to 15 years, plus renewal options. Substantially all of the single leases and master leases provide for minimum annual rentals that are typically subject to annual increases. Under the terms of the leases, the lessee is responsible for all maintenance, repairs, taxes and insurance on the leased properties. A summary of our investment in leased real estate properties is as follows: December 31, 2016 2015 (in thousands) Buildings $ 5,954,771 $ 5,320,482 Land 759,295 670,916 Furniture, fixtures and equipment 454,760 426,040 Site improvements 206,206 132,182 Construction in progress 191,326 194,338 Total real estate investments 7,566,358 6,743,958 Less accumulated depreciation (1,240,336 ) (1,019,150 ) Real estate investments - net $ 6,326,022 $ 5,724,808 For the years ended December 31, 2016 and 2015, we capitalized $6.6 million and $3.7 million, respectively of interest to our projects under development. The future minimum estimated contractual rents due for the remainder of the initial terms of the leases are as follows at December 31, 2016: (in thousands) 2017 $ 718,999 2018 711,714 2019 689,641 2020 701,543 2021 705,418 Thereafter 3,732,920 Total $ 7,260,235 The following tables summarize the significant transactions that occurred between 2016 and 2014. The 2015 table excludes the acquisition of Care Homes in the U.K. and the Aviv Merger in the second quarter of 2015, which are discussed separately below. 2016 Acquisitions and Other Number of Country/ Total Land Building & Site Improvements Furniture Initial Period SNF ALF State Investment (in millions) Yield (%) Q1 - 1 UK $ 8.3 $ 1.4 $ 6.7 $ 0.2 7.00 Q1 - 1 UK 6.1 0.6 5.3 0.2 7.00 Q1 10 - OH, VA, MI 169.0 (3) 10.5 152.5 6.0 8.50 Q1 - 2 GA 20.2 0.8 18.3 1.1 7.50 Q1 3 - MD 25.0 2.5 19.9 2.6 8.50 Q1 21 - VA, NC 212.5 19.3 181.1 12.1 8.50 Q2 - 10 UK 111.9 (4) 24.8 83.9 3.2 7.00 Q2 - 3 TX 66.0 (5) 5.8 58.6 1.6 6.80 Q2 3 - CO, MO 31.8 3.1 26.2 2.5 9.00 Q3 - 1 FL 4.3 2.3 1.8 0.2 8.00 Q3 - 1 GA 2.5 0.2 2.1 0.2 8.00 Q3 - 1 FL 16.5 1.8 14.3 0.4 8.00 Q3 1 - SC 10.1 2.7 6.5 0.9 9.00 Q3 1 - OH 9.0 (6) - 8.6 0.4 9.00 Q3 31 - FL, KY,TN 329.6 (1)(2) 24.6 290.8 14.2 9.00 Total 70 20 $ 1,022.8 $ 100.4 $ 876.6 $ 45.8 (1) The Company estimated the fair value of the assets acquired on the acquisition date based on certain valuation analyses that have yet to be finalized, and accordingly, the assets acquired, as detailed, are subject to adjustment once the analysis is completed. (2) The Company’s investment includes a purchase option buyout obligation with a fair value of approximately $29.6 million. The future buyout obligation is recorded in accrued expenses and other liabilities on our Consolidated Balance Sheet. The Company also acquired a term loan with a fair value of approximately $37.0 million which is recorded in other investments on our Consolidated Balance Sheet. Refer to Note – 6 Other Investments. (3) Acquired from a related party. Refer to Note – 2 Summary of Significant Accounting Policies - Related Party Transactions. (4) Omega also recorded a deferred tax asset of approximately $1.9 million in connection with the acquisition. (5) The Company paid $63.0 million in cash at closing to acquire the facilities. We have agreed to pay an additional $1.5 million in April 2017 and the remaining $1.5 million in April 2018. The additional consideration to be paid is contractually determined and not contingent on other factors. The $3.0 million liability is recorded in unsecured borrowings – net on our Consolidated Balance Sheet. (6) The Company paid approximately $3.5 million in cash to acquire the facility. The remainder of the purchase price (approximately $5.5 million) was funded with the redemption of an other investment note. During 2016, the Company also acquired five parcels of land which are not reflected in the table above for approximately $8.3 million with the intent of building new facilities for existing operators. For the year ended December 31, 2016, we recognized rental revenue of approximately $58.1 million and expensed approximately $9.6 million of acquisition related costs in connection with the aforementioned acquisitions. No goodwill was recorded in connection with these acquisitions. 2015 Acquisitions and Other Number of Total Land Building & Site Improvements Furniture Initial Period SNF ALF State Investment (in millions) Yield (%) Q1 1 - TX $ 6.8 $ 0.1 $ 6.1 $ 0.6 9.50 Q3 6 - NE 15.0 1.4 12.1 1.5 9.00 Q3 1 2 WA 18.0 2.2 14.9 0.9 8.00 Q3 - 2 GA 10.8 1.2 9.0 0.6 7.00 Q3 1 - VA 28.5 (1) 1.9 24.2 2.4 9.25 Q3 2 - FL 32.0 1.4 29.0 1.6 9.00 Q3 - - NY 111.7 (2)(3) 111.7 - - - Q4 1 - AZ 0.6 (3) 0.3 0.3 - 9.00 Q4 1 - TX 5.3 1.8 3.0 0.5 9.50 Total 13 4 $ 228.7 $ 122.0 $ 98.6 $ 8.1 (1) In July 2015, we leased the facility to a new operator with an initial lease term of 10 years. (2) On July 24, 2015, we purchased five buildings located in New York City, New York for approximately $111.7 million. We and our operator plan to construct a 201,000 square-foot assisted living and memory care facility. The properties were added to the operator’s existing master lease. The lease provides for a 5% annual cash yield on the land during the construction phase. Upon issuance of a certification of occupancy, the annual cash yield will increase to 7% in year one and 8% in year two with 2.5% annual escalators thereafter. (3) Accounted for as an asset acquisition. For the year ended December 31, 2015, we recognized rental revenue of approximately $4.9 million and expensed $2.2 million of acquisition related costs related to the aforementioned acquisitions. No goodwill was recorded in connection with these acquisitions. Acquisition of Care Homes in the U.K. On May 1, 2015, we closed on a purchase/leaseback Care Homes Transaction (the “Care Homes Transaction”) for 23 care homes located in the U.K. and operated by Healthcare Homes Holding Limited (“Healthcare Homes”). As part of the transaction, we acquired title to the 23 care homes with 1,018 registered beds and leased them back to Healthcare Homes pursuant to a 12-year master lease agreement with an initial annual cash yield of 7%, and annual escalators of 2.5%. The care homes, comparable to ALFs in the U.S., are located throughout the East Anglia region (north of London) of the U.K. Healthcare Homes is headquartered in Colchester (Essex County), England. We recorded approximately $193.8 million of assets consisting of land ($20.7 million), building and site improvements ($152.1 million), furniture and fixtures ($5.3 million) and goodwill ($15.7 million). For the year ended December 31, 2015, we recognized approximately $9.5 million of rental revenue and expensed approximately $3.2 million of acquisition related costs associated with the Care Homes Transaction. Aviv Merger On April 1, 2015, Omega completed the Aviv Merger, which was structured as a stock-for-stock merger. Under the terms of the Merger Agreement, each outstanding share of Aviv common stock was converted into 0.90 of a share of Omega Common Stock. In connection with the Aviv Merger, Omega issued approximately 43.7 million shares of Omega Common Stock to former Aviv stockholders. As a result of the Aviv Merger, Omega acquired 342 facilities, two facilities subject to direct financing leases, one medical office building, two mortgages and other investments. Omega also assumed certain outstanding equity awards and other debt and liabilities. Based on the closing price of Omega’s common stock on April 1, 2015, the fair value of the consideration exchanged was approximately $2.3 billion. The following table highlights the final allocation of the assets acquired and liabilities assumed and consideration transferred on April 1, 2015: (in thousands) Fair value of net assets acquired: Land and buildings $ 3,107,530 Investment in direct financing leases 26,823 Mortgages notes receivable 19,246 Other investments 23,619 Total investments 3,177,218 Goodwill 630,679 Accounts receivables and other assets 17,144 Cash acquired 84,858 Accrued expenses and other liabilities (223,002 ) Debt (1,410,637 ) Fair value of net assets acquired $ 2,276,260 The completion of the final valuation in the first quarter of 2016 did not result in material changes to our Consolidated Statements of Operations or our Consolidated Balance Sheets from our preliminary purchase price allocation reflected in the December 31, 2015 Form 10-K. For the year ended December 31, 2015, we recognized approximately $188.4 million of total revenue and expensed approximately $52.1 million in acquisition and merger related costs in connection with the Aviv Merger. Included within accrued expenses and other liabilities is a $67.3 million contingent liability related to a leasing arrangement with an operator assumed as a result of the Aviv Merger. 2014 Acquisitions and Other Number of Total Land Building & Site Furniture Initial Period SNF ALF State Investment (in millions) Yield (%) Q1 - 1 AZ $ 4.7 $ 0.4 $ 3.9 $ 0.4 9.75 Q2/Q3 3 - GA, SC 34.6 0.9 32.1 1.6 9.50 Q3 1 - TX 8.2 0.4 7.4 0.4 9.75 Q4 - 4 PA,OR,AR 84.2 5.1 76.7 2.4 6.00 4 5 $ 131.7 $ 6.8 $ 120.1 $ 4.8 For the year ended December 31, 2014, we recognized rental revenue of approximately $3.2 million and expensed $3.9 million of acquisition costs related to the above transactions. No goodwill was recorded in connection with these acquisitions. Transition of Two West Virginia Facilities to a New Operator On July 1, 2014, we transitioned two West Virginia SNFs that we previously leased to Diversicare Healthcare Services (“Diversicare” and formerly known as Advocat) to a new unrelated third party operator. The two facilities represented 150 operating beds. We amended our Diversicare master lease to reflect the transition of the two facilities to the new operator and for the year ended December 31, 2014 recorded a $0.8 million provision for uncollectible straight-line accounts receivable. Simultaneous with the Diversicare master lease amendment, we entered into a 12-year master lease with a new third party operator. Pro Forma Acquisition Results The businesses acquired in 2015 and 2014 are included in our results of operations from the dates of acquisition. The following unaudited pro forma results reflect the impact of the acquisitions as if they occurred on January 1, 2014. In the opinion of management, all significant necessary adjustments to reflect the effect of the acquisitions have been made. The following pro forma information is not indicative of future operations. Pro Forma Year Ended December 31, 2015 2014 (in thousands, except per share Pro forma revenues $ 817,642 $ 789,270 Pro forma net income $ 258,927 $ 318,271 Earnings per share – diluted: Net income – as reported $ 1.29 $ 1.74 Net income – pro forma $ 1.33 $ 1.74 Asset Sales, Impairments and Other In 2016, we sold 38 facilities (21 previously held-for-sale) for approximately $169.6 million in net proceeds recognizing a gain of approximately $50.2 million. We also recorded a total of $58.7 million provision for impairment related to 29 facilities to reduce their net book value to their estimated fair value less costs to sell. To estimate the fair value of these facilities we utilized a market approach and Level 3 inputs (which generally consist of non-binding offers from unrelated third parties). In 2015, we sold seven SNFs (four previously held-for-sale) for total cash proceeds of approximately $41.5 million, generating a gain of approximately $6.4 million. We also recorded a total of $17.7 million provision for impairment related to six SNFs to reduce their net book value to their estimated fair value less costs to sell. To estimate the fair value of these facilities we utilized a market approach and Level 3 inputs. In 2014, we sold four SNFs (three previously held-for-sale) and a parcel of land for total cash proceeds of $4.1 million, resulting in a $2.9 million gain. We also closed two SNFs and recorded a $3.7 million provision for impairment related to these facilities. To estimate the fair value of these facilities we utilized a market approach and Level 3 inputs. The recorded 2016 impairments were primarily the result of a decision to exit certain non-strategic facilities and operators primarily related to facilities acquired in the Aviv Merger. The recorded 2015 and 2014 impairments are primarily the result of closing facilities or updating the estimated proceeds we expected to receive for the sale of closed facilities at that time. See “ Note 8 – Assets Held For Sale

DIRECT FINANCING LEASES

DIRECT FINANCING LEASES	12 Months Ended
	Dec. 31, 2016
Leases, Capital [Abstract]
DIRECT FINANCING LEASES	NOTE 4 – DIRECT FINANCING LEASES The components of investments in direct financing leases consist of the following: December 31, 2016 2015 (in thousands) Minimum lease payments receivable $ 4,287,069 $ 4,320,876 Less unearned income (3,685,131 ) (3,733,175 ) Investment in direct financing leases - net $ 601,938 $ 587,701 Properties subject to direct financing leases 58 59 As of December 31, 2016 and 2015 we had seven direct financing leases with four different operators. The following table summarizes our investments in the direct financing leases by operator: December 31, 2016 2015 (in thousands) New Ark $ 574,581 $ 560,308 Reliance Health Care Management, Inc. 15,498 15,509 Sun Mar Healthcare 11,443 11,381 Markleysburg Healthcare Investors, LP 416 503 Investment in direct financing leases - net $ 601,938 $ 587,701 New Ark Investment Inc. On November 27, 2013, we closed an aggregate $529 million purchase/leaseback transaction in connection with the acquisition of Ark Holding Company, Inc. (“Ark Holding”) by 4 West Holdings Inc. At closing, we acquired 55 SNFs and 1 ALF operated by Ark Holding and leased the facilities back to Ark Holding, now known as New Ark Investment Inc. (“New Ark”), pursuant to four 50-year master leases with rental payments yielding 10.6% per annum over the term of the leases. The purchase/leaseback transaction is being accounted for as a direct financing lease. The lease agreements allow the tenant the right to purchase the facilities for a bargain purchase price plus closing costs at the end of the lease term. In addition, commencing in the 41st year of each lease, the tenant will have the right to prepay the remainder of its obligations thereunder for an amount equal to the sum of the unamortized portion of the original aggregate $529 million investment plus the net present value of the remaining payments under the lease and closing costs. In the event the tenant exercises either of these options, we have the right to purchase the properties for fair value at the time. The 56 facilities represent 5,623 licensed beds located in 12 states, predominantly in the southeastern United States. The 56 facilities are separated by region and divided amongst four cross-defaulted master leases. The four regions include the Southeast (39 facilities), the Northwest (7 facilities), Texas (9 facilities) and Indiana (1 facility). Additionally, we own four facilities and lease them to New Ark under a master lease which expires in 2026. The four facility lease is being accounted for as an operating lease. Aviv Merger On April 1, 2015, we acquired two additional direct financing leases as a result of the Aviv Merger. As of December 31, 2016, the following minimum rents are due under our direct financing leases for the next five years (in thousands): 2017 2018 2019 2020 2021 $50,772 $52,098 $53,377 $54,677 $55,919

MORTGAGE NOTES RECEIVABLE

MORTGAGE NOTES RECEIVABLE	12 Months Ended
	Dec. 31, 2016
Mortgage Notes Receivable Investments [Abstract]
MORTGAGE NOTES RECEIVABLE	NOTE 5 - MORTGAGE NOTES RECEIVABLE As of December 31, 2016, mortgage notes receivable relate to 25 fixed rate mortgages on 47 long-term care facilities. The mortgage notes are secured by first mortgage liens on the borrowers' underlying real estate and personal property. The mortgage notes receivable relate to facilities located in ten states, operated by seven independent healthcare operating companies. We monitor compliance with mortgages and when necessary have initiated collection, foreclosure and other proceedings with respect to certain outstanding loans. The outstanding principal amounts of mortgage notes receivable, net of allowances, were as follows: December 31, 2016 2015 (in thousands) Mortgage note due 2024; interest at 9.79% $ 112,500 $ 112,500 Mortgage note due 2028; interest at 11.00% 35,964 69,928 Mortgage note due 2029; interest at 9.45% 412,140 413,399 Other mortgage notes outstanding (1) 82,673 83,968 Mortgage notes receivable, gross 643,277 679,795 Allowance for loss on mortgage notes receivable (3,934 ) — Total mortgages — net $ 639,343 $ 679,795 (1) Other mortgage notes outstanding have stated interest rates ranging from 8.35% to 12.0% per annum and maturity dates through 2029. $112.5 Million of Mortgage Note due 2024 On January 17, 2014, we entered into a $112.5 million first mortgage loan with an existing operator. The loan is secured by 7 SNFs and 2 ALFs located in Pennsylvania (7) and Ohio (2). The mortgage is cross-defaulted and cross-collateralized with our existing master lease with the operator. Mortgage Note due 2028 On April 29, 2016, an existing operator exercised an option to repay certain mortgage notes. We received proceeds of approximately $47.8 million for the mortgage notes due. In connection with the repayment of the mortgage notes we recognized a net gain of approximately $5.4 million which is recorded in mortgage interest income on our Consolidated Statement of Operations. The remaining $36.0 million interest only mortgage is secured by three facilities located in Maryland. The interest rate will accrue at a fixed rate of 11% per annum through April 2018. After April 2018, the interest rate will increase to 13.75% per annum. The initial maturity date was extended to December 2028. The mortgage is cross-defaulted and cross-collateralized with our existing master lease and other investment notes with the operator. $415 Million of Refinancing/Consolidating Mortgage Loans due 2029 On June 30, 2014, we entered into an agreement to refinance/consolidate $117 million in existing mortgages with maturity dates ranging from 2021 to 2023 on 17 facilities into one mortgage and simultaneously provide mortgage financing for an additional 14 facilities. The original $415 million mortgage matures in 2029 and was secured by 31 facilities. The new loan bore an initial annual cash interest rate of 9.0% that increases by 0.225% per year (e.g., beginning in year 2 the annual cash interest rate will be 9.225%, in year 3 the annual cash interest rate will be 9.45%, etc.). The mortgage is cross-defaulted and cross-collateralized with our existing master lease and other investment notes with the operator. One of the existing mortgages that was refinanced/consolidated into the new $415 million mortgage included annual interest rate escalators and required the mortgagee to pay a prepayment penalty in the event the mortgage was retired early which resulted in us recording an effective yield interest receivable. In connection with the refinancing/consolidating transaction which was entered into at market terms, the old mortgage was considered to be retired early since the modifications made to the terms of the mortgage were more than minor. As of the date of the refinancing/consolidation transaction, the effective yield interest receivable was approximately $2.0 million. We forgave the prepayment penalty associated with the retired mortgage and recorded a $2.0 million provision to write-off the effective yield interest receivable related to the retired mortgage. Conversion of Mortgage Notes due 2046 to Leased Properties In January 2016, we acquired three facilities via a deed-in-lieu of foreclosure from a mortgagor. The fair value of the facilities approximated the $25 million carrying value of the mortgages. These facilities are located in Maryland. Simultaneously, we leased these facilities to an existing operator.

OTHER INVESTMENTS

OTHER INVESTMENTS	12 Months Ended
	Dec. 31, 2016
Receivables [Abstract]
OTHER INVESTMENTS	NOTE 6 - OTHER INVESTMENTS A summary of our other investments is as follows: December 31, 2016 2015 (in thousands) Other investment note due 2019; interest at 10.50% $ 49,458 $ — Other investment note due 2020; interest at 10.00% 23,000 23,000 Other investment note due 2020; interest at 14.00% 47,913 — Other investment note due 2022, interest at 9.00% 31,987 — Other investment note due 2030; interest at 6.66% 44,595 26,966 Other investment notes outstanding (1) 64,691 42,293 Other investments, gross 261,644 92,259 Allowance for loss on other investments (4,798 ) (2,960 ) Total other investments $ 256,846 $ 89,299 (1) Other investment notes have maturity dates through 2028 and interest rates ranging from 6.50% to 13.0% per annum. The following is an overview of certain notes entered into or repaid in 2016 and 2015. Other Investment note due 2019 On February 26, 2016, we acquired and funded a $50.0 million mezzanine note at a discount of approximately $0.75 million to a new operator. The mezzanine note bears interest at 10.50% per annum and matures in February 2019. Other Investment notes due 2020 In December 2015, we amended our five year $28.0 million loan agreement with an existing operator. The amendment permits the operator to re-borrow $6.0 million under the original loan agreement. We funded $6.0 million to the operator in December 2015. The loan bears interest at 10% per annum and the maturity date was extended from 2017 to 2020. As of December 31, 2016, approximately $23.0 million remains outstanding. On July 29, 2016, we provided an existing operator $48.0 million of term loan funding. The term loan bears interest at 14% per annum (LIBOR with a floor of 1% plus 13%) and matures on July 29, 2020. The term loan requires monthly principal payments of $0.25 million through July 2019, and $0.5 million from August 2019 through maturity. In addition, a portion of the monthly interest may be accrued to the outstanding principal balance of the loan. Other Investment notes due 2022 On September 30, 2016, we acquired and amended a term loan with a fair value of approximately $37.0 million with an existing operator. A $5.0 million tranche of the term loan bears interest at 13% and matures on September 30, 2019 and a $32.0 million tranche of the term loan bears interest at 9% per annum and matures on March 31, 2022. Other Investment note due 2030 On June 30, 2015, we entered into a $50.0 million revolving credit facility with an operator. The note bears interest at approximately 6.66% per annum and matures in 2030. As of December 31, 2016, approximately $44.6 million has been drawn and remains outstanding. Other Investment notes paid off On April 29, 2016, an existing operator exercised its option to pay off a working capital note due in 2022 and ten working capital notes due in 2023, for approximately $7.6 million. On March 1, 2016, we provided an operator a $15.0 million secured working capital note. The working capital note bore interest at 8.5% per annum and initially matured in March 2017. The loan was paid off in December 2016. On March 1, 2016, we provided an operator a $20.0 million acquisition note. The acquisition note bore interest at 8.5% per annum (increasing annually by 2.5% per annum) and initially matured in March 2028. The loan was paid off in October 2016.

INVESTMENT IN UNCONSOLIDATED JO

INVESTMENT IN UNCONSOLIDATED JOINT VENTURE	12 Months Ended
	Dec. 31, 2016
Investment In Unconsolidated Joint Venture [Abstract]
INVESTMENT IN UNCONSOLIDATED JOINT VENTURE	NOTE 7 – INVESTMENT IN UNCONSOLIDATED JOINT VENTURE On November 1, 2016, we invested approximately $50.0 million for an approximate 15% ownership interest in a joint venture operating as Second Spring Healthcare Investments. The other approximate 85% interest is owned by affiliates of Lindsey Goldberg LLC. We account for the joint venture using the equity method. On November 1, 2016, the joint venture acquired 64 SNFs from Welltower Inc. for approximately $1.1 billion. We receive asset management fees from the joint venture for services provided. For the year ended December 31, 2016, we recognized $0.3 million of asset management fees. These fees are included in miscellaneous income in the accompanying Consolidated Statement of Operations. The accounting policies for the unconsolidated joint venture are the same as those of the Company.

ASSETS HELD FOR SALE

ASSETS HELD FOR SALE	12 Months Ended
	Dec. 31, 2016
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract]
ASSETS HELD FOR SALE	NOTE 8 – ASSETS HELD FOR SALE The following is a summary of our assets held for sale: Properties Held-For-Sale Number of Net Book Value December 31, 2014 4 $ 12,792 Properties sold/other (1) (5 ) (16,877 ) Properties added (2) 4 10,684 December 31, 2015 3 $ 6,599 Properties sold/other (3) (24 ) (75,948 ) Properties added (4) 41 122,217 December 31, 2016 20 $ 52,868 (1) In 2015, a parcel of land was reclassified to closed facilities. In addition, we sold four facilities for approximately $25.5 million in net proceeds recognizing gains on sales of approximately $8.8 million. (2) In 2015, we recorded a $3.0 million impairment charge on a SNF in New Mexico to reduce its net book value to its estimated fair value less costs to sell. (3) In 2016, we sold 21 SNFs for approximately $86.7 million in net proceeds recognizing gains on sales of approximately $16.5 million. We also recorded approximately $4.9 million of impairments on 16 facilities to reduce their net book values to their estimated fair value less costs to sell. Two SNFs and one ALF classified as assets held for sale in the second quarter were no longer considered held for sale and were reclassified in the third quarter back to leased properties at their fair values (approximately $7.0 million). (4) In 2016, we reclassified ten ALFs and 31 SNFs to assets held for sale (including the two SNFs and one ALF mentioned above that were reclassified back to leased properties in the third quarter). We recorded approximately $49.4 million of impairment charges on 20 of these facilities to reduce their net book values to their estimated fair value less costs to sell.

INTANGIBLES

INTANGIBLES	12 Months Ended
	Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLES	NOTE 9 – INTANGIBLES The following is a summary of our intangibles as of December 31, 2016 and 2015: December 31, 2016 2015 (in thousands) Assets: Goodwill $ 643,474 $ 645,683 Above market leases $ 22,476 $ 21,901 In-place leases 167 386 Accumulated amortization (15,864 ) (14,162 ) Net intangible assets $ 6,779 $ 8,125 Liabilities: Below market leases $ 165,028 $ 165,331 Accumulated amortization (70,738 ) (55,131 ) Net intangible liabilities $ 94,290 $ 110,200 Goodwill was recorded in connection with the Aviv Merger and Care Homes Transaction and is shown as a separate line on our Consolidated Balance Sheets. Above market leases and in-place leases, net of accumulated amortization, are included in other assets on our Consolidated Balance Sheets. Below market leases, net of accumulated amortization, are included in accrued expenses and other liabilities on our Consolidated Balance Sheets. The net amortization related to the above and below market leases is included in our Consolidated Statements of Operations as an adjustment to rental income. For the years ended December 31, 2016, 2015 and 2014, our net amortization related to intangibles was $13.9 million, $13.9 million and $5.0 million, respectively. The estimated net amortization related to these intangibles for the subsequent five years is as follows: 2017 – $12.0 million; 2018 – $10.6 million; 2019 – $9.5 million; 2020 – $9.3 million; 2021 - $8.7 million and $37.3 million thereafter. As of December 31, 2016 the weighted average remaining amortization period of above market lease assets and below market lease liabilities is 8.1 years and 9.5 years, respectively. The following is a summary of our goodwill as of December 31 2016: (in thousands) Balance as of December 31, 2015 $ 645,683 Add: additional valuation adjustments related to preliminary valuations 275 Less: foreign currency translation (2,484 ) Balance as of December 31, 2016 $ 643,474

CONCENTRATION OF RISK

CONCENTRATION OF RISK	12 Months Ended
	Dec. 31, 2016
Risks and Uncertainties [Abstract]
CONCENTRATION OF RISK	NOTE 10 - CONCENTRATION OF RISK As of December 31, 2016, our portfolio of real estate investments consisted of 996 healthcare facilities, located in 42 states and the U.K. and operated by 79 third party operators. Our investments in these facilities, net of impairments and reserve for uncollectible loans, totaled approximately $8.9 billion at December 31, 2016, with approximately 99% of our real estate investments related to long-term care facilities. Our portfolio is made up of 809 SNFs, 101 ALFs, 16 specialty facilities, one medical office building, fixed rate mortgages on 44 SNFs and two ALFs, and 23 facilities that are closed/held-for-sale. At December 31, 2016, we also held other investments of approximately $256.8 million, consisting primarily of secured loans to third-party operators of our facilities. At December 31, 2016, the three states in which we had our highest concentration of investments were Ohio (10%), Florida (9%) and Texas (9%). No single operator or manager generated more than 10% of our total revenues for the year ended December 31, 2016 .

LEASE AND MORTGAGE DEPOSITS

LEASE AND MORTGAGE DEPOSITS	12 Months Ended
	Dec. 31, 2016
Security Deposits and Letters Of Credit [Abstract]
LEASE AND MORTGAGE DEPOSITS	NOTE 11 - LEASE AND MORTGAGE DEPOSITS We obtain liquidity deposits, security deposits and letters of credit from most operators pursuant to our lease and mortgage agreements with the operators. These generally represent the rental and mortgage interest for periods ranging from three to six months with respect to certain of our investments. At December 31, 2016, we held $5.7 million in liquidity deposits, $49.8 million in security deposits and $66.8 million in letters of credit. The liquidity deposits, security deposits and the letters of credit may be used in the event of lease and or loan defaults, subject to applicable limitations under bankruptcy law with respect to operators filing under Chapter 11 of the United States Bankruptcy Code. Liquidity deposits are recorded as restricted cash on our Consolidated Balance Sheets with the offset recorded as a liability in accrued expenses and other liabilities on our Consolidated Balance Sheets. Security deposits related to cash received from the operator are recorded in accrued expenses and other liabilities on our Consolidated Balance Sheets. Additional security for rental and mortgage interest revenue from operators is provided by covenants regarding minimum working capital and net worth, liens on accounts receivable and other operating assets of the operators, provisions for cross default, provisions for cross-collateralization and by corporate or personal guarantees.

BORROWING ARRANGEMENTS

BORROWING ARRANGEMENTS	12 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
BORROWING ARRANGEMENTS	NOTE 12 - BORROWING ARRANGEMENTS The following is a summary of our long-term borrowings: Interest Rate as December 31, Maturity 2016 2016 2015 (in thousands) Secured borrowings: Mortgage term loan $ — $ 180,000 HUD mortgages assumed December 2011 (1) 2044 3.06 % 54,954 56,204 Deferred financing costs – net (589 ) (611 ) Total secured borrowings – net 54,365 235,593 Unsecured borrowings: Revolving line of credit 2018 2.06 % 190,000 230,000 Tranche A-1 term loan 2019 2.27 % 200,000 200,000 Tranche A-2 term loan 2017 2.19 % 200,000 200,000 Tranche A-3 term loan 2021 2.27 % 350,000 — Omega OP term loan 2017 2.19 % 100,000 100,000 2015 term loan 2022 3.80 % 250,000 250,000 Deferred financing costs – net (5,657 ) (4,307 ) Total term loans – net 1,094,343 745,693 2023 notes 2023 4.375 % 700,000 — 2024 notes 2024 5.875 % 400,000 400,000 2024 notes 2024 4.95 % 400,000 400,000 2025 notes 2025 4.50 % 250,000 250,000 2026 notes 2026 5.25 % 600,000 600,000 2027 notes 2027 4.50 % 700,000 700,000 Other 2018 - 3,000 — Subordinated debt 2021 9.00 % 20,000 20,000 Discount - net (17,151 ) (17,118 ) Deferred financing costs – net (27,703 ) (24,155 ) Total unsecured borrowings – net 3,028,146 2,328,727 Total secured and unsecured borrowings – net $ 4,366,854 $ 3,540,013 (1) Reflects the weighted average annual contractual interest rate on the mortgages at December 31, 2016 excluding a third-party administration fee of approximately 0.5%. Secured by real estate assets with a net carrying value of $65.7 million as of December 31, 2016. Secured Borrowings Mortgage Term Loan As a result of the Aviv Merger in April 2015, we acquired two subsidiaries that were borrowers under a $180.0 million mortgage term loan secured by mortgages on 28 healthcare facilities owned by one of the borrowers. On July 25, 2016, we purchased the $180.0 million mortgage term loan, effectively eliminating the debt on our consolidated financial statements. The term loan was secured by real estate assets having a net carrying value of $290.5 million at June 30, 2016. The interest rate was based on LIBOR, with a floor of 50 basis points, plus a margin of 350 basis points. The interest rate at June 30, 2016 was 4.13% per annum. We paid $180.0 million plus a 1% premium to purchase the debt. HUD Mortgages Loans Payoff On December 31, 2015, we paid approximately $25.1 million to retire two mortgage loans guaranteed by the U.S. Department of Housing and Urban Development (“HUD”). The loans were assumed as part of an acquisition in a prior year, and had a blended interest rate of 5.5% per annum with maturities on March 1 and April 1, 2036. The payoff resulted in a $0.9 million gain on the extinguishment of the debt due to the write-off of the $2.1 million unamortized fair value adjustment recorded at the time of acquisition offset by a prepayment fee of approximately $1.2 million. On April 30, 2015, we paid approximately $9.1 million to retire one mortgage loan guaranteed by HUD. The loan was assumed as part of an acquisition in a prior year, and had an interest rate of 4.35% per annum with maturity on March 1, 2041. The payoff resulted in a $1.0 million gain on the extinguishment of the debt due to the write-off of the $1.5 million unamortized fair value adjustment recorded at the time of acquisition offset by a prepayment fee of approximately $0.5 million. On March 31, 2015, we paid approximately $154.3 million to retire 21 mortgage loans guaranteed by HUD, totaling approximately $146.9 million. 18 loans had an all-in blended interest rate of 5.35% per annum with maturities between January 2040 and January 2045 and three loans had an all-in blended interest rate of 5.23% per annum with maturities between February 2040 and February 2045. The payoff resulted in a $2.3 million gain on the extinguishment of the debt due to the write-off of the $9.7 million unamortized debt premium recorded at the time of acquisition offset by a prepayment fee of approximately $7.4 million. Unsecured Borrowings Unsecured Credit Facility On January 29, 2016, we entered into the Third Amendment to Credit Agreement (the “Third Amendment to Omega Credit Agreement,” as defined below) which amended and restated the existing Credit Agreement, dated June 27, 2014 (as amended and restated pursuant to the First Amendment to Credit Agreement, dated April 1, 2015, the Second Amendment to Credit Agreement, dated August 7, 2015 and the Third Amendment to Omega Credit Agreement, collectively the “Omega Credit Agreement”). As a result of the amendments, the Omega Credit Facilities (as defined below) now includes a $1.25 billion senior unsecured revolving credit facility (the “Revolving Credit Facility”), a $200 million senior unsecured term loan facility (the “Tranche A-1 Term Loan Facility”), a $200 million senior unsecured incremental term loan facility (the “Tranche A-2 Term Loan Facility”) and a $350 million senior unsecured incremental term loan facility which was borrowed in 2016 (the “Tranche A-3 Term Loan Facility” and, together with the Revolving Credit Facility, the Tranche A-1 Term Loan Facility and the Tranche A-2 Term Loan Facility, collectively, the “Omega Credit Facilities”). The Tranche A-1 Term Loan Facility, the Tranche A-2 Term Loan Facility and the Tranche A-3 Term Loan Facility may be referred to collectively herein as the “Omega Term Loan Facilities”. Borrowings under the Revolving Credit Facility bear interest at LIBOR plus an applicable percentage (beginning at 130 basis points, with a range of 92.5 to 170 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings, plus a facility fee based on the same ratings (initially 25 basis points, with a range of 12.5 to 30 basis points). The Revolving Credit Facility is used for acquisitions and general corporate purposes. The Revolving Credit Facility matures on June 27, 2018, subject to a one-time option by us to extend such maturity date by one year. The Tranche A-1 Term Loan Facility bears interest at LIBOR plus an applicable percentage (beginning at 150 basis points, with a range of 100 to 195 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings. The Tranche A-1 Term Loan Facility matures on June 27, 2019. The Tranche A-2 Term Loan Facility bears interest at LIBOR plus an applicable percentage (beginning at 150 basis points, with a range of 100 to 195 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings. The Tranche A-2 Term Loan Facility matures on June 27, 2017, subject to Omega’s option to extend the maturity date of the Tranche A-2 Term Loan Facility twice, the first extension until June 27, 2018 and the second extension until June 27, 2019. The Tranche A-3 Term Loan Facility bears interest at LIBOR plus an applicable percentage (beginning at 150 basis points, with a range of 100 to 195 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings. The Tranche A-3 Term Loan Facility matures on January 29, 2021. Omega OP Term Loan Facility On April 1, 2015, Omega OP entered into a credit agreement (the “Omega OP Credit Agreement”) providing it with a $100 million senior unsecured term loan facility (the “Omega OP Term Loan Facility”). The Omega OP Term Loan Facility bears interest at LIBOR plus an applicable percentage (beginning at 150 basis points, with a range of 100 to 195 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings. The Omega OP Term Loan Facility matures on June 27, 2017, subject to Omega OP’s option to extend such maturity date twice, the first extension until June 27, 2018 and the second extension until June 27, 2019. $250 Million Term Loan Facility On December 16, 2015, we entered into a $250 million senior unsecured term loan facility (the “2015 Term Loan Facility”). The 2015 Term Loan Facility bears interest at LIBOR plus an applicable percentage (beginning at 180 basis points, with a range of 140 to 235 basis points) based on our ratings from Standard & Poor’s, Moody’s and/or Fitch Ratings. The 2015 Term Loan Facility may be increased to an aggregate amount of $400 million. We used the proceeds from this loan to repay existing indebtedness and for general corporate purposes. The 2015 Term Loan Facility matures on December 16, 2022. As a result of exposure to interest rate movements associated with the 2015 Term Loan Facility, on December 16, 2015, we entered into various forward-starting interest rate swap arrangements, which effectively converted $250 million of our variable-rate debt based on one-month LIBOR to an aggregate fixed rate of approximately 3.8005% effective December 30, 2016. The effective fixed rate achieved by the combination of the 2015 Term Loan Facility and the interest rate swaps could fluctuate up by 55 basis points or down by 40 basis points based on future changes to our credit ratings. Each of these swaps began on December 30, 2016 and mature on December 15, 2022. On the date of inception, we designated the interest rate swaps as cash flow hedges in accordance with accounting guidance for derivatives and hedges and linked the interest rate swaps to the 2015 Term Loan Facility. Because the critical terms of the interest rate swaps and 2015 Term Loan Facility coincided, the hedges are expected to exactly offset changes in expected cash flows as a result of fluctuations in 1-month LIBOR over the term of the hedges. The purpose of entering into the swaps was to reduce our exposure to future changes in variable interest rates. The interest rate swaps settle on a monthly basis when interest payments are made. These settlements will occur through the maturity date of the 2015 Term Loan Facility. The interest rate for the 2015 Term Loan Facility was not hedged for the portion of the term prior to December 30, 2016. $700 Million 4.375% Senior Notes due 2023 On July 12, 2016, we issued $700 million aggregate principal amount of our 4.375% Senior Notes due 2023 (the “2023 Notes”). The 2023 Notes were sold at an issue price of 99.739% of their face value before the underwriters’ discount. Our net proceeds from the offering, after deducting underwriting discounts and expenses, were approximately $692.0 million. The net proceeds from the offering were used to repay outstanding borrowings under our revolving credit facility, to purchase the $180.0 million mortgage term loan and for general corporate purposes. The 2023 Notes mature on August 1, 2023 and pay interest semi-annually. $400 Million 5.875% Senior Notes due 2024 On March 19, 2012, we issued $400 million aggregate principal amount of our 5.875% Senior Notes due 2024. These notes mature on March 15, 2024 and pay interest semi-annually. $400 Million 4.95% Senior Notes due 2024 On March 11, 2014, we sold $400 million aggregate principal amount of our 4.95% Senior Notes due 2024 (the “2024 Notes”). These notes were sold at an issue price of 98.58% of the principal amount of the notes, before the initial purchasers’ discount resulting in gross proceeds of approximately $394.3 million. The 2024 Notes mature on April 1, 2024 and pay interest semi-annually. $250 Million 4.5% Senior Notes due 2025 On September 11, 2014, we sold $250 million aggregate principal amount of our 4.5% Senior Notes due 2025 (the “2025 Notes”). The 2025 Notes were sold at an issue price of 99.131% of their face value before the initial purchasers’ discount resulting in gross proceeds of approximately $247.8 million. The 2025 Notes mature on January 15, 2025 and pay interest semi-annually. $600 Million 5.25% Senior Notes due 2026 On September 23, 2015, we sold $600 million aggregate principal amount of our 5.250% Senior Notes due 2026 (the “2026 Notes”). The 2026 Notes were sold at an issue price of 99.717% of their face value before the initial purchasers’ discount. Our total net proceeds from the offering, after deducting initial purchasers’ discounts and other offering expenses, were approximately $594.4 million. The net proceeds of the offering were used to repay our outstanding $575 million aggregate principal amount 6.75% Senior Notes due 2022 and for general corporate purposes. The 2026 Notes mature on January 15, 2026 and pay interest semi-annually. $700 Million 4.5% Senior Notes due 2027 On March 18, 2015, we sold $700 million aggregate principal amount of our 4.5% Senior Notes due 2027 (the “2027 Notes”). The 2027 Notes were sold at an issue price of 98.546% of their face value before the initial purchasers’ discount. Our total net proceeds from the offering, after deducting initial purchasers’ discounts and other offering expenses, were approximately $683 million. The net proceeds of the offering were used for general corporate purposes, including the repayment of Aviv indebtedness on April 1, 2015 in connection with the Aviv Merger, and repayment of future maturities on our outstanding debt. The 2027 Notes mature on April 1, 2027 and pay interest semi-annually. $575 Million 6.75% Senior Notes due 2022 Redemption On October 26, 2015, we redeemed all of our outstanding 6.75% Senior Notes due 2022 (the “2022 Notes”). As a result of the redemption, during the fourth quarter of 2015, we recorded approximately $21.3 million in redemption related costs and write-offs, including $19.4 million for the early redemption or call premiums and $1.9 million in net write-offs associated with unamortized deferred financing costs and original issuance premiums/discounts. $200 Million 7.5% Senior Notes due 2020 Redemption On March 13, 2015, Omega redeemed all of its outstanding $200 million 7.5% Senior Notes due 2020 (the “2020 Notes”) at a redemption price of approximately $208.7 million, consisting of 103.750% of the principal amount, plus accrued and unpaid interest on such notes to, but not including, the date of redemption. In connection with the redemption, we recorded approximately $11.7 million redemption related costs and write-offs, including $7.5 million in prepayment fees for early redemption and $4.2 million of write-offs associated with unamortized deferred financing costs and discount. The consideration for the redemption of the 2020 Notes was funded from the net proceeds of the 10.925 million share common stock offering. See Note 16 – Stockholders’ Equity for additional details. Other Debt Repayments In connection with the Aviv Merger on April 1, 2015, we assumed notes payable with a face amount of $650 million and a revolving credit facility with an outstanding balance of $525 million. In connection with the Aviv Merger, we repaid this debt assumed from Aviv on April 1, 2015. Due to the contractual requirements for early repayments; we paid approximately $705.6 million to retire the $650 million notes assumed. The amount repaid in connection with the revolving credit facility was $525 million. General Certain of our other secured and unsecured borrowings are subject to customary affirmative and negative covenants, including financial covenants. As of December 31, 2016 and 2015, we were in compliance with all affirmative and negative covenants, including financial covenants, for our secured and unsecured borrowings. The required principal payments, excluding the premium or discount and deferred financing costs on our secured and unsecured borrowings, for each of the five years following December 31, 2016 and the aggregate due thereafter are set forth below: (in thousands) 2017 $ 302,788 2018 192,828 2019 201,369 2020 1,412 2021 371,456 Thereafter 3,348,101 Totals $ 4,417,954 The following summarizes the refinancing related costs: Year Ended December 31, 2016 2015 2014 (in thousands) Write off of deferred financing cost and unamortized premiums due to refinancing (1)(2)(3) $ 301 $ (7,134 ) $ 1,180 Prepayment and other costs associated with refinancing (4) 1,812 35,971 1,861 Total debt extinguishment costs $ 2,113 $ 28,837 $ 3,041 (1) In 2016, we recorded $0.3 million of write-offs of unamortized deferred financing costs associated with three facilities that were acquired via a deed-in-lieu foreclosure. (2) In 2015, we recorded: (a) $4.2 million of write-offs of unamortized deferred financing costs and discount associated with the early redemption of our 2020 Notes, (b) $1.9 million in net write-offs associated with unamortized deferred financing costs and original issuance premiums/discounts associated with the early redemption of our 2022 Notes, offset by (c) $13.2 million gain related to the early extinguishment of debt from the write off of unamortized premium on the HUD debt paid off in March, April and December 2015. (3) In 2014, we recorded: (a) $2.6 million write-off of deferred financing costs associated with the termination of the $700 million 2012 credit facilities, (b) $2.0 million write-off of deferred financing costs associated with the termination of our $200 million 2013 term loan facility offset by (c) $3.5 million gain related to the early extinguishment of debt from the write off of unamortized premium on the HUD debt paid off in September and December 2014. (4) In 2016, we purchased a $180 million mortgage term loan and paid a 1% premium of approximately $1.8 million to purchase the debt. In 2015, we made: (a) $7.5 million of prepayment penalties associated with the early redemption of our 2020 Notes, (b) $19.4 million of prepayment penalties associated with the early redemption of our 2022 Notes and (c) $9.1 million of prepayment penalties associated with 24 HUD mortgage loans that we paid off in March, April and December 2015. In 2014, we made prepayment penalties of $1.9 million associated with five HUD mortgage loans that we paid off in September and October 2014.

FINANCIAL INSTRUMENTS

FINANCIAL INSTRUMENTS	12 Months Ended
	Dec. 31, 2016
Fair Value Disclosures [Abstract]
FINANCIAL INSTRUMENTS	NOTE 13 - FINANCIAL INSTRUMENTS At December 31, 2016 and 2015, the carrying amounts and fair values of our financial instruments were as follows: 2016 2015 Carrying Amount Fair Value Carrying Amount Fair Value (in thousands) Assets: Cash and cash equivalents $ 93,687 $ 93,687 $ 5,424 $ 5,424 Restricted cash 13,589 13,589 14,607 14,607 Investments in direct financing leases – net 601,938 598,665 587,701 584,358 Mortgage notes receivable – net 639,343 644,961 679,795 687,130 Other investments – net 256,846 253,385 89,299 90,745 Total $ 1,605,403 $ 1,604,287 $ 1,376,826 $ 1,382,264 Liabilities: Revolving line of credit $ 190,000 $ 190,000 $ 230,000 $ 230,000 Tranche A-1 term loan 198,830 200,000 197,699 200,000 Tranche A-2 term loan 200,000 200,000 200,000 200,000 Tranche A-3 term loan 347,449 350,000 — — Omega OP term loan 100,000 100,000 100,000 100,000 2015 term loan 248,064 250,000 247,994 250,000 4.375% notes due 2023 – net 692,305 693,505 — — 5.875% notes due 2024 – net 395,065 432,938 394,382 429,956 4.95% notes due 2024 – net 392,669 406,361 391,658 403,064 4.50% notes due 2025 – net 245,949 249,075 245,446 242,532 5.25% notes due 2026 – net 593,616 611,461 593,032 612,760 4.50% notes due 2027 – net 685,052 681,978 683,596 667,651 Mortgage term loan due 2019 — — 180,000 180,000 HUD debt – net 54,365 52,510 55,593 52,678 Subordinated debt – net 20,490 23,944 20,613 24,366 Other 3,000 3,000 — — Total $ 4,366,854 $ 4,444,772 $ 3,540,013 $ 3,593,007 Fair value estimates are subjective in nature and are dependent on a number of important assumptions, including estimates of future cash flows, risks, discount rates and relevant comparable market information associated with each financial instrument (see Note 2 – Summary of Significant Accounting Policies). The use of different market assumptions and estimation methodologies may have a material effect on the reported estimated fair value amounts. The following methods and assumptions were used in estimating fair value disclosures for financial instruments. · Cash and cash equivalents and restricted cash: The carrying amount of cash and cash equivalents and restricted cash reported in the Consolidated Balance Sheets approximates fair value because of the short maturity of these instruments (i.e., less than 90 days) (Level 1). · Direct financing leases: The fair value of the investments in direct financing leases are estimated using a discounted cash flow analysis, using interest rates being offered for similar leases to borrowers with similar credit ratings (Level 3). · Mortgage notes receivable: The fair value of the mortgage notes receivables are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3). · Other investments: Other investments are primarily comprised of notes receivable. The fair values of notes receivable are estimated using a discounted cash flow analysis, using interest rates being offered for similar loans to borrowers with similar credit ratings (Level 3). · Revolving line of credit and term loans: The fair value of our borrowings under variable rate agreements are estimated using a present value technique based on expected cash flows discounted using the current market rates (Level 3). · Senior notes and subordinated debt: The fair value of our borrowings under fixed rate agreements are estimated using a present value technique based on inputs from trading activity provided by a third party (Level 2). · HUD debt: The fair value of our borrowings under HUD debt agreements are estimated using an expected present value technique based on quotes obtained by HUD debt brokers (Level 2).

TAXES

TAXES	12 Months Ended
	Dec. 31, 2016
Income Tax Disclosure [Abstract]
TAXES	NOTE 14 – TAXES We were organized, have operated, and intend to continue to operate in a manner that enables us to qualify for taxation as a REIT under Sections 856 through 860 of the Internal Revenue Code of 1986, as amended (the “Code”). On a quarterly and annual basis we perform several analyses to test our compliance within the REIT taxation rules. In order to qualify as a REIT, in addition to other requirements, we must: (i) distribute dividends (other than capital gain dividends) to our stockholders in an amount at least equal to (A) the sum of (a) 90% of our “REIT taxable income” (computed without regard to the dividends paid deduction and our net capital gain), and (b) 90% of the net income (after tax), if any, from foreclosure property, minus (B) the sum of certain items of non-cash income on an annual basis, (ii) ensure that at least 75% and 95%, respectively of our gross income is generated from qualifying sources that are described in the REIT tax law, (iii) ensure that at least 75% of our assets consist of qualifying assets, such as real property, mortgages, and other qualifying assets described in the REIT tax law, (iv) ensure that we do not own greater than 10% in voting power or value of securities of any one issuer, (v) ensure that we do not own either debt or equity securities of another company that are in excess of 5% of our total assets and (vi) ensure that no more than 25% of our assets are invested in one or more taxable REIT subsidiaries (and with respect to taxable years beginning after December 31, 2017, no more than 20%). In addition to the above requirements, the REIT rules require that no less than 100 stockholders own shares or an interest in the REIT and that five or fewer individuals do not own (directly or indirectly) more than 50% of the shares or proportionate interest in the REIT during the last half of any taxable year. If we fail to meet the above or any other requirements for qualification as a REIT in any tax year, we will be subject to federal income tax on our taxable income at regular corporate rates and may not be able to qualify as a REIT for the four subsequent years, unless we qualify for certain relief provisions that are available in the event we fail to satisfy any of these requirements. We are also subject to federal taxation of 100% of the net income derived from the sale or other disposition of property, other than foreclosure property, that we held primarily for sale to customers in the ordinary course of a trade or business. We believe that we do not hold assets for sale to customers in the ordinary course of business and that none of the assets currently held for sale or that have been sold would be considered a prohibited transaction within the REIT taxation rules. So long as we qualify as a REIT under the Code, we generally will not be subject to federal income taxes on the REIT taxable income that we distribute to stockholders, subject to certain exceptions. In 2016 and 2015, we distributed dividends in excess of our taxable income. Since the year 2000, the definition of foreclosure property has included any “qualified health care property,” as defined in Code Section 856(e)(6) acquired by us as the result of the termination or expiration of a lease of such property. We have from time to time operated qualified healthcare facilities acquired in this manner for up to two years (or longer if an extension was granted). Properties that we had taken back in a foreclosure or bankruptcy and operated for our own account were treated as foreclosure properties for income tax purposes, pursuant to Code Section 856(e). Gross income from foreclosure properties was classified as “good income” for purposes of the annual REIT income tests upon making the election on the tax return. Once made, the income was classified as “good” for a period of three years, or until the properties were no longer operated for our own account. In all cases of foreclosure property, we utilized an independent contractor to conduct day-to-day operations to maintain REIT status. In certain cases, we operated these facilities through a taxable REIT subsidiary. For those properties operated through the taxable REIT subsidiary, we formed a new entity (TC Healthcare) to act as the eligible independent contractor on our behalf and conduct the day-to-day operations with respect to the health care facilities we held as foreclosure property in order for us to maintain REIT status. We have not held foreclosure property since 2011. As a result of the foregoing, we do not believe that our past participation in the operation of nursing homes increased the risk that we would fail to qualify as a REIT. Through our 2016 taxable year, we had not paid any tax on our foreclosure property because those properties had been producing losses. As a result of our UPREIT Conversion, our Company and its subsidiaries may be subject to income or franchise taxes in certain states and municipalities. In connection with our UPREIT Conversion in 2015, we created five subsidiary REITs that are subject to all of the REIT qualification rules set forth in the Code, which were then consolidated through intercompany transfers of ownership that occurred at the end of 2015, which created a single REIT subsidiary with four wholly-owned qualified REIT subsidiaries. In 2016, we elected REIT status for another of our subsidiaries and in December of 2016, we transferred the ownership of that entity to our REIT subsidiary so that we now have a single REIT subsidiary that holds all the ownership interests in several qualified REIT subsidiaries. Our REIT subsidiary remains subject to all of the REIT qualification rules set forth in the Code as outlined above. In connection with our acquisition of Care Homes in May 2015, we acquired 10 legal entities consisting of 23 facilities. The tax basis in these legal entities acquired for U.K. taxes was approximately $82 million less than the purchase price. We recorded an initial deferred tax liability associated with the temporary tax basis difference of approximately $15 million.

RETIREMENT ARRANGEMENTS

RETIREMENT ARRANGEMENTS	12 Months Ended
	Dec. 31, 2016
Compensation Related Costs [Abstract]
RETIREMENT ARRANGEMENTS	NOTE 15 - RETIREMENT ARRANGEMENTS Our Company has a 401(k) Profit Sharing Plan covering all eligible employees. Under this plan, employees are eligible to make contributions, and we, at our discretion, may match contributions and make a profit sharing contribution. Amounts charged to operations with respect to these retirement arrangements totaled approximately $0.5 million, $0.4 million, $0.3 million in 2016, 2015 and 2014, respectively. In addition, we have a deferred stock compensation plan that allows employees and directors the ability to defer the receipt of stock awards. The deferred stock awards (units) participate in future dividends as well as the change in the value of the Company’s common stock. As of December 31, 2016 and 2015, the Company had 384,107 and 400,814 deferred stock units outstanding.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	12 Months Ended
	Dec. 31, 2016
Stockholders' Equity Note [Abstract]
STOCKHOLDERS' EQUITY	NOTE 16 – STOCKHOLDERS’ EQUITY $500 Million Equity Shelf Program On September 3, 2015, we entered into separate Equity Distribution Agreements (collectively, the “Equity Shelf Agreements”) to sell shares of our common stock having an aggregate gross sales price of up to $500 million (the “2015 Equity Shelf Program”) with several financial institutions, each as a sales agent and or principal (collectively, the “Managers”). Under the terms of the Equity Shelf Agreements, we may sell shares of our common stock, from time to time, through or to the Managers having an aggregate gross sales price of up to $500 million. Sales of the shares, if any, will be made by means of ordinary brokers’ transactions on the New York Stock Exchange at market prices, or as otherwise agreed with the applicable Manager. We will pay each Manager compensation for sales of the shares equal to 2% of the gross sales price per share for shares sold through such Manager under the applicable Equity Shelf Agreements. For the year ended December 31, 2015, we did not issue any shares under the 2015 Equity Shelf Program. For the year ended December 31, 2016, we issued approximately 0.7 million shares under the 2015 Equity Shelf Program, at an average price of $29.97 per share, generating gross proceeds of approximately $20.4 million, before $0.7 million of commissions and expenses. $250 Million Equity Shelf Program Termination Also on September 3, 2015, we terminated our $250 million Equity Shelf Program (the “2013 Equity Shelf Program”) that we entered into with several financial institutions on March 18, 2013. In 2015, we did not issue any shares under the 2013 Equity Shelf Program. For the year ended December 31, 2014, we issued approximately 1.8 million shares under the 2013 Equity Shelf Program, at an average price of $34.33 per share, generating gross proceeds of approximately $63.5 million, before $1.5 million of commissions and expenses. Since inception of the 2013 Equity Shelf Program, we sold a total of 7.4 million shares of common stock generating total gross proceeds of $233.8 million under the program, before $4.7 million of commissions. As a result of the termination of the 2013 Equity Shelf Program, no additional shares may be issued under the 2013 Equity Shelf Program. Increase of Authorized Omega Common Stock On March 27, 2015, we amended our charter to increase the number of authorized shares of our capital stock from 220 million to 370 million and the number of authorized shares of our common stock from 200 million to 350 million. 10.925 Million Common Stock Offering On February 9, 2015, we completed an underwritten public offering of 10.925 million shares of our common stock at $42.00 per share before underwriting and other offering expenses. The Company’s total net proceeds from the offering were approximately $440 million, after deducting underwriting discounts and commissions and other estimated offering expenses. Dividend Reinvestment and Common Stock Purchase Plan We have a Dividend Reinvestment and Common Stock Purchase Plan (the “DRSPP”) that allows for the reinvestment of dividends and the optional purchase of our common stock. For the year ended December 31, 2016, we issued 7.2 million shares of common stock for gross proceeds of approximately $240.0 million. For the year ended December 31, 2015, we issued 4.2 million shares of common stock for gross proceeds of approximately $150.8 million. For the year ended December 31, 2014, we issued 2.1 million shares of common stock for gross proceeds of approximately $71.5 million. Accumulated Other Comprehensive Loss The following is a summary of our accumulated other comprehensive loss, net of tax where applicable: December 31, 2016 2015 (in thousands) Foreign currency translation adjustments $ (52,495 ) $ (8,027 ) Cash flow hedge adjustments (1,332 ) (685 ) Total accumulated other comprehensive loss $ (53,827 ) $ (8,712 )

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION	12 Months Ended
	Dec. 31, 2016
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]
STOCK-BASED COMPENSATION	NOTE 17 – STOCK-BASED COMPENSATION Restricted Stock and Restricted Stock Units Restricted stock and restricted stock units (“RSUs”) are subject to forfeiture if the holder’s service to us terminates prior to vesting, subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company. Prior to vesting, ownership of the shares/units cannot be transferred. The restricted stock has the same dividend and voting rights as our common stock. RSUs accrue dividend equivalents but have no voting rights. Restricted stock and RSUs are valued at the price of our common stock on the date of grant. We expense the cost of these awards ratably over their vesting period. The RSUs assumed from Aviv as part of the Aviv Merger were valued at the closing price of our stock on the date of the transaction. The portion of the vesting accruing prior to the acquisition was recorded as part of the purchase price consideration. The expense associated with the vesting that will occur after the date of the transaction will be recorded as stock compensation expense ratably over the remaining life of the RSUs. The following table summarizes the activity in restricted stock and RSUs for the years ended December 31, 2014, 2015 and 2016: Number of Weighted - Compensation Cost (1) (in millions) Non-vested at December 31, 2013 257,198 $ 29.32 Granted during 2014 143,637 30.70 $ 4.4 Vested during 2014 (90,901 ) 28.87 Non-vested at December 31, 2014 309,934 $ 30.08 Granted during 2015 233,483 39.25 $ 9.2 Assumed in Aviv Merger (2) 38,268 23.50 $ 0.9 Cancelled during 2015 (61,911 ) 33.77 Vested during 2015 (106,146 ) 28.72 Non-vested at December 31, 2015 413,628 $ 34.45 Granted during 2016 158,506 34.49 $ 5.5 Cancelled during 2016 (905 ) 24.92 Vested during 2016 (235,176 ) 30.41 Non-vested at December 31, 2016 336,053 $ 37.32 (1) Total compensation cost to be recognized on the awards based on grant date fair value, which is based on the market price of the Company’s common stock on the date of grant. (2) Omega stock price on April 1, 2015 was $40.74. The weighted average stock price indicated in the table above represents the expense per unit that we will record related to the assumed Aviv RSUs. Performance Based Incentive Stock Units Performance restricted stock units (“PRSUs”) and long term incentive plan units (“LTIP Units”) are subject to forfeiture if the performance requirements are not achieved or if the holder’s service to us terminates prior to vesting, subject to certain exceptions for certain qualifying terminations of employment or a change in control of the Company. The PRSUs awarded in January 2011, January 2013, December 2013, January 2014, March 2015, April 2015 July 2015, and March 2016 and the LTIP Units awarded in March 2015, April 2015, July 2015 and March 2016 have varying degrees of performance requirements to achieve vesting, and each PRSU and LTIP Units award represents the right to a variable number of shares of common stock or partnership units (each LTIP Unit once earned is convertible into one Omega OP Unit in Omega OP, subject to certain conditions). The vesting requirements are based on either the (i) total shareholders return (“TSR”) of Omega or (ii) Omega’s TSR relative to other real estate investment trusts in the MSCI U.S. REIT Index for awards before 2016 and in the FTSE NAREIT Equity Health Care Index for awards in 2016 (“Relative TSR”). We expense the cost of these awards ratably over their service period. Prior to vesting and the distribution of shares, ownership of the PRSUs cannot be transferred. Dividends on the PRSUs are accrued and only paid to the extent the applicable performance requirements are met. While each LTIP Unit is unearned, the employee receives a partnership distribution equal to 10% of the quarterly approved regular periodic distributions per Omega OP Unit. The remaining partnership distributions (which in the case of normal periodic distributions is equal to the total approved quarterly dividend on Omega’s common stock) on the LTIP Units accumulate, and if the LTIP Units are earned, the accumulated distributions are paid. We used a Monte Carlo model to estimate the fair value for the PRSUs and LTIP Units granted to the employees. The following are the significant assumptions used in estimating the value of the awards for grants made on the following dates: January 1, December March April 1, July 31, March 17, Closing price on date of grant $ 23.85 $ 29.80 $ 40.57 $ 40.74 $ 36.26 $ 34.78 Dividend yield 4.24% 6.44% 5.23% 5.20% 6.07% 6.56% Risk free interest rate at time of grant 0.05% to 0.43% 0.04% to 0.86% 0.10% to 0.94% 0.09% to 0.91% 0.13% to 1.08% 0.05% to 1.14% Expected volatility 15.56% to 23.83% 24.16% to 25.86% 20.06% to 21.09% 20.06% to 21.08% 20.06% to 20.21% 23.92% to 24.88% The following table summarizes the activity in PRSUs and LTIP Units for the years ended December 31, 2014, 2015 and 2016: Number of Weighted- Compensation Cost (1) (in millions) Non-vested at December 31, 2013 1,038,024 $ 10.72 Granted during 2014 309,168 11.46 $ 3.5 Vested during 2014 (2) (496,979 ) 10.75 Non-vested at December 31, 2014 850,213 $ 10.97 Granted during 2015 537,923 18.51 $ 10.0 Cancelled during 2015 (165,570 ) 14.11 Forfeited during 2015 (128,073 ) 12.04 Vested during 2015 (2) (181,406 ) 10.10 Non-vested at December 31, 2015 913,087 $ 14.87 Granted during 2016 679,549 14.67 $ 10.0 Forfeited during 2016 (518,638 ) 12.10 Vested during 2016 - - Non-vested at December 31, 2016 1,073,998 $ 16.08 (1) Total compensation cost to be recognized on the awards was based on the grant date fair value or the modification date fair value. (2) PRSUs are shown as vesting in the year that the Compensation Committee determines the level of achievement of the applicable performance measures. The following table summarizes our total unrecognized compensation cost as of December 31, 2016 associated with restricted stock, restricted stock units, PRSU awards, and LTIP Unit awards to employees: Grant Year Shares/ Units Grant Date Average Fair Value Per Unit/ Share Total Compensation Cost (in millions) (1) Weighted Average Period of Expense Recognition (in months) Unrecognized Compensation Cost (in millions) Performance Period Vesting Dates RSUs 3/31/15 RSU 2015 109,985 40.57 4.5 33 1.6 N/A 12/31/2017 4/1/15 RSU 2015 40,464 40.74 1.6 33 0.6 N/A 12/31/2017 Assumed Aviv RSU 2015 7,799 35.08 0.3 33 0.1 N/A 11/1/2017 3/17/16 RSU 2016 131,006 34.78 4.6 33 3.3 N/A 12/31/2018 Restricted Stock Units Total 289,254 $ 37.82 $ 11.0 $ 5.6 TSR PRSUs and LTIP Units 2016 TSR 2014 135,634 8.67 1.2 48 0.3 1/1/2014-12/31/2016 Quarterly in 2017 3/31/15 2017 LTIP Units 2015 137,249 14.66 2.0 45 1.1 1/1/2015-12/31/2017 Quarterly in 2018 4/1/2015 2017 LTIP Units 2015 54,151 14.80 0.8 45 0.4 1/1/2015-12/31/2017 Quarterly in 2018 3/17/2016 2018 LTIP Units 2016 372,069 13.21 4.9 45 3.9 1/1/2016-12/31/2018 Quarterly in 2019 TSR PRSUs & LTIP Total 699,103 $ 12.74 $ 8.9 $ 5.7 Relative TSR PRSUs 2016 Relative TSR 2014 135,634 14.24 1.9 48 0.5 1/1/2014-12/31/2016 Quarterly in 2017 3/31/15 2017 Relative TSR 2015 137,249 22.50 3.1 45 1.6 1/1/2015-12/31/2017 Quarterly in 2018 4/1/2015 2017 Relative TSR 2015 54,151 22.91 1.2 45 0.7 1/1/2015-12/31/2017 Quarterly in 2018 3/17/2016 2018 Relative TSR 2016 307,480 16.45 5.1 45 4.0 1/1/2016-12/31/2018 Quarterly in 2019 Relative TSR PRSUs Total 634,514 $ 17.84 $ 11.3 $ 6.8 Grand Total 1,622,871 $ 19.20 $ 31.2 $ 18.1 (1) Total compensation costs are net of shares cancelled. Stock Options and Tax Withholding As part of the Aviv Merger, we assumed approximately 5.7 million Aviv employee stock options that were fully vested prior to the merger. On April 1, 2015, the Aviv stock options were converted into Omega stock options at an exchange ratio of 0.9 resulting in issuance of approximately 5.1 million Omega stock options. The intrinsic value of the stock option assumed on April 1, 2015 was approximately $99.2 million and was recorded as part of the consideration provided in the merger. During 2016 and 2015, approximately 2.5 million and 2.6 million options, respectively, were exercised at a weighted average price of $19.38 per share and $19.38 per share, respectively. At December 31, 2016, approximately 26 thousand options remain outstanding and exercisable. Options outstanding have a weighted average exercise price of $18.97. The aggregate intrinsic value of these options is $0.3 million and represents the total pre-tax intrinsic value (based upon the difference between the Company's closing stock price on the last trading day of 2016 of $31.26 and the exercise price) for all in-the-money options as of December 31, 2016. Options outstanding have no contractual term limitations. Stock withheld to pay minimum statutory tax withholdings for equity instruments granted under stock-based payment arrangements for the years ended December 31, 2016, 2015 and 2014, was $23.4 million, $26.7 million and $3.6 million, respectively. Shares Available for Issuance for Compensation Purposes On June 6, 2013, at our Company’s Annual Meeting, our stockholders approved the 2013 Stock Incentive Plan (the “2013 Plan”), which amended and restated the Company’s 2004 Stock Incentive Plan. The 2013 Plan is a comprehensive incentive compensation plan that allows for various types of equity-based compensation, including restricted stock units (including performance-based restricted stock units and LTIP units), stock awards, deferred restricted stock units, incentive stock options, non-qualified stock options, stock appreciation rights, dividend equivalent rights and certain cash-based awards (including performance-based cash awards). The 2013 Plan increased the number of shares reserved for issuance for compensation purposes by 3,000,000. As of December 31, 2016, approximately 2.0 million shares of common stock were reserved for issuance to our employees, directors and consultants under our stock incentive plans. Awards under our stock incentive plans may be in the form of stock, stock options, restricted stock and performance restricted stock units. Director Restricted Stock Grants In 2014, 2015 and 2016, we issued 21,500, 30,500 and 27,500 shares of restricted stock to members of our Board of Directors. The fair value of these awards was approximately $0.8 million, $1.1 million and $0.9 million, respectively, for 2014, 2015 and 2016. As of December 31, 2016, we had 51,999 shares of restricted stock outstanding to directors. The directors’ restricted shares are scheduled to vest over the next three years. As of December 31, 2016, the unrecognized compensation cost associated with outstanding director restricted stock grants is approximately $1.4 million.

DIVIDENDS

DIVIDENDS	12 Months Ended
	Dec. 31, 2016
Dividends [Abstract]
DIVIDENDS	NOTE 18 - DIVIDENDS Common Dividends On January 12, 2017, the Board of Directors declared a common stock dividend of $0.62 per share, increasing the quarterly common dividend by $0.01 per share over the prior quarter. The common dividends were paid February 15, 2017 to common stockholders of record as of the close of business on January 31, 2017. On October 13, 2016, the Board of Directors declared a common stock dividend of $0.61 per share, increasing the quarterly common dividend rate by $0.01 per share over the previous quarter. The common dividends were paid November 15, 2016 to common stockholders of record as of the close of business on October 31, 2016. On July 14, 2016, the Board of Directors declared a common stock dividend of $0.60 per share, increasing the quarterly common dividend rate by $0.02 per share over the prior quarter. The common dividends were paid on August 15, 2016 to common stockholders of record as of the close of business on August 1, 2016. On April 14, 2016, the Board of Directors declared a common stock dividend of $0.58 per share, increasing the quarterly common dividend by $0.01 per share over the prior quarter. The common dividends were paid May 16, 2016 to common stockholders of record on May 2, 2016. On January 14, 2016, the Board of Directors declared a common stock dividend of $0.57 per share, increasing the quarterly common dividend by $0.01 per share over the previous quarter. The common dividends were paid February 16, 2016 to common stockholders of record as of February 2, 2016. Per Share Distributions Per share distributions by our Company were characterized in the following manner for income tax purposes (unaudited): Year Ended December 31, 2016 2015 2014 Common Ordinary income $ 1.968 $ 1.133 $ 1.834 Return of capital 0.322 1.047 0.186 Capital gains 0.070 - - Total dividends paid $ 2.360 $ 2.180 $ 2.020 For additional information regarding dividends, see Note 14 – Taxes.

LITIGATION

LITIGATION	12 Months Ended
	Dec. 31, 2016
Commitments and Contingencies Disclosure [Abstract]
LITIGATION	NOTE 19 - LITIGATION We are subject to various legal proceedings, claims and other actions arising out of the normal course of business. While any legal proceeding or claim has an element of uncertainty, management believes that the outcome of each lawsuit, claim or legal proceeding that is pending or threatened, or all of them combined, will not have a material adverse effect on our consolidated financial position or results of operations.

SUMMARY OF QUARTERLY RESULTS (U

SUMMARY OF QUARTERLY RESULTS (UNAUDITED)	12 Months Ended
	Dec. 31, 2016
Quarterly Financial Information Disclosure [Abstract]
SUMMARY OF QUARTERLY RESULTS (UNAUDITED)	NOTE 20 - SUMMARY OF QUARTERLY RESULTS (UNAUDITED) The following summarizes quarterly results of operations for the years ended December 31, 2016 and 2015: March 31 June 30 September 30 December 31 (in thousands, except per share amounts) 2016 Revenues $ 212,879 $ 228,824 $ 224,638 $ 234,486 Net income 58,196 113,154 82,134 129,883 Net income available to common stockholders 55,555 108,052 78,549 124,259 Net income available to common per share: Basic $ 0.30 $ 0.57 $ 0.40 $ 0.63 Net income per share: Diluted $ 0.29 $ 0.57 $ 0.40 $ 0.63 Cash dividends paid on common stock $ 0.57 $ 0.58 $ 0.60 $ 0.61 2015 Revenues $ 133,420 $ 197,711 $ 201,974 $ 210,512 Net income 43,052 43,466 83,254 63,543 Net income available to common stockholders 43,052 41,428 79,402 60,642 Net income available to common per share: Basic $ 0.32 $ 0.23 $ 0.43 $ 0.32 Net income per share: Diluted $ 0.32 $ 0.22 $ 0.43 $ 0.32 Cash dividends paid on common stock $ 0.53 $ 0.54 $ 0.55 $ 0.56

EARNINGS PER SHARE

EARNINGS PER SHARE	12 Months Ended
	Dec. 31, 2016
Earnings Per Share [Abstract]
EARNINGS PER SHARE	NOTE 21 - EARNINGS PER SHARE The following tables set forth the computation of basic and diluted earnings per share: Year Ended December 31, 2016 2015 2014 (in thousands, except per share amounts) Numerator: Net income $ 383,367 $ 233,315 $ 221,349 Less: Net income attributable to noncontrolling interests (16,952 ) (8,791 ) — Net income available to common stockholders $ 366,415 $ 224,524 $ 221,349 Denominator: Denominator for basic earnings per share 191,781 172,242 126,550 Effect of dilutive securities: Common stock equivalents 956 1,539 744 Noncontrolling interest – OP units 8,898 6,727 — Denominator for diluted earnings per share 201,635 180,508 127,294 Earnings per share - basic: Net income available to common stockholders $ 1.91 $ 1.30 $ 1.75 Earnings per share - diluted: Net income $ 1.90 $ 1.29 $ 1.74

CONSOLIDATING FINANCIAL STATEME

CONSOLIDATING FINANCIAL STATEMENTS	12 Months Ended
	Dec. 31, 2016
Condensed Financial Information Of Parent Company Only Disclosure [Abstract]
CONSOLIDATING FINANCIAL STATEMENTS	NOTE 22– CONSOLIDATING FINANCIAL STATEMENTS As of December 31, 2016, we had outstanding: (i) $700 million 4.375% Senior Notes due 2023, (ii) $400 million 5.875% Senior Notes due 2024, (iii) $400 million 4.95% Senior Notes due 2024, (iv) $250 million 4.50% Senior Notes due 2025, (v) $600 million 5.25% Senior Notes due 2026 and (vi) $700 million 4.5% Senior Notes due 2027 (collectively, the “Senior Notes”). The Senior Notes are fully and unconditionally guaranteed, jointly and severally, by each of our subsidiaries that guarantee other indebtedness of Omega or any of the subsidiary guarantors. All of our subsidiaries that guarantee the Senior Notes also guarantee amounts outstanding under the Omega Credit Facilities and 2015 Term Loan Facility listed in Note 12– Borrowing Arrangements. In addition, all such subsidiary guarantors that are subsidiaries of Omega OP also guarantee amounts outstanding under the Omega OP Term Loan listed in Note 12– Borrowing Arrangements. The following summarized condensed consolidating financial information segregates the financial information of the non-guarantor subsidiaries from the financial information of Omega Healthcare Investors, Inc. and the subsidiary guarantors under the Senior Notes. Our non-guarantor subsidiaries include, among others, all subsidiaries securing secured debt that is currently outstanding and our U.K. subsidiaries. The results and financial position of acquired entities are included from the dates of their respective acquisitions. The 2014 and 2015 financial statements presented below have been adjusted to reflect our current guarantor and non-guarantor relationships as of December 31, 2016. OMEGA HEALTHCARE INVESTORS, INC. CONSOLIDATING BALANCE SHEET (in thousands) December 31, 2016 Issuer & Non – Elimination Consolidated ASSETS Real estate properties Real estate investments $ 6,923,469 $ 642,889 $ — $ 7,566,358 Less accumulated depreciation (1,191,117 ) (49,219 ) — (1,240,336 ) Real estate investments – net 5,732,352 593,670 — 6,326,022 Investment in direct financing leases - net 601,938 — — 601,938 Mortgage notes receivable - net 639,343 — — 639,343 6,973,633 593,670 — 7,567,303 Other investments 256,846 — — 256,846 Investment in unconsolidated joint venture 48,776 — — 48,776 Assets held for sale – net 52,868 — — 52,868 Total investments 7,332,123 593,670 — 7,925,793 Cash and cash equivalents 87,098 6,589 — 93,687 Restricted cash 6,915 6,674 — 13,589 Accounts receivable – net 230,097 9,938 — 240,035 Goodwill 630,679 12,795 — 643,474 Investments in and advances to affiliates 569,194 — (569,194 ) — Other assets 21,293 11,389 — 32,682 Total assets $ 8,877,399 $ 641,055 $ (569,194 ) $ 8,949,260 LIABILITIES AND EQUITY Revolving line of credit $ 190,000 $ — $ — $ 190,000 Term loans - net 1,094,343 — — 1,094,343 Secured borrowings - net — 429,214 (374,849 ) 54,365 Unsecured borrowings – net 3,028,146 — — 3,028,146 Accrued expenses and other liabilities 352,924 7,590 — 360,514 Deferred income taxes — 9,906 — 9,906 Intercompany payable — 7,890 (7,890 ) — Total liabilities 4,665,413 454,600 (382,739 ) 4,737,274 Equity: Common stock 19,614 — — 19,614 Equity investment from affiliates — 156,446 (156,446 ) — Common stock – additional paid-in capital 4,861,408 — — 4,861,408 Cumulative net earnings 1,738,937 29,479 (29,479 ) 1,738,937 Cumulative dividends paid (2,707,387 ) — — (2,707,387 ) Accumulated other comprehensive (loss) income (53,827 ) 530 (530 ) (53,827 ) Total stockholders’ equity 3,858,745 186,455 (186,455 ) 3,858,745 Noncontrolling interest 353,241 — — 353,241 Total equity 4,211,986 186,455 (186,455 ) 4,211,986 Total liabilities and equity $ 8,877,399 $ 641,055 $ (569,194 ) $ 8,949,260 OMEGA HEALTHCARE INVESTORS, INC. CONSOLIDATING BALANCE SHEET (in thousands) December 31, 2015 Issuer & Non – Elimination Consolidated ASSETS Real estate properties Real estate investments $ 6,184,507 $ 559,451 $ — $ 6,743,958 Less accumulated depreciation (991,314 ) (27,836 ) — (1,019,150 ) Real estate investments – net 5,193,193 531,615 — 5,724,808 Investment in direct financing leases - net 587,701 — — 587,701 Mortgage notes receivable - net 679,795 — — 679,795 6,460,689 531,615 — 6,992,304 Other investments 89,299 — — 89,299 Assets held for sale – net 6,599 — — 6,599 Total investments 6,556,587 531,615 — 7,088,202 Cash and cash equivalents 1,592 3,832 — 5,424 Restricted cash 8,058 6,549 — 14,607 Accounts receivable – net 196,107 7,755 — 203,862 Goodwill 630,404 15,279 — 645,683 Investments in and advances to affiliates 300,409 — (300,409 ) — Other assets 25,270 6,888 — 32,158 Total assets $ 7,718,427 $ 571,918 $ (300,409 ) $ 7,989,936 LIABILITIES AND EQUITY Revolving line of credit $ 230,000 $ — $ — $ 230,000 Term loans - net 745,693 — — 745,693 Secured borrowings - net — 360,849 (125,256 ) 235,593 Unsecured borrowings – net 2,328,727 — — 2,328,727 Accrued expenses and other liabilities 326,815 6,891 — 333,706 Deferred income taxes — 15,352 — 15,352 Intercompany payable (13,673 ) 13,673 — — Total liabilities 3,617,562 396,765 (125,256 ) 3,889,071 Equity: Common stock 18,740 — — 18,740 Equity investment from affiliates — 156,830 (156,830 ) — Common stock – additional paid-in capital 4,609,474 — — 4,609,474 Cumulative net earnings 1,372,522 18,246 (18,246 ) 1,372,522 Cumulative dividends paid (2,254,038 ) — — (2,254,038 ) Accumulated other comprehensive (loss) income (8,712 ) 77 (77 ) (8,712 ) Total stockholders’ equity 3,737,986 175,153 (175,153 ) 3,737,986 Noncontrolling interest 362,879 — — 362,879 Total equity 4,100,865 175,153 (175,153 ) 4,100,865 Total liabilities and equity $ 7,718,427 $ 571,918 $ (300,409 ) $ 7,989,936 OMEGA HEALTHCARE INVESTORS, INC. CONSOLIDATING STATEMENT OF OPERATIONS (in thousands) Year Ended December 31, 2016 Issuer & Non – Elimination Consolidated Revenue Rental income $ 684,771 $ 59,114 $ - $ 743,885 Income from direct financing leases 62,298 - - 62,298 Mortgage interest income 69,811 - - 69,811 Other investment income – net 25,056 56 (3,260 ) 21,852 Miscellaneous income 2,981 - - 2,981 Total operating revenues 844,917 59,170 (3,260 ) 900,827 Expenses Depreciation and amortization 244,290 22,772 - 267,062 General and administrative 45,413 454 - 45,867 Acquisition and merger related costs 5,777 3,805 - 9,582 Impairment loss on real estate properties 58,508 218 - 58,726 Provisions for uncollectible mortgages, notes and accounts receivable 6,583 3,262 - 9,845 Total operating expenses 360,571 30,511 - 391,082 Income before other income and expense 484,346 28,659 (3,260 ) 509,745 Other income (expense): Interest income 161 12 - 173 Interest expense (148,092 ) (19,271 ) 3,260 (164,103 ) Interest – amortization of deferred financing costs (9,302 ) (43 ) - (9,345 ) Interest – refinancing costs (2,113 ) - - (2,113 ) Realized loss on foreign exchange (232 ) - - (232 ) Equity in earnings 11,233 - (11,233 ) - Total other expense (148,345 ) (19,302 ) (7,973 ) (175,620 ) Income before gain on assets sold 336,001 9,357 (11,233 ) 334,125 Gain on assets sold - net 50,208 - - 50,208 Income from continuing operations 386,209 9,357 (11,233 ) 384,333 Income tax expense (3,281 ) 1,876 - (1,405 ) Income from unconsolidated joint venture 439 - - 439 Net income 383,367 11,233 (11,233 ) 383,367 Net income attributable to noncontrolling interest (16,952 ) - - (16,952 ) Net income available to common stockholders $ 366,415 $ 11,233 $ (11,233 ) $ 366,415 CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (in thousands) Year Ended December 31, 2016 Issuer & Non – Elimination Consolidated Net income $ 383,367 $ 11,233 $ (11,233 ) $ 383,367 Other comprehensive income (loss) Foreign currency translation (46,535 ) - - (46,535 ) Cash flow hedges (702 ) - - (702 ) Total other comprehensive income (loss) (47,237 ) - - (47,237 ) Comprehensive income 336,130 11,233 (11,233 ) 336,130 Comprehensive income attributable to noncontrolling interest (14,830 ) - - (14,830 ) Comprehensive income attributable to common stockholders $ 321,300 $ 11,233 $ (11,233 ) $ 321,300 OMEGA HEALTHCARE INVESTORS, INC. CONSOLIDATING STATEMENT OF OPERATIONS (in thousands) Year Ended December 31, 2015 Issuer & Non – Elimination Consolidated Revenue Rental income $ 564,112 $ 41,879 $ - $ 605,991 Income from direct financing leases 59,936 - - 59,936 Mortgage interest income 68,910 - - 68,910 Other investment income – net 7,534 - - 7,534 Miscellaneous income – net 1,246 - - 1,246 Total operating revenues 701,738 41,879 - 743,617 Expenses Depreciation and amortization 194,328 16,375 - 210,703 General and administrative 38,140 428 - 38,568 Acquisition and merger related costs 55,012 2,513 - 57,525 Impairment loss on real estate properties 17,681 - - 17,681 Provisions for uncollectible mortgages, notes and accounts receivable 7,871 - - 7,871 Total operating expenses 313,032 19,316 - 332,348 Income before other income and expense 388,706 22,563 - 411,269 Other income (expense): Interest income 272 13 - 285 Interest expense (135,631 ) (11,750 ) - (147,381 ) Interest – amortization of deferred financing costs (6,969 ) (21 ) - (6,990 ) Interest – refinancing costs (28,837 ) - - (28,837 ) Realized loss on foreign exchange (173 ) - - (173 ) Equity in earnings 10,610 - (10,610 ) - Total other expense (160,728 ) (11,758 ) (10,610 ) (183,096 ) Income before gain on assets sold 227,978 10,805 (10,610 ) 228,173 Gain on assets sold - net 6,353 - - 6,353 Income from continuing operations 234,331 10,805 (10,610 ) 234,526 Income tax expense (1,016 ) (195 ) - (1,211 ) Net income 233,315 10,610 (10,610 ) 233,315 Net income attributable to noncontrolling interest (8,791 ) - - (8,791 ) Net income available to common stockholders $ 224,524 $ 10,610 $ (10,610 ) $ 224,524 CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (in thousands) Year Ended December 31, 2015 Issuer & Non – Elimination Consolidated Net income $ 233,315 $ 10,610 $ (10,610 ) $ 233,315 Other comprehensive income (loss) Foreign currency translation (8,413 ) - - (8,413 ) Cash flow hedges (718 ) - - (718 ) Total other comprehensive income (loss) (9,131 ) - - (9,131 ) Comprehensive income 224,184 10,610 (10,610 ) 224,184 Comprehensive income attributable to noncontrolling interest (8,373 ) - - (8,373 ) Comprehensive income attributable to common stockholders $ 215,811 $ 10,610 $ (10,610 ) $ 215,811 OMEGA HEALTHCARE INVESTORS, INC. CONSOLIDATING STATEMENT OF OPERATIONS (in thousands) Year Ended December 31, 2014 Issuer & Non – Elimination Consolidated Revenue Rental income $ 379,180 $ 9,263 $ - $ 388,443 Income from direct financing leases 56,719 - - 56,719 Mortgage interest income 53,007 - - 53,007 Other investment income – net 6,369 - - 6,369 Miscellaneous income – net 249 - - 249 Total operating revenues 495,524 9,263 - 504,787 Expenses Depreciation and amortization 119,367 3,890 - 123,257 General and administrative 25,778 110 - 25,888 Acquisition costs 3,948 - - 3,948 Impairment loss on real estate properties 3,660 - - 3,660 Provisions for uncollectible mortgages, notes and accounts receivable 2,723 - - 2,723 Total operating expenses 155,476 4,000 - 159,476 Income before other income and expense 340,048 5,263 - 345,311 Other income (expense): Interest income 32 12 - 44 Interest expense (117,258 ) (2,111 ) - (119,369 ) Interest – amortization of deferred financing costs (4,438 ) (21 ) - (4,459 ) Interest – refinancing costs (3,041 ) - - (3,041 ) Equity in earnings 3,143 - (3,143 ) - Total other expense (121,562 ) (2,120 ) (3,143 ) (126,825 ) Income before gain on assets sold 218,486 3,143 (3,143 ) 218,486 Gain on assets sold - net 2,863 - - 2,863 Net income available to common stockholders $ 221,349 $ 3,143 $ (3,143 ) $ 221,349 OMEGA HEALTHCARE INVESTORS, INC. CONSOLIDATING STATEMENT OF CASH FLOWS (in thousands ) Year Ended December 31, 2016 Issuer & Subsidiary Non-Guarantor Elimination Consolidated Cash flows from operating activities Net income $ 383,367 $ 11,233 $ (11,233 ) $ 383,367 Adjustment to reconcile net income to net cash provided by operating activities: Depreciation and amortization 244,290 22,772 — 267,062 Impairment loss on real estate properties 58,508 218 — 58,726 Provision for uncollectible mortgages, notes and accounts receivable 6,583 3,262 — 9,845 Refinancing costs and amortization of deferred financing costs 11,415 43 — 11,458 Accretion of direct financing leases (12,157 ) — — (12,157 ) Stock-based compensation expense 13,790 — — 13,790 Gain on assets sold – net (50,208 ) — — (50,208 ) Amortization of acquired in-place leases - net (13,991 ) — — (13,991 ) Equity in earnings (11,233 ) — 11,233 — Change in operating assets and liabilities – net of amounts assumed/acquired: Accounts receivable, net (4,876 ) — — (4,876 ) Straight-line rent receivables (36,263 ) (5,828 ) — (42,091 ) Lease inducements 2,589 — — 2,589 Effective yield receivable on mortgage notes (721 ) — — (721 ) Other operating assets and liabilities 18,661 (15,663 ) — 2,998 Net cash provided by operating activities 609,754 16,037 — 625,791 Cash flows from investing activities Acquisition of real estate – net of liabilities assumed and escrows acquired (833,390 ) (126,358 ) — (959,748 ) Investments in construction in progress (68,983 ) — — (68,983 ) Investment in U.K. subsidiary (116,099 ) — 116,099 — Investments in direct financing leases (2,080 ) — — (2,080 ) Placement of mortgage loans (48,722 ) — — (48,722 ) Investments in unconsolidated joint venture (50,032 ) — — (50,032 ) Distributions from unconsolidated joint venture 1,318 — — 1,318 Proceeds from sale of real estate investments 169,603 — — 169,603 Capital improvements to real estate investments (38,824 ) (1,647 ) — (40,471 ) Proceeds from other investments 94,840 1,949 — 96,789 Investments in other investments (269,423 ) (2,134 ) — (271,557 ) Collection of mortgage principal 59,975 — — 59,975 Net cash used in investing activities (1,101,817 ) (128,190 ) 116,099 (1,113,908 ) Cash flows from financing activities Proceeds from credit facility borrowings 1,304,000 — — 1,304,000 Payments on credit facility borrowings (1,344,000 ) — — (1,344,000 ) Receipts of other long-term borrowings 1,048,173 — — 1,048,173 Payments of other long-term borrowings (180,000 ) (1,249 ) — (181,249 ) Payments of financing related costs (11,806 ) (24 ) — (11,830 ) Receipts from dividend reinvestment plan 240,041 — — 240,041 Payments for exercised options and restricted stock (23,426 ) — — (23,426 ) Net proceeds from issuance of common stock 19,651 — — 19,651 Dividends paid (453,152 ) — — (453,152 ) Contributions from affiliates — 116,099 (116,099 ) — Redemption of OP Units (733 ) — — (733 ) Distributions to OP Unit holders (21,179 ) — — (21,179 ) Net cash provided by financing activities 577,569 114,826 (116,099 ) 576,296 Effect of foreign currency translation on cash and cash equivalents — 84 — 84 Increase in cash and cash equivalents 85,506 2,757 — 88,263 Cash and cash equivalents at beginning of period 1,592 3,832 — 5,424 Cash and cash equivalents at end of period $ 87,098 $ 6,589 $ — $ 93,687 OMEGA HEALTHCARE INVESTORS, INC. CONSOLIDATING STATEMENT OF CASH FLOWS (in thousands ) Year Ended December 31, 2015 Issuer & Subsidiary Non-Guarantor Elimination Consolidated Cash flows from operating activities Net income $ 233,315 $ 10,610 $ (10,610 ) $ 233,315 Adjustment to reconcile net income to net cash provided by operating activities: Depreciation and amortization 194,328 16,375 — 210,703 Impairment loss on real estate properties 17,681 — — 17,681 Provision for uncollectible mortgages, notes and accounts receivable 7,871 — — 7,871 Refinancing costs and amortization of deferred financing costs 35,806 21 — 35,827 Accretion of direct financing leases (11,007 ) — — (11,007 ) Stock-based compensation expense 11,133 — — 11,133 Gain on assets sold – net (6,353 ) — — (6,353 ) Amortization of acquired in-place leases - net (13,846 ) — — (13,846 ) Change in operating assets and liabilities – net of amounts assumed/acquired: Accounts receivable, net 248 — — 248 Straight-line rent receivables (31,237 ) (4,820 ) — (36,057 ) Lease inducements 994 — — 994 Effective yield receivable on mortgage notes (4,065 ) — — (4,065 ) Other operating assets and liabilities 10,550 (3,719 ) 10,610 17,441 Net cash provided by operating activities 445,418 18,467 — 463,885 Cash flows from investing activities Acquisition of real estate – net of liabilities assumed and escrows acquired (116,698 ) (177,484 ) — (294,182 ) Cash acquired in merger 84,858 — — 84,858 Investments in construction in progress (164,226 ) — — (164,226 ) Investment in U.K. subsidiary (166,082 ) 166,082 — — Investments in direct financing leases (6,793 ) — — (6,793 ) Placement of mortgage loans (14,042 ) — — (14,042 ) Proceeds from sale of real estate investments 41,543 — — 41,543 Capital improvements to real estate investments (24,599 ) (1,798 ) — (26,397 ) Proceeds from other investments 45,871 — — 45,871 Investments in other investments (65,402 ) — — (65,402 ) Collection of mortgage principal 1,359 — — 1,359 Net cash used in investing activities (384,211 ) (13,200 ) — (397,411 ) Cash flows from financing activities Proceeds from credit facility borrowings 1,826,000 — — 1,826,000 Payments on credit facility borrowings (1,681,000 ) — — (1,681,000 ) Receipts of other long-term borrowings 1,838,124 — — 1,838,124 Payments of other long-term borrowings (2,186,102 ) (1,212 ) — (2,187,314 ) Payments of financing related costs (54,721 ) — — (54,721 ) Receipts from dividend reinvestment plan 150,847 — — 150,847 Payments for exercised options and restricted stock (26,706 ) — — (26,706 ) Net proceeds from issuance of common stock 439,322 — — 439,322 Dividends paid (358,232 ) — — (358,232 ) Distributions to OP Unit holders (11,636 ) — — (11,636 ) Net cash used in financing activities (64,104 ) (1,212 ) — (65,316 ) Effect of foreign currency translation on cash and cash equivalents — (223 ) — (223 ) (Decrease) increase in cash and cash equivalents (2,897 ) 3,832 — 935 Cash and cash equivalents at beginning of period 4,489 — — 4,489 Cash and cash equivalents at end of period $ 1,592 $ 3,832 $ — $ 5,424 OMEGA HEALTHCARE INVESTORS, INC. CONSOLIDATING STATEMENT OF CASH FLOWS (in thousands ) Year Ended December 31, 2014 Issuer & Subsidiary Non-Guarantor Elimination Consolidated Cash flows from operating activities Net income $ 221,349 $ 3,143 $ (3,143 ) $ 221,349 Adjustment to reconcile net income to net cash provided by operating activities: Depreciation and amortization 119,367 3,890 — 123,257 Impairment loss on real estate properties 3,660 — — 3,660 Provision for uncollectible mortgages, notes and accounts receivable 2,723 — — 2,723 Refinancing costs and amortization of deferred financing costs 7,479 21 — 7,500 Accretion of direct financing leases (9,787 ) — — (9,787 ) Stock-based compensation expense 8,592 — — 8,592 Gain on assets sold – net (2,863 ) — — (2,863 ) Amortization of acquired in-place leases - net (4,986 ) — — (4,986 ) Change in operating assets and liabilities – net of amounts assumed/acquired: Accounts receivable, net (2,264 ) — — (2,264 ) Straight-line rent receivables (20,164 ) (792 ) — (20,956 ) Lease inducements 2,656 — — 2,656 Effective yield receivable on mortgage notes (2,878 ) — — (2,878 ) Other operating assets and liabilities 11,089 (2,695 ) 3,143 11,537 Net cash provided by operating activities 333,973 3,567 — 337,540 Cash flows from investing activities Acquisition of real estate – net of liabilities assumed and escrows acquired (131,689 ) — — (131,689 ) Placement of mortgage loans (529,548 ) — — (529,548 ) Proceeds from sale of real estate investments 4,077 — — 4,077 Capital improvements to real estate investments (15,525 ) (2,392 ) — (17,917 ) Proceeds from other investments 13,589 — — 13,589 Investments in other investments (9,441 ) — — (9,441 ) Collection of mortgage principal 122,984 — — 122,984 Net cash used in investing activities (545,553 ) (2,392 ) — (547,945 ) Cash flows from financing activities Proceeds from credit facility borrowings 900,000 — — 900,000 Payments on credit facility borrowings (1,141,000 ) — — (1,141,000 ) Receipts of other long-term borrowings 842,148 — — 842,148 Payments of other long-term borrowings (241,369 ) (1,175 ) — (242,544 ) Payments of financing related costs (17,716 ) — — (17,716 ) Receipts from dividend reinvestment plan 71,487 — — 71,487 Payments for exercised options and restricted stock (3,577 ) — — (3,577 ) Net proceeds from issuance of common stock 61,981 — — 61,981 Dividends paid (258,501 ) — — (258,501 ) Net cash provided by (used in) financing activities 213,453 (1,175 ) — 212,278 Increase in cash and cash equivalents 1,873 — — 1,873 Cash and cash equivalents at beginning of period 2,616 — — 2,616 Cash and cash equivalents at end of period $ 4,489 $ — $ — $ 4,489

SCHEDULE III REAL ESTATE AND AC

SCHEDULE III REAL ESTATE AND ACCUMULATED DEPRECIATION	12 Months Ended
	Dec. 31, 2016
Real Estate and Accumulated Depreciation Disclosure [Abstract]
REAL ESTATE AND ACCUMULATED DEPRECIATION	SCHEDULE III REAL ESTATE AND ACCUMULATED DEPRECIATION OMEGA HEALTHCARE INVESTORS, INC. December 31, 2016 (3) Gross Amount at Initial Cost to Cost Capitalized Which Carried at Life on Which Company Subsequent to Close of Period Depreciation Acquisition (4) in Latest Buildings and Carrying (6) Buildings and Accumulated Date of Date Income Statements Description (1) Encumbrances Land Improvements Improvements Cost Other Land Improvements Total Depreciation Construction Acquired is Computed Signature Holdings II: Florida (SNF) $ 14,926,960 $ 184,977,257 $ 10,162,810 $ 20,238 $ - $ 14,926,960 $ 195,160,305 $ 210,087,265 $ 47,922,023 1940-1997 1996-2016 3 years to 39 years Georgia (SNF) 3,832,748 10,846,566 3,950,028 - - 3,832,748 14,796,594 18,629,342 8,654,672 1970-1964 2007 20 years Kentucky (SNF) 13,335,341 87,790,543 4,174,496 - - 13,335,341 91,965,039 105,300,380 19,646,496 1964-1980 1999-2016 20 years to 33 years Maryland (SNF) 1,480,000 19,662,571 1,183,051 - - 1,480,000 20,845,622 22,325,622 6,981,961 1977-1959 2010 29 years to 30 years Tennessee (AL, SNF) 10,813,664 187,388,817 3,440,595 - - 10,813,664 190,829,412 201,643,076 2,696,466 1966-2016 2014-2016 25 years to 30 years Total Signature 44,388,713 490,665,754 22,910,980 20,238 - 44,388,713 513,596,972 557,985,685 85,901,618 Maplewood Real Estate Holdings: Connecticut (AL) 19,531,583 216,537,730 2,241,593 - - 19,531,583 218,779,323 238,310,906 12,740,033 1968-2015 2015 33 years Massachusetts (AL, SNF) 19,041,468 69,409,856 39,267,802 342,695 (680,345 ) 19,041,468 108,340,008 127,381,476 5,826,713 1988-2016 2015 30 years to 33 years New York (AL) 118,604,252 - 6,655,755 7,092,469 - 118,604,252 13,748,224 132,352,476 - - 2015 - Ohio (AL) 3,683,238 8,180,400 19,496,317 - - 3,683,238 27,676,717 31,359,955 1,096,131 1999-2016 2015 30 years to 33 years Total Maplewood 160,860,541 294,127,986 67,661,467 7,435,164 (680,345 ) 160,860,541 368,544,272 529,404,813 19,662,877 Saber Health Group: Florida (SNF) 422,935 4,422,325 - - - 422,935 4,422,325 4,845,260 337,550 2009 2015 33 years North Carolina (SNF) 10,780,000 106,694,700 2,312,955 47,891 - 10,780,000 109,055,546 119,835,546 4,660,696 1965-2013 2016 20 years to 30 years Ohio (SNF, AL) 5,269,177 109,002,482 2,438,309 - (268,000 ) 5,269,177 111,172,791 116,441,968 6,862,544 1968-2000 2015-2016 30 years to 33 years Pennsylvania (SNF) 7,134,354 124,475,985 1,825,909 - - 7,134,354 126,301,894 133,436,248 8,140,340 1873-2002 2015 33 years Virginia (SNF) 8,500,000 85,982,265 - - - 8,500,000 85,982,265 94,482,265 3,320,131 1964-2013 2016 30 years Total Saber Health Group 32,106,466 430,577,757 6,577,173 47,891 (268,000 ) 32,106,466 436,934,821 469,041,287 23,321,261 Ciena Healthcare: Indiana (SNF) 321,066 7,703,262 - - - 321,066 7,703,262 8,024,328 574,610 1973 2015 33 years Michigan (SNF, AL) 4,086,842 115,546,920 - - - 4,086,842 115,546,920 119,633,762 7,812,153 1964-1997 2015 33 years North Carolina (ILF, SNF) 4,330,580 65,027,000 - - - 4,330,580 65,027,000 69,357,580 4,446,154 1927-1997 2015 33 years Ohio (SNF, AL) 10,342,621 159,846,959 - - - 10,342,621 159,846,959 170,189,580 10,349,693 1960-2007 2010-2016 20 years to 33 years Virginia (SNF) 6,300,000 87,771,876 - - - 6,300,000 87,771,876 94,071,876 3,220,463 1979-2007 2016 30 years Total Ciena HealthCare 25,381,109 435,896,017 - - - 25,381,109 435,896,017 461,277,126 26,403,073 Other: Alabama (SNF) 1,817,320 33,356,170 12,915,787 - - 1,817,320 46,271,957 48,089,277 30,926,414 1960-1982 1992-1997 31.5 years to 33 years Arizona (TBI, SNF, AL) 10,995,190 86,868,402 - - - 10,995,190 86,868,402 97,863,592 10,017,581 1949-1999 2012-2015 33 years to 40 years Arkansas (SNF, AL) (2) 9,057,536 161,016,248 13,045,870 - (36,350 ) 9,057,536 174,025,768 183,083,304 55,208,651 1960-2009 1992-2015 20 years to 38 years California (SNF, TBI) 78,596,505 423,131,800 2,823,085 63,156 - 78,596,505 426,018,041 504,614,546 55,083,670 1927-2013 1997-2015 5 years to 35 years Colorado (SNF, ILF) 11,279,262 88,830,136 7,790,478 - - 11,279,262 96,620,614 107,899,876 29,232,095 1925-1975 1998-2016 20 years to 39 years Connecticut (land only) 878,937 4,445,263 980,393 - (5,425,656 ) 878,937 - 878,937 - N/A 1999 N/A Florida (SNF, AL) 61,806,778 481,225,245 36,333,087 948,913 (9,736,615 ) 61,806,778 508,770,630 570,577,408 150,266,763 1933-2007 1992-2016 2 years to 40 years Georgia (SNF, AL) 3,730,000 47,387,507 - - - 3,730,000 47,387,507 51,117,507 5,230,371 1967-1998 1998-2016 30 years to 40 years Idaho (SNF, AL) 6,705,560 62,572,804 1,321,587 - - 6,705,560 63,894,391 70,599,951 12,106,038 1911-2008 1997-2015 25 years to 39 years Illinois (SNF) 5,809,737 111,441,468 510,576 - - 5,809,737 111,952,044 117,761,781 15,117,035 1926-1990 1996-2015 30 years to 33 years Indiana (SNF, ILF, AL, MOB, SH,) 28,245,140 366,055,214 2,332,364 - (1,828,124 ) 28,237,640 366,566,954 394,804,594 77,812,713 1923-2008 1992-2015 20 years to 40 years Iowa (SNF, AL) 2,923,947 68,736,698 2,084,807 - - 2,923,947 70,821,505 73,745,452 13,120,583 1961-1998 1997-2015 23 years to 33 years Kansas (SNF) 4,799,714 47,680,306 9,250,851 - - 4,799,714 56,931,157 61,730,871 6,164,491 1957-1985 2010-2015 20 years to 33 years Kentucky (SNF, AL) 6,279,163 123,327,734 8,677,102 - - 6,279,163 132,004,836 138,283,999 20,157,352 1917-2002 1994-2015 33 years Louisiana (SNF) 2,177,542 52,869,373 1,749,991 - - 2,177,542 54,619,364 56,796,906 17,883,426 1957-1983 1997-2006 33 years to 39 years Maryland (SNF) 7,190,000 74,028,613 2,518,228 - - 7,190,000 76,546,841 83,736,841 14,350,237 1921-1985 2010-2011 25 years to 30 years Massachusetts (SNF) 5,898,952 41,120,152 2,160,034 - - 5,898,952 43,280,186 49,179,138 20,605,218 1964-1993 1997-2010 20 years to 39 years Michigan (SNF) 829,621 30,921,159 - - - 829,621 30,921,159 31,750,780 4,655,127 1964-1975 2011-2015 25 years to 33 years Minnesota (SNF, AL, ILF) 10,571,691 52,399,655 653,399 - - 10,571,691 53,053,054 63,624,745 3,949,866 1958-1983 2015 33 years Mississippi (SNF) 2,910,000 49,506,905 826,654 - - 2,910,000 50,333,559 53,243,559 14,274,382 1962-1988 2009-2010 20 years to 40 years Missouri (SNF) 7,333,114 121,480,904 692,135 - (152,575 ) 7,333,114 122,020,464 129,353,578 14,794,489 1955-1994 1999-2016 30 years to 33 years Montana (SNF) 1,319,454 11,698,411 - - - 1,319,454 11,698,411 13,017,865 811,679 1963-1971 2015 33 years Nebraska (SNF) 1,599,631 23,142,177 - - - 1,599,631 23,142,177 24,741,808 2,256,512 1963-1969 2015 20 years to 33 years Nevada (SNF, SH, TBI) 5,501,308 50,472,213 8,350,000 - - 5,501,308 58,822,213 64,323,521 10,013,989 1972-2004 2009-2015 26 years to 33 years New Hampshire (SNF, AL) 1,782,067 19,837,436 1,462,797 - - 1,782,067 21,300,233 23,082,300 8,439,787 1963-1999 1998-2006 33 years to 39 years New Mexico (SNF) 9,002,270 68,658,130 130,323 - - 9,002,270 68,788,453 77,790,723 7,348,628 1960-1989 2008-2015 20 years to 33 years North Carolina (SNF) 3,069,856 52,675,612 3,550,986 - - 3,069,856 56,226,598 59,296,454 26,436,775 1964-1987 1994-2010 25 years to 36 years Ohio (SNF, SH, AL) 35,367,198 439,998,943 30,731,141 - (1,166,009 ) 35,367,198 469,564,075 504,931,273 133,969,181 1920-2008 1994-2015 20 years to 39 years Oklahoma (SNF, AL) 4,650,087 36,246,616 - - - 4,650,087 36,246,616 40,896,703 7,883,686 1965-2013 2010-2015 20 years to 33 years Oregon (AL, SNF) 3,640,572 45,217,827 2,610,185 - - 3,640,572 47,828,012 51,468,584 3,179,897 1959-2004 2014-2015 25 years to 33 years Pennsylvania (SNF, AL, ILF) 11,733,450 206,264,434 11,281,116 - - 11,733,450 217,545,550 229,279,000 66,127,725 1942-2012 1998-2015 16 years to 39 years Rhode Island (SNF) 3,658,261 35,082,551 4,792,882 - - 3,658,261 39,875,433 43,533,694 16,190,347 1965-1981 2006 39 years South Carolina (SNF) 7,800,000 59,782,493 - - - 7,800,000 59,782,493 67,582,493 5,718,501 1959-2007 2014-2016 20 years to 30 years Tennessee (SNF) 5,932,773 99,743,478 4,897,458 - (527,491 ) 5,827,316 104,218,902 110,046,218 46,714,574 1958-1985 1992-2015 20 years to 31 years Texas (AL, SNF) 67,370,202 667,695,852 24,223,887 203,265 (1,000 ) 67,370,202 692,122,004 759,492,206 97,331,606 1952-2015 1997-2016 2 years to 40 years United Kingdom (AL) 47,432,242 256,409,736 1,646,761 - (52,350,758 ) 39,822,262 213,315,719 253,137,981 10,141,108 1750-2011 2015-2016 30 years Utah (SNF) 633,938 2,986,062 - - - 633,938 2,986,062 3,620,000 247,001 1977 2015 24 years Vermont (SNF) 317,500 6,005,388 602,296 - - 317,500 6,607,684 6,925,184 2,416,363 1971 2004 39 years Virginia (SNF) 2,566,363 30,009,385 - - - 2,566,363 30,009,385 32,575,748 1,582,827 1989-1995 2015 33 years to 40 years Washington (SNF, AL) 11,719,119 138,054,574 2,626,926 - (1,500 ) 11,717,619 140,681,500 152,399,119 22,271,862 1930-2004 1995-2015 20 years to 33 years West Virginia (SNF) 1,972,682 66,945,947 7,000,345 - - 1,972,682 73,946,292 75,918,974 32,588,074 1961-1996 1994-2011 25 years to 39 years Wisconsin (SNF, AL) 7,377,429 53,224,076 5,252,877 - (1,500 ) 7,377,429 58,475,453 65,852,882 12,420,492 1930-1994 2009-2015 20 years to 33 years Total Other 504,282,111 4,898,553,097 215,826,408 1,215,334 (71,227,578 ) 496,557,674 5,052,091,698 5,548,649,372 1,085,047,116 Total $ 767,018,940 $ 6,549,820,611 $ 312,976,028 $ 8,718,627 $ (72,175,923 ) $ 759,294,503 $ 6,807,063,780 $ 7,566,358,283 $ 1,240,335,945 (1) The real estate included in this schedule is being used in either the operation of skilled nursing facilities (SNF), assisted living facilities (AL), independent living facilities (ILF), tramatic brain injury (TBI), medical office building (MOB) or specialty hospitals (SH) located in the states or country indicated. (2) Certain of the real estate indicated are security for the HUD loan borrowings totaling $54,954,695 at December 31, 2016. Year Ended December 31, (3) 2014 2015 2016 Balance at beginning of period $ 3,099,547,182 $ 3,223,785,295 $ 6,743,957,698 Acquisitions through foreclosure - - 25,000,000 Acquisitions 131,689,483 3,371,233,860 1,017,760,963 Impairment (3,660,381 ) (12,916,233 ) (53,716,724 ) Improvements 17,916,855 220,272,401 95,806,618 Disposals/other (21,707,844 ) (58,417,625 ) (262,450,272 ) Balance at close of period $ 3,223,785,295 $ 6,743,957,698 $ 7,566,358,283 Year Ended December 31, (4) 2014 2015 2016 Balance at beginning of period $ 707,409,888 $ 821,711,991 $ 1,019,149,678 Provisions for depreciation 123,141,880 210,554,569 266,904,418 Dispositions/other (8,839,777 ) (13,116,882 ) (45,718,151 ) Balance at close of period $ 821,711,991 $ 1,019,149,678 $ 1,240,335,945 (5) The reported amount of our real estate at December 31, 2016 is greater than the tax basis of the real estate by approximately $1.1 billion. (6) Reflects bed sales, land easements and impacts from foreign currency exchange rates.

SCHEDULE IV MORTGAGE LOANS ON R

SCHEDULE IV MORTGAGE LOANS ON REAL ESTATE	12 Months Ended
	Dec. 31, 2016
Mortgage Loans On Real Estate [Abstract]
MORTGAGE LOANS ON REAL ESTATE	SCHEDULE IV MORTGAGE LOANS ON REAL ESTATE OMEGA HEALTHCARE INVESTORS, INC. December 31, 2016 Grouping Description (1) Interest Rate Final Maturity Periodic Payment Prior Liens Face Amount of Carrying Amount (2) (3) Principal Amount 1 Louisiana (1 AL facility) 8.75 % 2018 Interest accrues monthly None $ 9,870,626 $ 9,870,626 2 Maryland (3 SNF facilities) 11.00 % 2028 Interest payable monthly None 74,927,751 35,963,840 3 Michigan (31 SNF facilities) 9.45 % 2029 Interest plus $105,000 of principal payable monthly None 415,000,000 412,140,060 4 Michigan (1 SNF facility) 10.77 % 2021 Interest payable monthly None 3,917,030 3,917,030 - 5 Michigan (1 SNF facility) 10.51 % 2021 Interest payable monthly None 4,111,387 4,111,387 - 6 Michigan (1 SNF facility) 10.25 % 2029 Interest payable monthly None 2,214,376 2,214,376 - 7 Michigan (1 SNF facility) 10.25 % 2029 Interest payable monthly None 560,601 560,601 - 8 Michigan (1 SNF facility) 10.25 % 2029 Interest payable monthly None 267,170 267,170 - 9 Michigan (1 SNF facility) 10.25 % 2029 Interest payable monthly None 100,000 100,000 - 10 Michigan (1 SNF facility) 10.25 % 2029 Interest payable monthly None 252,241 252,241 - 11 Michigan (1 SNF facility) 10.25 % 2029 Interest payable monthly None 269,740 269,740 - 12 Michigan (1 SNF facility) 10.25 % 2029 Interest payable monthly None 4,036,982 4,036,982 - 13 Michigan (1 SNF facility) 10.25 % 2029 Interest payable monthly None 4,089,039 4,089,039 - 14 Michigan (1 SNF facility) 9.50 % 2029 Interest payable monthly None 597,022 597,022 - 15 Michigan (1 SNF facility) 9.50 % 2029 Interest payable monthly None 125,930 125,930 - 16 Michigan (1 SNF facility) 9.50 % 2029 Interest payable monthly None 1,803,905 1,803,905 - 17 Michigan (1 SNF facility) 9.50 % 2029 Interest payable monthly None 432,754 432,754 - 18 Michigan (1 SNF facility) 9.50 % 2029 Interest payable monthly None 190,842 190,842 - 19 Michigan (1 SNF facility) 8.50 % 2029 Interest payable monthly None 14,044,762 14,044,762 - 20 Missouri (1 SNF facility) and Tennessee ( 1 SNF facility) 8.35 % 2015 Interest plus $0 of principal payable monthly None 6,997,610 2,500,000 21 New Jersey (1 AL facility) 10.00 % 2017 Interest payable monthly None 3,195,000 3,195,000 - 22 Ohio (2 SNF facilities) and Pennsylvania (5 SNF and 2 AL facilities) 9.79 % 2024 Interest payable monthly None 112,500,000 112,500,000 - 23 Ohio (1 SNF facility) 11.67 % 2018 Interest payable monthly None 11,874,013 12,254,985 24 South Carolina (1 AL facility) 8.75 % 2018 Interest accrues monthly None 8,762,943 8,762,943 - 25 Virginia (1 AL facility) 8.75 % 2018 Interest accrues monthly None 5,142,008 5,142,008 - $ 685,283,732 $ 639,343,243 (1) Mortgage loans included in this schedule represent first mortgages on facilities used in the delivery of long-term healthcare of which such facilities are located in the states indicated. (2) The aggregate cost for federal income tax purposes is equal to the carrying amount. Year Ended December 31, (3) 2014 2015 2016 Balance at beginning of period $ 241,514,812 $ 648,078,550 $ 679,795,236 Additions during period - Placements 529,547,836 33,288,320 48,721,953 Deductions during period - collection of principal/other (122,984,098 ) (1,571,634 ) (89,173,946 ) Balance at close of period $ 648,078,550 $ 679,795,236 $ 639,343,243

SUMMARY OF SIGNIFICANT ACCOUN34

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2016
Organization, Consolidation and Presentation Of Financial Statements [Abstract]
Accounting Estimates	Accounting Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Fair Value Measurement	Fair Value Measurement The Company measures and discloses the fair value of nonfinancial and financial assets and liabilities utilizing a hierarchy of valuation techniques based on whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy: · Level 1 - quoted prices for identical instruments in active markets; · Level 2 - quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and · Level 3 - fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The Company measures fair value using a set of standardized procedures that are outlined herein for all assets and liabilities which are required to be measured at fair value. When available, the Company utilizes quoted market prices from an independent third party source to determine fair value and classifies such items in Level 1. In some instances where a market price is available, but the instrument is in an inactive or over-the-counter market, the Company consistently applies the dealer (market maker) pricing estimate and classifies such items in Level 2. If quoted market prices or inputs are not available, fair value measurements are based upon valuation models that utilize current market or independently sourced market inputs, such as interest rates, option volatilities, credit spreads and/or market capitalization rates. Items valued using such internally-generated valuation techniques are classified according to the lowest level input that is significant to the fair value measurement. As a result, these items could be classified in either Level 2 or Level 3 even though there may be some significant inputs that are readily observable. Internal fair value models and techniques used by the Company include discounted cash flow and Monte Carlo valuation models.
Risks and Uncertainties	Risks and Uncertainties Our Company is subject to certain risks and uncertainties affecting the healthcare industry as a result of healthcare legislation and growing regulation by federal, state and local governments. Additionally, we are subject to risks and uncertainties as a result of changes affecting operators of nursing home facilities due to the actions of governmental agencies and insurers to limit the rising cost of healthcare services (see Note 10 – Concentration of Risk).
Business Combinations	Business Combinations We record the purchase of properties to net tangible and identified intangible assets acquired and liabilities assumed at fair value. Transaction costs are expensed as incurred as part of a business combination. In making estimates of fair value for purposes of recording the purchase, we utilize a number of sources, including independent appraisals that may be obtained in connection with the acquisition or financing of the respective property and other market data. We also consider information obtained about each property as a result of our pre-acquisition due diligence, marketing and leasing activities as well as other critical valuation metrics such as current capitalization rates and discount rates used to estimate the fair value of the tangible and intangible assets acquired (Level 3). When liabilities are assumed as part of a transaction, we consider information obtained about the liabilities and use similar valuation metrics (Level 3). In some instances when debt is assumed and an identifiable active market for similar debt is present, we use market interest rates for similar debt to estimate the fair value of the debt assumed (Level 2). The Company determines fair value as follows: · Land is determined based on third party appraisals which typically include market comparables. · Buildings and site improvements acquired are valued using a combination of discounted cash flow projections that assume certain future revenues and costs and consider capitalization and discount rates using current market conditions as well as replacement cost analysis. · Furniture and fixtures are determined based on third party appraisals which typically utilize a replacement cost approach. · Intangible assets and liabilities acquired are valued using a combination of discounted cash flow projections as well as other valuation techniques based on current market conditions for the intangible asset or liability being acquired. When evaluating below market leases we consider extension options controlled by the lessee in our evaluation. For additional information regarding above and below market leases assumed as part of an acquisition see “In-Place Leases" below. · Other assets acquired and liabilities assumed are typically valued at stated amounts, which approximate fair value on the date of the acquisition. · Assumed debt balances are valued by discounting the remaining contractual cash flows using a current market rate of interest. · Stock based compensation and noncontrolling interests are valued using a stock price on the acquisition date. · Goodwill represents the purchase price in excess of the fair value of assets acquired and liabilities assumed and the cost associated with expanding our investment portfolio. Goodwill is not amortized.
Asset Acquisitions	Asset Acquisitions For acquisitions not accounted for as a business combination, assets and liabilities are recognized based on their cost to the Company which generally includes transaction costs. The costs of the acquisition are allocated to the assets and liabilities acquired on a relative fair value basis.
Real Estate Investments and Depreciation	Real Estate Investments and Depreciation The costs of significant improvements, renovations and replacements, including interest are capitalized. In addition, we capitalize leasehold improvements when certain criteria are met, including when we supervise construction and will own the improvement. Expenditures for maintenance and repairs are charged to operations as they are incurred. Depreciation is computed on a straight-line basis over the estimated useful lives ranging from 20 to 40 years for buildings, eight to 15 years for site improvements, and three to ten years for furniture, fixtures and equipment. Leasehold interests are amortized over the shorter of the estimated useful life or term of the lease. As of December 31, 2016 and 2015, we had identified conditional asset retirement obligations primarily related to the future removal and disposal of asbestos that is contained within certain of our real estate investment properties. The asbestos is appropriately contained, and we believe we are compliant with current environmental regulations. If these properties undergo major renovations or are demolished, certain environmental regulations are in place, which specify the manner in which asbestos must be handled and disposed. We are required to record the fair value of these conditional liabilities if they can be reasonably estimated. As of December 31, 2016 and 2015, sufficient information was not available to estimate our liability for conditional asset retirement obligations as the obligations to remove the asbestos from these properties have indeterminable settlement dates. As such, no liability for conditional asset retirement obligations was recorded on our accompanying Consolidated Balance Sheets as of December 31, 2016 and 2015.
Lease Accounting	Lease Accounting At the inception of the lease and during the amendment process, we evaluate each lease to determine if the lease should be considered an operating lease, sales-type lease, or direct financing lease. We have determined that all but seven of our leases should be accounted for as operating leases. The other seven leases are accounted for as direct financing leases. For leases accounted for as operating leases, we retain ownership of the asset and record depreciation expense, see “Business Combinations” and “Real Estate Investments and Depreciation” above for additional information regarding our investment in real estate leased under operating lease agreements. We also record lease revenue based on the contractual terms of the operating lease agreement which often includes annual rent escalators, see “Revenue Recognition” below for further discussion regarding the recordation of revenue on our operating leases. For leases accounted for as , we record the present value of the future minimum lease payments (utilizing a constant interest rate over the term of the lease agreement) as a receivable and record
In-Place Leases	In-Place Leases In-place lease assets and liabilities result when we assume a lease as part of a facility purchase or business combination. The fair value of in-place leases consists of the following components, as applicable (1) the estimated cost to replace the leases, and (2) the above or below market cash flow of the leases, determined by comparing the projected cash flows of the leases in place at the time of acquisition to projected cash flows of comparable market-rate leases (referred to as Lease Intangibles). Lease Intangible assets and liabilities are classified as lease contracts above and below market value, respectively, in other assets and accrued expenses and other liabilities on our Consolidated Balance Sheets, and amortized on a straight-line basis as decreases and increases, respectively, to rental income over the estimated remaining term of the underlying leases. Should a tenant terminate the lease, the unamortized portion of the lease intangible is recognized immediately as income or expense. For additional information, see Note 9 – Intangibles.
Asset Impairment	Asset Impairment Management evaluates our real estate investments for impairment indicators at each reporting period, including the evaluation of our assets’ useful lives. The judgment regarding the existence of impairment indicators is based on factors such as, but not limited to, market conditions, operator performance, legal structure, as well as our intent with respect to holding or disposing of the asset. If indicators of impairment are present, management evaluates the carrying value of the related real estate investments in relation to the future undiscounted cash flows of the underlying facilities. Provisions for impairment losses related to long-lived assets are recognized when expected future undiscounted cash flows based on our intended use of the property are determined to be less than the carrying values of the assets. An adjustment is made to the net carrying value of the real estate investments for the excess of carrying value over fair value. The fair value of the real estate investment is determined by market research, which includes valuing the property as a nursing home as well as other alternative uses. All impairments are taken as a period cost at that time, and depreciation is adjusted going forward to reflect the new value assigned to the asset. Management’s impairment evaluation process, and when applicable, impairment calculations involve estimation of the future cash flows from management’s intended use of the property. Changes in the facts and circumstances that drive management’s assumptions may result in an impairment of the Company’s assets in a future period that could be material to the Company’s results of operations. If we decide to sell real estate properties or land holdings, we evaluate the recoverability of the carrying amounts of the assets. If the evaluation indicates that the carrying value is not recoverable from estimated net sales proceeds, the property is written down to estimated fair value less costs to sell. Our estimates of cash flows and fair values of the properties are based on current market conditions and consider matters such as rental rates and occupancies for comparable properties, recent sales data for comparable properties, and, where applicable, contracts or the results of negotiations with purchasers or prospective purchasers. For the years ended December 31, 2016, 2015 and 2014, we recognized impairment losses of $58.7 million, $17.7 million and $3.7 million, respectively. For additional information, see Note 3 – Properties and Note 8 – Assets Held For Sale.
Loan and Direct Financing Lease Impairment	Loan and Direct Financing Lease Impairment Management evaluates our outstanding mortgage notes, direct financing leases and other notes receivable for impairment. When management identifies potential loan or direct financing lease impairment indicators, such as non-payment under the loan documents, impairment of the underlying collateral, financial difficulty of the operator or other circumstances that may impair full execution of the loan documents or direct financing leases, and management believes it is probable that all amounts will not be collected under the contractual terms of the loan or direct financing lease, the loan or direct financing lease is written down to the present value of the expected future cash flows. In cases where expected future cash flows are not readily determinable, the loan or direct financing lease is written down to the fair value of the collateral. The fair value of the loan or direct financing lease is determined by market research, which includes valuing the property as a nursing home as well as other alternative uses. We account for impaired loans and direct financing leases using (a) the cost-recovery method, and/or (b) the cash basis method. We generally utilize the cost-recovery method for impaired loans or direct financing leases for which impairment reserves were recorded. We utilize the cash basis method for impaired loans or direct financing leases for which no impairment reserves were recorded because the net present value of the discounted cash flows expected under the loan or direct financing lease and/or the underlying collateral supporting the loan or direct financing lease were equal to or exceeded the book value of the loans or direct financing leases. Under the cost-recovery method, we apply cash received against the outstanding loan balance or direct financing lease prior to recording interest income. Under the cash basis method, we apply cash received to principal or interest income based on the terms of the agreement. As of December 31, 2016 and 2015, we had $8.7 million and $3.0 million, respectively, of reserves on our mortgages and other investments and no reserves on our direct financing leases. For additional information, see Note 4 – Direct Financing Leases, Note 5 – Mortgage Notes Receivable and Note 6 – Other Investments.
Investment in Unconsolidated Joint Venture	Investment in Unconsolidated Joint Venture We account for our investment in an unconsolidated joint venture using the equity method of accounting as we exercise significant influence, but do not control the entity. Under the equity method of accounting, the net equity investment of the Company is reflected in the accompanying Consolidated Balance Sheets and the Company's share of net income and comprehensive income from the joint venture is included in the accompanying Consolidated Statements of Operations and Consolidated Statements of Comprehensive Income, respectively. On a periodic basis, management assesses whether there are any indicators that the value of the Company's investment in the unconsolidated joint venture may be other-than-temporarily-impaired. An investment is impaired only if management's estimate of the value of the investment is less than the carrying value of the investment, and such a decline in value is deemed to be other than-temporary. To the extent impairment has occurred, the loss is measured as the excess of the carrying amount of the investment over the estimated fair value of the investment. The estimated fair value of the investment is determined using a discounted cash flow model which is a Level 3 valuation. We consider a number of assumptions that are subject to economic and market uncertainties including, among others, rental rates, operating costs, capitalization rates, holding periods and discount rates. No impairment loss on our investment in unconsolidated joint venture was recognized during the year ended December 31, 2016.
Assets Held for Sale	Assets Held for Sale We consider properties to be assets held for sale when (1) management commits to a plan to sell the property; (2) it is unlikely that the disposal plan will be significantly modified or discontinued; (3) the property is available for immediate sale in its present condition; (4) actions required to complete the sale of the property have been initiated; (5) sale of the property is probable and we expect the completed sale will occur within one year; and (6) the property is actively being marketed for sale at a price that is reasonable given our estimate of current market value. Upon designation of a property as an asset held for sale, we record the property's value at the lower of its carrying value or its estimated fair value, less estimated costs to sell, and we cease depreciation. For additional information, see Note 8 – Assets Held for Sale.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents consist of cash on hand and highly liquid investments with a maturity date of three months or less when purchased. These investments are stated at cost, which approximates fair value. The majority of our cash and cash equivalents are held at major commercial banks.
Restricted Cash	Restricted Cash Restricted cash consists primarily of funds escrowed for tenants’ security deposits required by us pursuant to certain contractual terms (see Note 11 – Lease and Mortgage Deposits).
Accounts Receivable	Accounts Receivable Accounts receivable includes: contractual receivables, effective yield interest receivables, straight-line rent receivables and lease inducements, net of an estimated provision for losses related to uncollectible and disputed accounts. Contractual receivables relate to the amounts currently owed to us under the terms of our lease and loan agreements. Effective yield interest receivables relate to the difference between the interest income recognized on an effective yield basis over the term of the loan agreement and the interest currently due to us according to the contractual agreement. Straight-line rent receivables relate to the difference between the rental revenue recognized on a straight-line basis and the amounts currently due to us according to the contractual agreement. Lease inducements result from value provided by us to the lessee, at the inception or renewal of the lease, and are amortized as a reduction of rental revenue over the non-cancellable lease term. On a quarterly basis, we review our accounts receivable to determine their collectability. The determination of collectability of these assets requires significant judgment and is affected by several factors relating to the credit quality of our operators that we regularly monitor, including (i) payment history, (ii) the age of the contractual receivables, (iii) the current economic conditions and reimbursement environment, (iv) the ability of the tenant to perform under the terms of their lease and/or contractual loan agreements and (v) the value of the underlying collateral of the agreement. If we determine collectability of any of our contractual receivables is at risk, we estimate the potential uncollectible amounts and provide an allowance. In the case of a lease recognized on a straight-line basis, a mortgage recognized on an effective yield basis or the existence of lease inducements, we generally provide an allowance for straight-line, effective interest, and or lease inducement accounts receivable when certain conditions or indicators of adverse collectability are present. If the accounts receivable balance is subsequently deemed uncollectible, the receivable and allowance for doubtful account balance are written off. A summary of our net receivables by type is as follows: December 31, 2016 2015 (in thousands) Contractual receivables $ 13,376 $ 8,452 Effective yield interest receivables 9,749 9,028 Straight-line rent receivables 208,874 175,709 Lease inducements 8,393 10,982 Allowance (357 ) (309 ) Accounts receivable – net $ 240,035 $ 203,862 In 2016, we wrote-off approximately $4.3 million of straight-line rent receivable. The write-off primarily related to the transition of facilities from a former operator to a current operator. In 2015, we wrote-off $3.2 million of straight-line rent receivables and $1.5 million of effective yield interest receivables associated with four facilities that were transitioned to a new operator and three mortgages that were repaid prior to their maturity. This transaction closed in 2016. In 2014, we wrote-off $0.8 million of straight-line rent receivables associated with a lease amendment to an existing operator for two facilities that were transitioned to a new operator and $2.0 million of effective yield interest receivables associated with the termination of a mortgage note that was due November 2021.
Goodwill Impairment	Goodwill Impairment We assess goodwill for potential impairment during the fourth quarter of each fiscal year, or during the year if an event or other circumstance indicates that we may not be able to recover the carrying amount of the net assets of the reporting unit. In evaluating goodwill for impairment on an interim basis, we assess qualitative factors such as a current macroeconomic conditions, state of the equity and capital markets and our overall financial and operating performance In the first step of the two-step goodwill impairment test (“Step 1”), we compare the fair value of the reporting unit to its net book value, including goodwill. As the Company has only one reporting unit, the fair value of the reporting unit is determined by reference to the market capitalization of the Company as determined through quoted market prices and adjusted for other relevant factors. A potential impairment exists if the fair value of the reporting unit is lower than its net book value. The second step (“Step 2”) of the process is only performed if a potential impairment exists, and it involves determining the difference between the fair value of the reporting unit's net assets other than goodwill and the fair value of the reporting unit. If the difference is less than the net book value of goodwill, impairment exists and is recorded. The Company has not been required to perform Step 2 of the process because the fair value of the reporting unit has significantly exceeded its book value at the measurement date. There was no impairment of goodwill during 2016 and 2015.
Income Taxes	Income Taxes We were organized to qualify for taxation as a REIT under Section 856 through 860 of the Internal Revenue Code (“Code”). As long as we qualify as a REIT; we will not be subject to federal income taxes on the REIT taxable income that we distributed to stockholders, subject to certain exceptions. However, with respect to certain of our subsidiaries that have elected to be treated as taxable REIT subsidiaries (“TRSs”), we record income tax expense or benefit, as those entities are subject to federal income tax similar to regular corporations. We account for deferred income taxes using the asset and liability method and recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in our financial statements or tax returns. Under this method, we determine deferred tax assets and liabilities based on the differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Any increase or decrease in the deferred tax liability that results from a change in circumstances, and that causes us to change our judgment about expected future tax consequences of events, is included in the tax provision when such changes occur. Deferred income taxes also reflect the impact of operating loss and tax credit carryforwards. A valuation allowance is provided if we believe it is more likely than not that all or some portion of the deferred tax asset will not be realized. Any increase or decrease in the valuation allowance that results from a change in circumstances, and that causes us to change our judgment about the realizability of the related deferred tax asset, is included in the tax provision when such changes occur. For additional information on income taxes, see Note 14 – Taxes.
Revenue Recognition	Revenue Recognition We have various different investments that generate revenue, including leased and mortgaged properties, as well as other investments, including working capital loans. We recognize rental income and other investment income as earned over the terms of the related leases and notes, respectively. Interest income is recorded on an accrual basis to the extent that such amounts are expected to be collected using the effective interest method. In applying the effective interest method, the effective yield on a loan is determined based on its contractual payment terms, adjusted for prepayment terms. Substantially all of our operating leases contain provisions for specified annual increases over the rents of the prior year and are generally computed in one of three methods depending on specific provisions of each lease as follows: (i) a specific annual increase over the prior year’s rent, generally between 2.0% and 3.0%; (ii) an increase based on the change in pre-determined formulas from year to year (e.g. increases in the Consumer Price Index); or (iii) specific dollar increases over prior years. Revenue under lease arrangements with minimum fixed and determinable increases is recognized over the non-cancellable term of the lease on a straight-line basis. The authoritative guidance does not provide for the recognition of contingent revenue until all possible contingencies have been eliminated. We consider the operating history of the lessee, the payment history, the general condition of the industry and various other factors when evaluating whether all possible contingencies have been eliminated. We do not recognize contingent rents as income until the contingencies have been resolved. In the case of rental revenue recognized on a straight-line basis, we generally record reserves against earned revenues from leases when collection becomes questionable or when negotiations for restructurings of troubled operators result in significant uncertainty regarding ultimate collection. The amount of the reserve is estimated based on what management believes will likely be collected. We continually evaluate the collectability of our straight-line rent assets. If it appears that we will not collect future rent due under our leases, we will record a provision for loss related to the straight-line rent asset. We record direct financing lease income on a constant interest rate basis over the term of the lease. The costs related to originating the direct financing leases have been deferred and are being amortized on a straight-line basis as a reduction to income from direct financing leases over the term of the direct financing leases. Mortgage interest income is recognized as earned over the terms of the related mortgage notes, using the effective yield method. Allowances are provided against earned revenues from mortgage interest when collection of amounts due becomes questionable or when negotiations for restructurings of troubled operators lead to lower expectations regarding ultimate collection. When collection is uncertain, mortgage interest income on impaired mortgage loans is recognized as received after taking into account the application of security deposits. Gains on sales of real estate assets are recognized in accordance with the authoritative guidance for sales of real estate. The specific timing of the recognition of the sale and the related gain is measured against the various criteria in the guidance related to the terms of the transactions and any continuing involvement associated with the assets sold. To the extent the sales criteria are not met, we defer gain recognition until the sales criteria are met.
Stock-Based Compensation	Stock-Based Compensation We recognize stock-based compensation expense adjusted for estimated forfeitures to employees and directors, in general and administrative in our Consolidated Statements of Operations on a straight-line basis over the requisite service period of the awards, see Note 17 – Stock-Based Compensation for additional details.
Deferred Financing Costs and Original Issuance Premium and/or Discounts for Debt Issuance	Deferred Financing Costs and Original Issuance Premium and/or Discounts for Debt Issuance In April 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2015-03, Simplifying the Presentation of Debt Issuance Costs Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements External costs incurred from the placement of our debt are capitalized and amortized on a straight-line basis over the terms of the related borrowings which approximates the effective interest method. Deferred financing costs related to our revolving line of credit are included in other assets on our Consolidated Balance Sheets and deferred financing costs related to our other borrowings are included as a direct deduction from the carrying amount of the related debt liability on our Consolidated Balance Sheets. Original issuance premium or discounts reflect the difference between the face amount of the debt issued and the cash proceeds received and are amortized on a straight-line basis over the term of the related borrowings. All premiums and discounts are recorded as an addition to or reduction from debt on our Consolidated Balance Sheets. Amortization of deferred financing costs and original issuance premiums or discounts totaled $9.3 million, $7.0 million and $4.5 million in 2016, 2015 and 2014, respectively, and are classified as interest - amortization of deferred financing costs on our Consolidated Statements of Operations. When financings are terminated, unamortized deferred financing costs and unamortized premiums or discounts, as well as charges incurred for the termination, are recognized as expense or income at the time the termination is made. Gains and losses from the extinguishment of debt are presented in interest-refinancing costs on our Consolidated Statements of Operations.
Earnings Per Share	Earnings Per Share Basic earnings per common share (“EPS”) is computed by dividing net income available to common stockholders by the weighted-average number of shares of common stock outstanding during the year. Diluted EPS is computed using the treasury stock method, which is net income divided by the total weighted-average number of common outstanding shares plus the effect of dilutive common equivalent shares during the respective period. Dilutive common shares reflect the assumed issuance of additional common shares pursuant to certain of our share-based compensation plans, including stock options, restricted stock and performance restricted stock units and the assumed issuance of additional shares related to Omega OP Units held by outside investors. All outstanding unvested share-based payment awards that contain rights to non-forfeitable dividends or dividend equivalents that participate in undistributed earnings with common stockholders are considered participating securities that shall be included in the two-class method of computing basic EPS. The impact of the two class method is immaterial. For additional information, see Note 21 – Earnings Per Share.
Redeemable Limited Partnership Unitholder Interests and Noncontrolling Interests	Redeemable Limited Partnership Unitholder Interests and Noncontrolling Interests As of April 1, 2015 and after giving effect to the Aviv Merger, the Company owned approximately 138.8 million Omega OP Units and Aviv OP owned approximately 52.9 million Omega OP Units. Each of the Omega OP Units (other than the Omega OP Units owned by Omega) is redeemable at the election of the Omega OP Unit holder for cash equal to the then-fair market value of one share of Omega common stock, par value $0.10 per share (“Omega Common Stock”), subject to the Company’s election to exchange the Omega OP Units tendered for redemption for unregistered shares of Omega Common Stock on a one-for-one basis, subject to adjustment as set forth in the Partnership Agreement. Effective June 30, 2015, the Company (through Merger Sub, in its capacity as the general partner of Aviv OP) caused Aviv OP to make a distribution of Omega OP Units held by Aviv OP (or equivalent value) to Aviv OP investors (the “Aviv OP Distribution”) in connection with the liquidation of Aviv OP. As a result of the Aviv OP Distribution, Omega directly and indirectly owned approximately 95% of the outstanding Omega OP Units, and the other investors owned approximately 5% of the outstanding Omega OP Units. As a part of the Aviv OP Distribution, Omega settled approximately 0.2 million units via cash settlement. As of December 31, 2016, Omega directly and indirectly owns approximately 96% of the outstanding Omega OP Units, and the other investors own approximately 4% of the outstanding Omega OP Units.
Noncontrolling Interests	Noncontrolling Interests Noncontrolling interests is the portion of equity in the Omega OP not attributable to the Company. We present the portion of any equity that we do not own in consolidated entities as noncontrolling interests and classify those interests as a component of total equity, separate from total stockholders’ equity, on our Consolidated Balance Sheets. We include net income attributable to the noncontrolling interests in net income in our Consolidated Statements of Operations. As our ownership of a controlled subsidiary increases or decreases, any difference between the aggregate consideration paid to acquire the noncontrolling interests and our noncontrolling interest balance is recorded as a component of equity in additional paid-in capital, so long as we maintain a controlling ownership interest.
Foreign Operations	Foreign Operations The U.S. dollar is the functional currency for our consolidated subsidiaries operating in the United States. The functional currency for our consolidated subsidiaries operating in countries other than the United States is the principal currency in which the entity primarily generates and expends cash. For our consolidated subsidiaries whose functional currency is not the U.S. dollar, we translate their financial statements into the U.S. dollar. We translate assets and liabilities at the exchange rate in effect as of the financial statement date. Revenue and expense accounts are translated using an average exchange rate for the period. Gains and losses resulting from this translation are included in accumulated other comprehensive loss (“AOCL”) as a separate component of equity and a proportionate amount of gain or loss is allocated to noncontrolling interest. We and certain of our consolidated subsidiaries may have intercompany and third-party debt that is not denominated in the entity’s functional currency. When the debt is remeasured against the functional currency of the entity, a gain or loss can result. The resulting adjustment is reflected in results of operations, unless it is intercompany debt that is deemed to be long-term in nature and then the adjustments are included in AOCL.
Derivative Instruments	Derivative Instruments During our normal course of business, we may use certain types of derivative instruments for the purpose of managing interest rate and currency risk. To qualify for hedge accounting, derivative instruments used for risk management purposes must effectively reduce the risk exposure that they are designed to hedge. In addition, at the inception of a qualifying cash flow hedging relationship, the underlying transaction or transactions, must be, and are expected to remain, probable of occurring in accordance with the Company’s related assertions. The Company recognizes all derivative instruments, including embedded derivatives required to be bifurcated, as assets or liabilities on the Consolidated Balance Sheets at fair value which is determined using a market approach and Level 2 inputs. Changes in the fair value of derivative instruments that are not designated in hedging relationships or that do not meet the criteria of hedge accounting are recognized in earnings. For derivatives designated as qualifying cash flow hedging relationships, the change in fair value of the effective portion of the derivatives is recognized in AOCL as a separate component of equity and a proportionate amount of gain or loss is allocated to noncontrolling interest, whereas the change in fair value of the ineffective portion is recognized in earnings. We formally document all relationships between hedging instruments and hedged items, as well as our risk-management objectives and strategy for undertaking various hedge transactions. This process includes designating all derivatives that are part of a hedging relationship to specific forecasted transactions as well as recognized liabilities or assets on the Consolidated Balance Sheets. We also assess and document, both at inception of the hedging relationship and on a quarterly basis thereafter, whether the derivatives are highly effective in offsetting the designated risks associated with the respective hedged items. If it is determined that a derivative ceases to be highly effective as a hedge, or that it is probable the underlying forecasted transaction will not occur, we discontinue hedge accounting prospectively and record the appropriate adjustment to earnings based on the current fair value of the derivative. As a matter of policy, we do not use derivatives for trading or speculative purposes. At December 2016 and 2015, we had $1.5 million and $0.7 million, respectively, of qualifying cash flow hedges recorded at fair value in accrued expenses and other liabilities on our Consolidated Balance Sheets.
Related Party Transactions	Related Party Transactions The Company has a policy which generally requires related party transactions to be approved or ratified by the Audit Committee. On February 1, 2016, we acquired 10 SNFs from Laurel Healthcare Holdings, Inc. (“Laurel”) for approximately $169.0 million in cash and leased them to an unrelated existing operator. A former member of the Board of Directors of the Company, together with certain members of his immediate family, beneficially owned approximately 34% of the equity of Laurel prior to the transaction. Immediately following our acquisition, the unrelated existing operator acquired all of the outstanding equity interests of Laurel, including the interests previously held by the former director of the Company and his family.
Reclassification	Reclassification Certain prior year amounts have been reclassified to conform with the current year presentation.
Change in Accounting Principle	Change in Accounting Principle We have retrospectively adjusted the presentation of deferred financing costs on the Company’s Consolidated Balance Sheets for all prior periods, as required by ASU 2015-03 and ASU 2015-15. The guidance requires debt issuance costs to be presented as a direct deduction from the related debt liability rather than as an asset, except for costs associated with our revolving credit facility. The prior period amounts that have been impacted by the new accounting guidance were retrospectively adjusted to their respective debt liability line items on the Company’s Consolidated Balance Sheets. The following table presents the impact of the change in accounting principle to the Consolidated Balance Sheets of the Company as of December 31, 2016: As of December 31, 2016 Term Loans, Secured Unsecured (in thousands) Prior to change in accounting principle $ 1,100,000 $ 54,954 $ 3,055,849 Impact of change in accounting principle (5,657 ) (589 ) (27,703 ) As reported $ 1,094,343 $ 54,365 $ 3,028,146 The following table presents the impact of the change in accounting principle to the Consolidated Balance Sheets of the Company as of December 31, 2015: As of December 31, 2015 Term Loans, Secured Unsecured (in thousands) As previously reported $ 750,000 $ 236,204 $ 2,352,882 Impact of change in accounting principle (4,307 ) (611 ) (24,155 ) As adjusted and currently reported $ 745,693 $ 235,593 $ 2,328,727
Recent Accounting Pronouncements	Recently Adopted Accounting Pronouncements In February 2015, the FASB issued ASU 2015-02, Amendments to the Consolidation Analysis In January 2017, the FASB issued ASU 2017-01, Business Combinations-Clarifying the Definition of a Business
Recent Accounting Pronouncements - Pending Adoption	Recent Accounting Pronouncements - Pending Adoption In 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers Principal versus Agent Considerations (Reporting Revenue Gross versus Net), Identifying Performance Obligations and Licensing, Narrow-Scope Improvements and Practical Expedients. In February 2016, the FASB issued ASU 2016-02, Leases In March 2016, the FASB issued ASU 2016-09, Compensation-Stock Compensation (Topic 718) In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326 In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments . In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230) Restricted Cash ,

SUMMARY OF SIGNIFICANT ACCOUN35

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2016
Accounting Policies [Abstract]
Schedule of summary of net receivables	December 31, 2016 2015 (in thousands) Contractual receivables $ 13,376 $ 8,452 Effective yield interest receivables 9,749 9,028 Straight-line rent receivables 208,874 175,709 Lease inducements 8,393 10,982 Allowance (357 ) (309 ) Accounts receivable – net $ 240,035 $ 203,862
Schedule of impact of the change in accounting principle to the Consolidated Balance Sheets	As of December 31, 2016 Term Loans, Secured Unsecured (in thousands) Prior to change in accounting principle $ 1,100,000 $ 54,954 $ 3,055,849 Impact of change in accounting principle (5,657 ) (589 ) (27,703 ) As reported $ 1,094,343 $ 54,365 $ 3,028,146 As of December 31, 2015 Term Loans, Secured Unsecured (in thousands) As previously reported $ 750,000 $ 236,204 $ 2,352,882 Impact of change in accounting principle (4,307 ) (611 ) (24,155 ) As adjusted and currently reported $ 745,693 $ 235,593 $ 2,328,727

PROPERTIES (Tables)

PROPERTIES (Tables)	12 Months Ended
	Dec. 31, 2016
Real Estate Properties [Line Items]
Schedule of investment in leased real estate properties	December 31, 2016 2015 (in thousands) Buildings $ 5,954,771 $ 5,320,482 Land 759,295 670,916 Furniture, fixtures and equipment 454,760 426,040 Site improvements 206,206 132,182 Construction in progress 191,326 194,338 Total real estate investments 7,566,358 6,743,958 Less accumulated depreciation (1,240,336 ) (1,019,150 ) Real estate investments - net $ 6,326,022 $ 5,724,808
Schedule of future minimum estimated contractual rents due for the remainder of the initial terms of the leases	(in thousands) 2017 $ 718,999 2018 711,714 2019 689,641 2020 701,543 2021 705,418 Thereafter 3,732,920 Total $ 7,260,235
Schedule of final fair value of the assets acquired and liabilities assumed	(in thousands) Fair value of net assets acquired: Land and buildings $ 3,107,530 Investment in direct financing leases 26,823 Mortgages notes receivable 19,246 Other investments 23,619 Total investments 3,177,218 Goodwill 630,679 Accounts receivables and other assets 17,144 Cash acquired 84,858 Accrued expenses and other liabilities (223,002 ) Debt (1,410,637 ) Fair value of net assets acquired $ 2,276,260
Schedule of pro forma information not indicative of future operations	Pro Forma Year Ended December 31, 2015 2014 (in thousands, except per share Pro forma revenues $ 817,642 $ 789,270 Pro forma net income $ 258,927 $ 318,271 Earnings per share – diluted: Net income – as reported $ 1.29 $ 1.74 Net income – pro forma $ 1.33 $ 1.74
2016 Acquisitions and Other
Real Estate Properties [Line Items]
Schedule of acquisitions and other	2016 Acquisitions and Other Number of Country/ Total Land Building & Site Improvements Furniture Initial Period SNF ALF State Investment (in millions) Yield (%) Q1 - 1 UK $ 8.3 $ 1.4 $ 6.7 $ 0.2 7.00 Q1 - 1 UK 6.1 0.6 5.3 0.2 7.00 Q1 10 - OH, VA, MI 169.0 (3) 10.5 152.5 6.0 8.50 Q1 - 2 GA 20.2 0.8 18.3 1.1 7.50 Q1 3 - MD 25.0 2.5 19.9 2.6 8.50 Q1 21 - VA, NC 212.5 19.3 181.1 12.1 8.50 Q2 - 10 UK 111.9 (4) 24.8 83.9 3.2 7.00 Q2 - 3 TX 66.0 (5) 5.8 58.6 1.6 6.80 Q2 3 - CO, MO 31.8 3.1 26.2 2.5 9.00 Q3 - 1 FL 4.3 2.3 1.8 0.2 8.00 Q3 - 1 GA 2.5 0.2 2.1 0.2 8.00 Q3 - 1 FL 16.5 1.8 14.3 0.4 8.00 Q3 1 - SC 10.1 2.7 6.5 0.9 9.00 Q3 1 - OH 9.0 (6) - 8.6 0.4 9.00 Q3 31 - FL, KY,TN 329.6 (1)(2) 24.6 290.8 14.2 9.00 Total 70 20 $ 1,022.8 $ 100.4 $ 876.6 $ 45.8 (1) The Company estimated the fair value of the assets acquired on the acquisition date based on certain valuation analyses that have yet to be finalized, and accordingly, the assets acquired, as detailed, are subject to adjustment once the analysis is completed. (2) The Company’s investment includes a purchase option buyout obligation with a fair value of approximately $29.6 million. The future buyout obligation is recorded in accrued expenses and other liabilities on our Consolidated Balance Sheet. The Company also acquired a term loan with a fair value of approximately $37.0 million which is recorded in other investments on our Consolidated Balance Sheet. Refer to Note – 6 Other Investments. (3) Acquired from a related party. Refer to Note – 2 Summary of Significant Accounting Policies - Related Party Transactions. (4) Omega also recorded a deferred tax asset of approximately $1.9 million in connection with the acquisition. (5) The Company paid $63.0 million in cash at closing to acquire the facilities. We have agreed to pay an additional $1.5 million in April 2017 and the remaining $1.5 million in April 2018. The additional consideration to be paid is contractually determined and not contingent on other factors. The $3.0 million liability is recorded in unsecured borrowings – net on our Consolidated Balance Sheet. (6) The Company paid approximately $3.5 million in cash to acquire the facility. The remainder of the purchase price (approximately $5.5 million) was funded with the redemption of an other investment note.
2015 Acquisitions and Other
Real Estate Properties [Line Items]
Schedule of acquisitions and other	2015 Acquisitions and Other Number of Total Land Building & Site Improvements Furniture Initial Period SNF ALF State Investment (in millions) Yield (%) Q1 1 - TX $ 6.8 $ 0.1 $ 6.1 $ 0.6 9.50 Q3 6 - NE 15.0 1.4 12.1 1.5 9.00 Q3 1 2 WA 18.0 2.2 14.9 0.9 8.00 Q3 - 2 GA 10.8 1.2 9.0 0.6 7.00 Q3 1 - VA 28.5 (1) 1.9 24.2 2.4 9.25 Q3 2 - FL 32.0 1.4 29.0 1.6 9.00 Q3 - - NY 111.7 (2)(3) 111.7 - - - Q4 1 - AZ 0.6 (3) 0.3 0.3 - 9.00 Q4 1 - TX 5.3 1.8 3.0 0.5 9.50 Total 13 4 $ 228.7 $ 122.0 $ 98.6 $ 8.1 (1) In July 2015, we leased the facility to a new operator with an initial lease term of 10 years. (2) On July 24, 2015, we purchased five buildings located in New York City, New York for approximately $111.7 million. We and our operator plan to construct a 201,000 square-foot assisted living and memory care facility. The properties were added to the operator’s existing master lease. The lease provides for a 5% annual cash yield on the land during the construction phase. Upon issuance of a certification of occupancy, the annual cash yield will increase to 7% in year one and 8% in year two with 2.5% annual escalators thereafter. (3) Accounted for as an asset acquisition.
2014 Acquisitions and Other
Real Estate Properties [Line Items]
Schedule of acquisitions and other	2014 Acquisitions and Other Number of Total Land Building & Site Furniture Initial Period SNF ALF State Investment (in millions) Yield (%) Q1 - 1 AZ $ 4.7 $ 0.4 $ 3.9 $ 0.4 9.75 Q2/Q3 3 - GA, SC 34.6 0.9 32.1 1.6 9.50 Q3 1 - TX 8.2 0.4 7.4 0.4 9.75 Q4 - 4 PA,OR,AR 84.2 5.1 76.7 2.4 6.00 4 5 $ 131.7 $ 6.8 $ 120.1 $ 4.8

DIRECT FINANCING LEASES (Tables

DIRECT FINANCING LEASES (Tables)	12 Months Ended
	Dec. 31, 2016
Leases, Capital [Abstract]
Schedule of components of investment in direct financing leases	December 31, 2016 2015 (in thousands) Minimum lease payments receivable $ 4,287,069 $ 4,320,876 Less unearned income (3,685,131 ) (3,733,175 ) Investment in direct financing leases - net $ 601,938 $ 587,701 Properties subject to direct financing leases 58 59
Schedule of investment in the direct financing leases by operator	December 31, 2016 2015 (in thousands) New Ark $ 574,581 $ 560,308 Reliance Health Care Management, Inc. 15,498 15,509 Sun Mar Healthcare 11,443 11,381 Markleysburg Healthcare Investors, LP 416 503 Investment in direct financing leases - net $ 601,938 $ 587,701
Schedule of minimum rents due under direct financing leases	2017 2018 2019 2020 2021 $50,772 $52,098 $53,377 $54,677 $55,919

MORTGAGE NOTES RECEIVABLE (Tabl

MORTGAGE NOTES RECEIVABLE (Tables)	12 Months Ended
	Dec. 31, 2016
Mortgage Notes Receivable Investments [Abstract]
Schedule of mortgage notes receivable, net of allowances	December 31, 2016 2015 (in thousands) Mortgage note due 2024; interest at 9.79% $ 112,500 $ 112,500 Mortgage note due 2028; interest at 11.00% 35,964 69,928 Mortgage note due 2029; interest at 9.45% 412,140 413,399 Other mortgage notes outstanding (1) 82,673 83,968 Mortgage notes receivable, gross 643,277 679,795 Allowance for loss on mortgage notes receivable (3,934 ) — Total mortgages — net $ 639,343 $ 679,795 (1) Other mortgage notes outstanding have stated interest rates ranging from 8.35% to 12.0% per annum and maturity dates through 2029.

OTHER INVESTMENTS (Tables)

OTHER INVESTMENTS (Tables)	12 Months Ended
	Dec. 31, 2016
Receivables [Abstract]
Schedule of other investments	December 31, 2016 2015 (in thousands) Other investment note due 2019; interest at 10.50% $ 49,458 $ — Other investment note due 2020; interest at 10.00% 23,000 23,000 Other investment note due 2020; interest at 14.00% 47,913 — Other investment note due 2022, interest at 9.00% 31,987 — Other investment note due 2030; interest at 6.66% 44,595 26,966 Other investment notes outstanding (1) 64,691 42,293 Other investments, gross 261,644 92,259 Allowance for loss on other investments (4,798 ) (2,960 ) Total other investments $ 256,846 $ 89,299 (1) Other investment notes have maturity dates through 2028 and interest rates ranging from 6.50% to 13.0% per annum.

ASSETS HELD FOR SALE (Tables)

ASSETS HELD FOR SALE (Tables)	12 Months Ended
	Dec. 31, 2016
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract]
Schedule of properties held-for-sale	Properties Held-For-Sale Number of Net Book Value December 31, 2014 4 $ 12,792 Properties sold/other (1) (5 ) (16,877 ) Properties added (2) 4 10,684 December 31, 2015 3 $ 6,599 Properties sold/other (3) (24 ) (75,948 ) Properties added (4) 41 122,217 December 31, 2016 20 $ 52,868 (1) In 2015, a parcel of land was reclassified to closed facilities. In addition, we sold four facilities for approximately $25.5 million in net proceeds recognizing gains on sales of approximately $8.8 million. (2) In 2015, we recorded a $3.0 million impairment charge on a SNF in New Mexico to reduce its net book value to its estimated fair value less costs to sell. (3) In 2016, we sold 21 SNFs for approximately $86.7 million in net proceeds recognizing gains on sales of approximately $16.5 million. We also recorded approximately $4.9 million of impairments on 16 facilities to reduce their net book values to their estimated fair value less costs to sell. Two SNFs and one ALF classified as assets held for sale in the second quarter were no longer considered held for sale and were reclassified in the third quarter back to leased properties at their fair values (approximately $7.0 million). (4) In 2016, we reclassified ten ALFs and 31 SNFs to assets held for sale (including the two SNFs and one ALF mentioned above that were reclassified back to leased properties in the third quarter). We recorded approximately $49.4 million of impairment charges on 20 of these facilities to reduce their net book values to their estimated fair value less costs to sell.

INTANGIBLES (Tables)

INTANGIBLES (Tables)	12 Months Ended
	Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of intangibles	December 31, 2016 2015 (in thousands) Assets: Goodwill $ 643,474 $ 645,683 Above market leases $ 22,476 $ 21,901 In-place leases 167 386 Accumulated amortization (15,864 ) (14,162 ) Net intangible assets $ 6,779 $ 8,125 Liabilities: Below market leases $ 165,028 $ 165,331 Accumulated amortization (70,738 ) (55,131 ) Net intangible liabilities $ 94,290 $ 110,200
Schedule of reconciliation of goodwill	(in thousands) Balance as of December 31, 2015 $ 645,683 Add: additional valuation adjustments related to preliminary valuations 275 Less: foreign currency translation (2,484 ) Balance as of December 31, 2016 $ 643,474

BORROWING ARRANGEMENTS (Tables)

BORROWING ARRANGEMENTS (Tables)	12 Months Ended
	Dec. 31, 2016
Debt Disclosure [Abstract]
Schedule of long-term borrowings	Interest Rate as December 31, Maturity 2016 2016 2015 (in thousands) Secured borrowings: Mortgage term loan $ — $ 180,000 HUD mortgages assumed December 2011 (1) 2044 3.06 % 54,954 56,204 Deferred financing costs – net (589 ) (611 ) Total secured borrowings – net 54,365 235,593 Unsecured borrowings: Revolving line of credit 2018 2.06 % 190,000 230,000 Tranche A-1 term loan 2019 2.27 % 200,000 200,000 Tranche A-2 term loan 2017 2.19 % 200,000 200,000 Tranche A-3 term loan 2021 2.27 % 350,000 — Omega OP term loan 2017 2.19 % 100,000 100,000 2015 term loan 2022 3.80 % 250,000 250,000 Deferred financing costs – net (5,657 ) (4,307 ) Total term loans – net 1,094,343 745,693 2023 notes 2023 4.375 % 700,000 — 2024 notes 2024 5.875 % 400,000 400,000 2024 notes 2024 4.95 % 400,000 400,000 2025 notes 2025 4.50 % 250,000 250,000 2026 notes 2026 5.25 % 600,000 600,000 2027 notes 2027 4.50 % 700,000 700,000 Other 2018 - 3,000 — Subordinated debt 2021 9.00 % 20,000 20,000 Discount - net (17,151 ) (17,118 ) Deferred financing costs – net (27,703 ) (24,155 ) Total unsecured borrowings – net 3,028,146 2,328,727 Total secured and unsecured borrowings – net $ 4,366,854 $ 3,540,013 (1) Reflects the weighted average annual contractual interest rate on the mortgages at December 31, 2016 excluding a third-party administration fee of approximately 0.5%. Secured by real estate assets with a net carrying value of $65.7 million as of December 31, 2016.
Schedule of principal payments, excluding the premium/discount and the aggregate due thereafter	(in thousands) 2017 $ 302,788 2018 192,828 2019 201,369 2020 1,412 2021 371,456 Thereafter 3,348,101 Totals $ 4,417,954
Schedule of refinancing related costs	Year Ended December 31, 2016 2015 2014 (in thousands) Write off of deferred financing cost and unamortized premiums due to refinancing (1)(2)(3) $ 301 $ (7,134 ) $ 1,180 Prepayment and other costs associated with refinancing (4) 1,812 35,971 1,861 Total debt extinguishment costs $ 2,113 $ 28,837 $ 3,041 (1) In 2016, we recorded $0.3 million of write-offs of unamortized deferred financing costs associated with three facilities that were acquired via a deed-in-lieu foreclosure. (2) In 2015, we recorded: (a) $4.2 million of write-offs of unamortized deferred financing costs and discount associated with the early redemption of our 2020 Notes, (b) $1.9 million in net write-offs associated with unamortized deferred financing costs and original issuance premiums/discounts associated with the early redemption of our 2022 Notes, offset by (c) $13.2 million gain related to the early extinguishment of debt from the write off of unamortized premium on the HUD debt paid off in March, April and December 2015. (3) In 2014, we recorded: (a) $2.6 million write-off of deferred financing costs associated with the termination of the $700 million 2012 credit facilities, (b) $2.0 million write-off of deferred financing costs associated with the termination of our $200 million 2013 term loan facility offset by (c) $3.5 million gain related to the early extinguishment of debt from the write off of unamortized premium on the HUD debt paid off in September and December 2014. (4) In 2016, we purchased a $180 million mortgage term loan and paid a 1% premium of approximately $1.8 million to purchase the debt. In 2015, we made: (a) $7.5 million of prepayment penalties associated with the early redemption of our 2020 Notes, (b) $19.4 million of prepayment penalties associated with the early redemption of our 2022 Notes and (c) $9.1 million of prepayment penalties associated with 24 HUD mortgage loans that we paid off in March, April and December 2015. In 2014, we made prepayment penalties of $1.9 million associated with five HUD mortgage loans that we paid off in September and October 2014.

FINANCIAL INSTRUMENTS (Tables)

FINANCIAL INSTRUMENTS (Tables)	12 Months Ended
	Dec. 31, 2016
Fair Value Disclosures [Abstract]
Schedule of the carrying amounts and fair values of financial instruments	2016 2015 Carrying Amount Fair Value Carrying Amount Fair Value (in thousands) Assets: Cash and cash equivalents $ 93,687 $ 93,687 $ 5,424 $ 5,424 Restricted cash 13,589 13,589 14,607 14,607 Investments in direct financing leases – net 601,938 598,665 587,701 584,358 Mortgage notes receivable – net 639,343 644,961 679,795 687,130 Other investments – net 256,846 253,385 89,299 90,745 Total $ 1,605,403 $ 1,604,287 $ 1,376,826 $ 1,382,264 Liabilities: Revolving line of credit $ 190,000 $ 190,000 $ 230,000 $ 230,000 Tranche A-1 term loan 198,830 200,000 197,699 200,000 Tranche A-2 term loan 200,000 200,000 200,000 200,000 Tranche A-3 term loan 347,449 350,000 — — Omega OP term loan 100,000 100,000 100,000 100,000 2015 term loan 248,064 250,000 247,994 250,000 4.375% notes due 2023 – net 692,305 693,505 — — 5.875% notes due 2024 – net 395,065 432,938 394,382 429,956 4.95% notes due 2024 – net 392,669 406,361 391,658 403,064 4.50% notes due 2025 – net 245,949 249,075 245,446 242,532 5.25% notes due 2026 – net 593,616 611,461 593,032 612,760 4.50% notes due 2027 – net 685,052 681,978 683,596 667,651 Mortgage term loan due 2019 — — 180,000 180,000 HUD debt – net 54,365 52,510 55,593 52,678 Subordinated debt – net 20,490 23,944 20,613 24,366 Other 3,000 3,000 — — Total $ 4,366,854 $ 4,444,772 $ 3,540,013 $ 3,593,007

STOCKHOLDERS' EQUITY (Tables)

STOCKHOLDERS' EQUITY (Tables)	12 Months Ended
	Dec. 31, 2016
Stockholders' Equity Note [Abstract]
Schedule of accumulated other comprehensive loss, net of tax	December 31, 2016 2015 (in thousands) Foreign currency translation adjustments $ (52,495 ) $ (8,027 ) Cash flow hedge adjustments (1,332 ) (685 ) Total accumulated other comprehensive loss $ (53,827 ) $ (8,712 )

STOCK-BASED COMPENSATION (Table

STOCK-BASED COMPENSATION (Tables)	12 Months Ended
	Dec. 31, 2016
Disclosure Of Compensation Related Costs, Share-Based Payments [Abstract]
Schedule of activity in restricted stock and RSUs	Number of Weighted - Compensation Cost (1) (in millions) Non-vested at December 31, 2013 257,198 $ 29.32 Granted during 2014 143,637 30.70 $ 4.4 Vested during 2014 (90,901 ) 28.87 Non-vested at December 31, 2014 309,934 $ 30.08 Granted during 2015 233,483 39.25 $ 9.2 Assumed in Aviv Merger (2) 38,268 23.50 $ 0.9 Cancelled during 2015 (61,911 ) 33.77 Vested during 2015 (106,146 ) 28.72 Non-vested at December 31, 2015 413,628 $ 34.45 Granted during 2016 158,506 34.49 $ 5.5 Cancelled during 2016 (905 ) 24.92 Vested during 2016 (235,176 ) 30.41 Non-vested at December 31, 2016 336,053 $ 37.32 (1) Total compensation cost to be recognized on the awards based on grant date fair value, which is based on the market price of the Company’s common stock on the date of grant. (2) Omega stock price on April 1, 2015 was $40.74. The weighted average stock price indicated in the table above represents the expense per unit that we will record related to the assumed Aviv RSUs.
Schedule of assumptions used for estimating fair value of stock awards using Monte-Carlo model	January 1, December March April 1, July 31, March 17, Closing price on date of grant $ 23.85 $ 29.80 $ 40.57 $ 40.74 $ 36.26 $ 34.78 Dividend yield 4.24% 6.44% 5.23% 5.20% 6.07% 6.56% Risk free interest rate at time of grant 0.05% to 0.43% 0.04% to 0.86% 0.10% to 0.94% 0.09% to 0.91% 0.13% to 1.08% 0.05% to 1.14% Expected volatility 15.56% to 23.83% 24.16% to 25.86% 20.06% to 21.09% 20.06% to 21.08% 20.06% to 20.21% 23.92% to 24.88%
Schedule of activity in PRSU and LTIP Units	Number of Weighted- Compensation Cost (1) (in millions) Non-vested at December 31, 2013 1,038,024 $ 10.72 Granted during 2014 309,168 11.46 $ 3.5 Vested during 2014 (2) (496,979 ) 10.75 Non-vested at December 31, 2014 850,213 $ 10.97 Granted during 2015 537,923 18.51 $ 10.0 Cancelled during 2015 (165,570 ) 14.11 Forfeited during 2015 (128,073 ) 12.04 Vested during 2015 (2) (181,406 ) 10.10 Non-vested at December 31, 2015 913,087 $ 14.87 Granted during 2016 679,549 14.67 $ 10.0 Forfeited during 2016 (518,638 ) 12.10 Vested during 2016 - - Non-vested at December 31, 2016 1,073,998 $ 16.08 (1) Total compensation cost to be recognized on the awards was based on the grant date fair value or the modification date fair value. (2) PRSUs are shown as vesting in the year that the Compensation Committee determines the level of achievement of the applicable performance measures.
Schedule of total unrecognized compensation cost associated with outstanding restricted stock, restricted stock units and PRSU awards to employees	Grant Year Shares/ Units Grant Date Average Fair Value Per Unit/ Share Total Compensation Cost (in millions) (1) Weighted Average Period of Expense Recognition (in months) Unrecognized Compensation Cost (in millions) Performance Period Vesting Dates RSUs 3/31/15 RSU 2015 109,985 40.57 4.5 33 1.6 N/A 12/31/2017 4/1/15 RSU 2015 40,464 40.74 1.6 33 0.6 N/A 12/31/2017 Assumed Aviv RSU 2015 7,799 35.08 0.3 33 0.1 N/A 11/1/2017 3/17/16 RSU 2016 131,006 34.78 4.6 33 3.3 N/A 12/31/2018 Restricted Stock Units Total 289,254 $ 37.82 $ 11.0 $ 5.6 TSR PRSUs and LTIP Units 2016 TSR 2014 135,634 8.67 1.2 48 0.3 1/1/2014-12/31/2016 Quarterly in 2017 3/31/15 2017 LTIP Units 2015 137,249 14.66 2.0 45 1.1 1/1/2015-12/31/2017 Quarterly in 2018 4/1/2015 2017 LTIP Units 2015 54,151 14.80 0.8 45 0.4 1/1/2015-12/31/2017 Quarterly in 2018 3/17/2016 2018 LTIP Units 2016 372,069 13.21 4.9 45 3.9 1/1/2016-12/31/2018 Quarterly in 2019 TSR PRSUs & LTIP Total 699,103 $ 12.74 $ 8.9 $ 5.7 Relative TSR PRSUs 2016 Relative TSR 2014 135,634 14.24 1.9 48 0.5 1/1/2014-12/31/2016 Quarterly in 2017 3/31/15 2017 Relative TSR 2015 137,249 22.50 3.1 45 1.6 1/1/2015-12/31/2017 Quarterly in 2018 4/1/2015 2017 Relative TSR 2015 54,151 22.91 1.2 45 0.7 1/1/2015-12/31/2017 Quarterly in 2018 3/17/2016 2018 Relative TSR 2016 307,480 16.45 5.1 45 4.0 1/1/2016-12/31/2018 Quarterly in 2019 Relative TSR PRSUs Total 634,514 $ 17.84 $ 11.3 $ 6.8 Grand Total 1,622,871 $ 19.20 $ 31.2 $ 18.1 (1) Total compensation costs are net of shares cancelled.

DIVIDENDS (Tables)

DIVIDENDS (Tables)	12 Months Ended
	Dec. 31, 2016
Dividends [Abstract]
Schedule of per share distribution for income tax purpose	Year Ended December 31, 2016 2015 2014 Common Ordinary income $ 1.968 $ 1.133 $ 1.834 Return of capital 0.322 1.047 0.186 Capital gains 0.070 - - Total dividends paid $ 2.360 $ 2.180 $ 2.020

SUMMARY OF QUARTERLY RESULTS 47

SUMMARY OF QUARTERLY RESULTS (UNAUDITED) (Tables)	12 Months Ended
	Dec. 31, 2016
Quarterly Financial Information Disclosure [Abstract]
Schedule of quarterly financial information	March 31 June 30 September 30 December 31 (in thousands, except per share amounts) 2016 Revenues $ 212,879 $ 228,824 $ 224,638 $ 234,486 Net income 58,196 113,154 82,134 129,883 Net income available to common stockholders 55,555 108,052 78,549 124,259 Net income available to common per share: Basic $ 0.30 $ 0.57 $ 0.40 $ 0.63 Net income per share: Diluted $ 0.29 $ 0.57 $ 0.40 $ 0.63 Cash dividends paid on common stock $ 0.57 $ 0.58 $ 0.60 $ 0.61 2015 Revenues $ 133,420 $ 197,711 $ 201,974 $ 210,512 Net income 43,052 43,466 83,254 63,543 Net income available to common stockholders 43,052 41,428 79,402 60,642 Net income available to common per share: Basic $ 0.32 $ 0.23 $ 0.43 $ 0.32 Net income per share: Diluted $ 0.32 $ 0.22 $ 0.43 $ 0.32 Cash dividends paid on common stock $ 0.53 $ 0.54 $ 0.55 $ 0.56

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	12 Months Ended
	Dec. 31, 2016
Earnings Per Share [Abstract]
Schedule of computation of basic and diluted earnings per share	Year Ended December 31, 2016 2015 2014 (in thousands, except per share amounts) Numerator: Net income $ 383,367 $ 233,315 $ 221,349 Less: Net income attributable to noncontrolling interests (16,952 ) (8,791 ) — Net income available to common stockholders $ 366,415 $ 224,524 $ 221,349 Denominator: Denominator for basic earnings per share 191,781 172,242 126,550 Effect of dilutive securities: Common stock equivalents 956 1,539 744 Noncontrolling interest – OP units 8,898 6,727 — Denominator for diluted earnings per share 201,635 180,508 127,294 Earnings per share - basic: Net income available to common stockholders $ 1.91 $ 1.30 $ 1.75 Earnings per share - diluted: Net income $ 1.90 $ 1.29 $ 1.74

CONSOLIDATING FINANCIAL STATE49

CONSOLIDATING FINANCIAL STATEMENTS (Tables)	12 Months Ended
	Dec. 31, 2016
Condensed Financial Information Of Parent Company Only Disclosure [Abstract]
Schedule of consolidating balance sheets	CONSOLIDATING BALANCE SHEET (in thousands) December 31, 2016 Issuer & Non – Elimination Consolidated ASSETS Real estate properties Real estate investments $ 6,923,469 $ 642,889 $ — $ 7,566,358 Less accumulated depreciation (1,191,117 ) (49,219 ) — (1,240,336 ) Real estate investments – net 5,732,352 593,670 — 6,326,022 Investment in direct financing leases - net 601,938 — — 601,938 Mortgage notes receivable - net 639,343 — — 639,343 6,973,633 593,670 — 7,567,303 Other investments 256,846 — — 256,846 Investment in unconsolidated joint venture 48,776 — — 48,776 Assets held for sale – net 52,868 — — 52,868 Total investments 7,332,123 593,670 — 7,925,793 Cash and cash equivalents 87,098 6,589 — 93,687 Restricted cash 6,915 6,674 — 13,589 Accounts receivable – net 230,097 9,938 — 240,035 Goodwill 630,679 12,795 — 643,474 Investments in and advances to affiliates 569,194 — (569,194 ) — Other assets 21,293 11,389 — 32,682 Total assets $ 8,877,399 $ 641,055 $ (569,194 ) $ 8,949,260 LIABILITIES AND EQUITY Revolving line of credit $ 190,000 $ — $ — $ 190,000 Term loans - net 1,094,343 — — 1,094,343 Secured borrowings - net — 429,214 (374,849 ) 54,365 Unsecured borrowings – net 3,028,146 — — 3,028,146 Accrued expenses and other liabilities 352,924 7,590 — 360,514 Deferred income taxes — 9,906 — 9,906 Intercompany payable — 7,890 (7,890 ) — Total liabilities 4,665,413 454,600 (382,739 ) 4,737,274 Equity: Common stock 19,614 — — 19,614 Equity investment from affiliates — 156,446 (156,446 ) — Common stock – additional paid-in capital 4,861,408 — — 4,861,408 Cumulative net earnings 1,738,937 29,479 (29,479 ) 1,738,937 Cumulative dividends paid (2,707,387 ) — — (2,707,387 ) Accumulated other comprehensive (loss) income (53,827 ) 530 (530 ) (53,827 ) Total stockholders’ equity 3,858,745 186,455 (186,455 ) 3,858,745 Noncontrolling interest 353,241 — — 353,241 Total equity 4,211,986 186,455 (186,455 ) 4,211,986 Total liabilities and equity $ 8,877,399 $ 641,055 $ (569,194 ) $ 8,949,260 CONSOLIDATING BALANCE SHEET (in thousands) December 31, 2015 Issuer & Non – Elimination Consolidated ASSETS Real estate properties Real estate investments $ 6,184,507 $ 559,451 $ — $ 6,743,958 Less accumulated depreciation (991,314 ) (27,836 ) — (1,019,150 ) Real estate investments – net 5,193,193 531,615 — 5,724,808 Investment in direct financing leases - net 587,701 — — 587,701 Mortgage notes receivable - net 679,795 — — 679,795 6,460,689 531,615 — 6,992,304 Other investments 89,299 — — 89,299 Assets held for sale – net 6,599 — — 6,599 Total investments 6,556,587 531,615 — 7,088,202 Cash and cash equivalents 1,592 3,832 — 5,424 Restricted cash 8,058 6,549 — 14,607 Accounts receivable – net 196,107 7,755 — 203,862 Goodwill 630,404 15,279 — 645,683 Investments in and advances to affiliates 300,409 — (300,409 ) — Other assets 25,270 6,888 — 32,158 Total assets $ 7,718,427 $ 571,918 $ (300,409 ) $ 7,989,936 LIABILITIES AND EQUITY Revolving line of credit $ 230,000 $ — $ — $ 230,000 Term loans - net 745,693 — — 745,693 Secured borrowings - net — 360,849 (125,256 ) 235,593 Unsecured borrowings – net 2,328,727 — — 2,328,727 Accrued expenses and other liabilities 326,815 6,891 — 333,706 Deferred income taxes — 15,352 — 15,352 Intercompany payable (13,673 ) 13,673 — — Total liabilities 3,617,562 396,765 (125,256 ) 3,889,071 Equity: Common stock 18,740 — — 18,740 Equity investment from affiliates — 156,830 (156,830 ) — Common stock – additional paid-in capital 4,609,474 — — 4,609,474 Cumulative net earnings 1,372,522 18,246 (18,246 ) 1,372,522 Cumulative dividends paid (2,254,038 ) — — (2,254,038 ) Accumulated other comprehensive (loss) income (8,712 ) 77 (77 ) (8,712 ) Total stockholders’ equity 3,737,986 175,153 (175,153 ) 3,737,986 Noncontrolling interest 362,879 — — 362,879 Total equity 4,100,865 175,153 (175,153 ) 4,100,865 Total liabilities and equity $ 7,718,427 $ 571,918 $ (300,409 ) $ 7,989,936
Schedule of consolidating statement of operations	CONSOLIDATING STATEMENT OF OPERATIONS (in thousands) Year Ended December 31, 2016 Issuer & Non – Elimination Consolidated Revenue Rental income $ 684,771 $ 59,114 $ - $ 743,885 Income from direct financing leases 62,298 - - 62,298 Mortgage interest income 69,811 - - 69,811 Other investment income – net 25,056 56 (3,260 ) 21,852 Miscellaneous income 2,981 - - 2,981 Total operating revenues 844,917 59,170 (3,260 ) 900,827 Expenses Depreciation and amortization 244,290 22,772 - 267,062 General and administrative 45,413 454 - 45,867 Acquisition and merger related costs 5,777 3,805 - 9,582 Impairment loss on real estate properties 58,508 218 - 58,726 Provisions for uncollectible mortgages, notes and accounts receivable 6,583 3,262 - 9,845 Total operating expenses 360,571 30,511 - 391,082 Income before other income and expense 484,346 28,659 (3,260 ) 509,745 Other income (expense): Interest income 161 12 - 173 Interest expense (148,092 ) (19,271 ) 3,260 (164,103 ) Interest – amortization of deferred financing costs (9,302 ) (43 ) - (9,345 ) Interest – refinancing costs (2,113 ) - - (2,113 ) Realized loss on foreign exchange (232 ) - - (232 ) Equity in earnings 11,233 - (11,233 ) - Total other expense (148,345 ) (19,302 ) (7,973 ) (175,620 ) Income before gain on assets sold 336,001 9,357 (11,233 ) 334,125 Gain on assets sold - net 50,208 - - 50,208 Income from continuing operations 386,209 9,357 (11,233 ) 384,333 Income tax expense (3,281 ) 1,876 - (1,405 ) Income from unconsolidated joint venture 439 - - 439 Net income 383,367 11,233 (11,233 ) 383,367 Net income attributable to noncontrolling interest (16,952 ) - - (16,952 ) Net income available to common stockholders $ 366,415 $ 11,233 $ (11,233 ) $ 366,415 CONSOLIDATING STATEMENT OF OPERATIONS (in thousands) Year Ended December 31, 2015 Issuer & Non – Elimination Consolidated Revenue Rental income $ 564,112 $ 41,879 $ - $ 605,991 Income from direct financing leases 59,936 - - 59,936 Mortgage interest income 68,910 - - 68,910 Other investment income – net 7,534 - - 7,534 Miscellaneous income – net 1,246 - - 1,246 Total operating revenues 701,738 41,879 - 743,617 Expenses Depreciation and amortization 194,328 16,375 - 210,703 General and administrative 38,140 428 - 38,568 Acquisition and merger related costs 55,012 2,513 - 57,525 Impairment loss on real estate properties 17,681 - - 17,681 Provisions for uncollectible mortgages, notes and accounts receivable 7,871 - - 7,871 Total operating expenses 313,032 19,316 - 332,348 Income before other income and expense 388,706 22,563 - 411,269 Other income (expense): Interest income 272 13 - 285 Interest expense (135,631 ) (11,750 ) - (147,381 ) Interest – amortization of deferred financing costs (6,969 ) (21 ) - (6,990 ) Interest – refinancing costs (28,837 ) - - (28,837 ) Realized loss on foreign exchange (173 ) - - (173 ) Equity in earnings 10,610 - (10,610 ) - Total other expense (160,728 ) (11,758 ) (10,610 ) (183,096 ) Income before gain on assets sold 227,978 10,805 (10,610 ) 228,173 Gain on assets sold - net 6,353 - - 6,353 Income from continuing operations 234,331 10,805 (10,610 ) 234,526 Income tax expense (1,016 ) (195 ) - (1,211 ) Net income 233,315 10,610 (10,610 ) 233,315 Net income attributable to noncontrolling interest (8,791 ) - - (8,791 ) Net income available to common stockholders $ 224,524 $ 10,610 $ (10,610 ) $ 224,524 CONSOLIDATING STATEMENT OF OPERATIONS (in thousands) Year Ended December 31, 2014 Issuer & Non – Elimination Consolidated Revenue Rental income $ 379,180 $ 9,263 $ - $ 388,443 Income from direct financing leases 56,719 - - 56,719 Mortgage interest income 53,007 - - 53,007 Other investment income – net 6,369 - - 6,369 Miscellaneous income – net 249 - - 249 Total operating revenues 495,524 9,263 - 504,787 Expenses Depreciation and amortization 119,367 3,890 - 123,257 General and administrative 25,778 110 - 25,888 Acquisition costs 3,948 - - 3,948 Impairment loss on real estate properties 3,660 - - 3,660 Provisions for uncollectible mortgages, notes and accounts receivable 2,723 - - 2,723 Total operating expenses 155,476 4,000 - 159,476 Income before other income and expense 340,048 5,263 - 345,311 Other income (expense): Interest income 32 12 - 44 Interest expense (117,258 ) (2,111 ) - (119,369 ) Interest – amortization of deferred financing costs (4,438 ) (21 ) - (4,459 ) Interest – refinancing costs (3,041 ) - - (3,041 ) Equity in earnings 3,143 - (3,143 ) - Total other expense (121,562 ) (2,120 ) (3,143 ) (126,825 ) Income before gain on assets sold 218,486 3,143 (3,143 ) 218,486 Gain on assets sold - net 2,863 - - 2,863 Net income available to common stockholders $ 221,349 $ 3,143 $ (3,143 ) $ 221,349
Schedule of consolidating statement of comprehensive income	CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (in thousands) Year Ended December 31, 2016 Issuer & Non – Elimination Consolidated Net income $ 383,367 $ 11,233 $ (11,233 ) $ 383,367 Other comprehensive income (loss) Foreign currency translation (46,535 ) - - (46,535 ) Cash flow hedges (702 ) - - (702 ) Total other comprehensive income (loss) (47,237 ) - - (47,237 ) Comprehensive income 336,130 11,233 (11,233 ) 336,130 Comprehensive income attributable to noncontrolling interest (14,830 ) - - (14,830 ) Comprehensive income attributable to common stockholders $ 321,300 $ 11,233 $ (11,233 ) $ 321,300 CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (in thousands) Year Ended December 31, 2015 Issuer & Non – Elimination Consolidated Net income $ 233,315 $ 10,610 $ (10,610 ) $ 233,315 Other comprehensive income (loss) Foreign currency translation (8,413 ) - - (8,413 ) Cash flow hedges (718 ) - - (718 ) Total other comprehensive income (loss) (9,131 ) - - (9,131 ) Comprehensive income 224,184 10,610 (10,610 ) 224,184 Comprehensive income attributable to noncontrolling interest (8,373 ) - - (8,373 ) Comprehensive income attributable to common stockholders $ 215,811 $ 10,610 $ (10,610 ) $ 215,811
Schedule of consolidating statement of cash flows	CONSOLIDATING STATEMENT OF CASH FLOWS (in thousands ) Year Ended December 31, 2016 Issuer & Subsidiary Non-Guarantor Elimination Consolidated Cash flows from operating activities Net income $ 383,367 $ 11,233 $ (11,233 ) $ 383,367 Adjustment to reconcile net income to net cash provided by operating activities: Depreciation and amortization 244,290 22,772 — 267,062 Impairment loss on real estate properties 58,508 218 — 58,726 Provision for uncollectible mortgages, notes and accounts receivable 6,583 3,262 — 9,845 Refinancing costs and amortization of deferred financing costs 11,415 43 — 11,458 Accretion of direct financing leases (12,157 ) — — (12,157 ) Stock-based compensation expense 13,790 — — 13,790 Gain on assets sold – net (50,208 ) — — (50,208 ) Amortization of acquired in-place leases - net (13,991 ) — — (13,991 ) Equity in earnings (11,233 ) — 11,233 — Change in operating assets and liabilities – net of amounts assumed/acquired: Accounts receivable, net (4,876 ) — — (4,876 ) Straight-line rent receivables (36,263 ) (5,828 ) — (42,091 ) Lease inducements 2,589 — — 2,589 Effective yield receivable on mortgage notes (721 ) — — (721 ) Other operating assets and liabilities 18,661 (15,663 ) — 2,998 Net cash provided by operating activities 609,754 16,037 — 625,791 Cash flows from investing activities Acquisition of real estate – net of liabilities assumed and escrows acquired (833,390 ) (126,358 ) — (959,748 ) Investments in construction in progress (68,983 ) — — (68,983 ) Investment in U.K. subsidiary (116,099 ) — 116,099 — Investments in direct financing leases (2,080 ) — — (2,080 ) Placement of mortgage loans (48,722 ) — — (48,722 ) Investments in unconsolidated joint venture (50,032 ) — — (50,032 ) Distributions from unconsolidated joint venture 1,318 — — 1,318 Proceeds from sale of real estate investments 169,603 — — 169,603 Capital improvements to real estate investments (38,824 ) (1,647 ) — (40,471 ) Proceeds from other investments 94,840 1,949 — 96,789 Investments in other investments (269,423 ) (2,134 ) — (271,557 ) Collection of mortgage principal 59,975 — — 59,975 Net cash used in investing activities (1,101,817 ) (128,190 ) 116,099 (1,113,908 ) Cash flows from financing activities Proceeds from credit facility borrowings 1,304,000 — — 1,304,000 Payments on credit facility borrowings (1,344,000 ) — — (1,344,000 ) Receipts of other long-term borrowings 1,048,173 — — 1,048,173 Payments of other long-term borrowings (180,000 ) (1,249 ) — (181,249 ) Payments of financing related costs (11,806 ) (24 ) — (11,830 ) Receipts from dividend reinvestment plan 240,041 — — 240,041 Payments for exercised options and restricted stock (23,426 ) — — (23,426 ) Net proceeds from issuance of common stock 19,651 — — 19,651 Dividends paid (453,152 ) — — (453,152 ) Contributions from affiliates — 116,099 (116,099 ) — Redemption of OP Units (733 ) — — (733 ) Distributions to OP Unit holders (21,179 ) — — (21,179 ) Net cash provided by financing activities 577,569 114,826 (116,099 ) 576,296 Effect of foreign currency translation on cash and cash equivalents — 84 — 84 Increase in cash and cash equivalents 85,506 2,757 — 88,263 Cash and cash equivalents at beginning of period 1,592 3,832 — 5,424 Cash and cash equivalents at end of period $ 87,098 $ 6,589 $ — $ 93,687 CONSOLIDATING STATEMENT OF CASH FLOWS (in thousands ) Year Ended December 31, 2015 Issuer & Subsidiary Non-Guarantor Elimination Consolidated Cash flows from operating activities Net income $ 233,315 $ 10,610 $ (10,610 ) $ 233,315 Adjustment to reconcile net income to net cash provided by operating activities: Depreciation and amortization 194,328 16,375 — 210,703 Impairment loss on real estate properties 17,681 — — 17,681 Provision for uncollectible mortgages, notes and accounts receivable 7,871 — — 7,871 Refinancing costs and amortization of deferred financing costs 35,806 21 — 35,827 Accretion of direct financing leases (11,007 ) — — (11,007 ) Stock-based compensation expense 11,133 — — 11,133 Gain on assets sold – net (6,353 ) — — (6,353 ) Amortization of acquired in-place leases - net (13,846 ) — — (13,846 ) Change in operating assets and liabilities – net of amounts assumed/acquired: Accounts receivable, net 248 — — 248 Straight-line rent receivables (31,237 ) (4,820 ) — (36,057 ) Lease inducements 994 — — 994 Effective yield receivable on mortgage notes (4,065 ) — — (4,065 ) Other operating assets and liabilities 10,550 (3,719 ) 10,610 17,441 Net cash provided by operating activities 445,418 18,467 — 463,885 Cash flows from investing activities Acquisition of real estate – net of liabilities assumed and escrows acquired (116,698 ) (177,484 ) — (294,182 ) Cash acquired in merger 84,858 — — 84,858 Investments in construction in progress (164,226 ) — — (164,226 ) Investment in U.K. subsidiary (166,082 ) 166,082 — — Investments in direct financing leases (6,793 ) — — (6,793 ) Placement of mortgage loans (14,042 ) — — (14,042 ) Proceeds from sale of real estate investments 41,543 — — 41,543 Capital improvements to real estate investments (24,599 ) (1,798 ) — (26,397 ) Proceeds from other investments 45,871 — — 45,871 Investments in other investments (65,402 ) — — (65,402 ) Collection of mortgage principal 1,359 — — 1,359 Net cash used in investing activities (384,211 ) (13,200 ) — (397,411 ) Cash flows from financing activities Proceeds from credit facility borrowings 1,826,000 — — 1,826,000 Payments on credit facility borrowings (1,681,000 ) — — (1,681,000 ) Receipts of other long-term borrowings 1,838,124 — — 1,838,124 Payments of other long-term borrowings (2,186,102 ) (1,212 ) — (2,187,314 ) Payments of financing related costs (54,721 ) — — (54,721 ) Receipts from dividend reinvestment plan 150,847 — — 150,847 Payments for exercised options and restricted stock (26,706 ) — — (26,706 ) Net proceeds from issuance of common stock 439,322 — — 439,322 Dividends paid (358,232 ) — — (358,232 ) Distributions to OP Unit holders (11,636 ) — — (11,636 ) Net cash used in financing activities (64,104 ) (1,212 ) — (65,316 ) Effect of foreign currency translation on cash and cash equivalents — (223 ) — (223 ) (Decrease) increase in cash and cash equivalents (2,897 ) 3,832 — 935 Cash and cash equivalents at beginning of period 4,489 — — 4,489 Cash and cash equivalents at end of period $ 1,592 $ 3,832 $ — $ 5,424 CONSOLIDATING STATEMENT OF CASH FLOWS (in thousands ) Year Ended December 31, 2014 Issuer & Subsidiary Non-Guarantor Elimination Consolidated Cash flows from operating activities Net income $ 221,349 $ 3,143 $ (3,143 ) $ 221,349 Adjustment to reconcile net income to net cash provided by operating activities: Depreciation and amortization 119,367 3,890 — 123,257 Impairment loss on real estate properties 3,660 — — 3,660 Provision for uncollectible mortgages, notes and accounts receivable 2,723 — — 2,723 Refinancing costs and amortization of deferred financing costs 7,479 21 — 7,500 Accretion of direct financing leases (9,787 ) — — (9,787 ) Stock-based compensation expense 8,592 — — 8,592 Gain on assets sold – net (2,863 ) — — (2,863 ) Amortization of acquired in-place leases - net (4,986 ) — — (4,986 ) Change in operating assets and liabilities – net of amounts assumed/acquired: Accounts receivable, net (2,264 ) — — (2,264 ) Straight-line rent receivables (20,164 ) (792 ) — (20,956 ) Lease inducements 2,656 — — 2,656 Effective yield receivable on mortgage notes (2,878 ) — — (2,878 ) Other operating assets and liabilities 11,089 (2,695 ) 3,143 11,537 Net cash provided by operating activities 333,973 3,567 — 337,540 Cash flows from investing activities Acquisition of real estate – net of liabilities assumed and escrows acquired (131,689 ) — — (131,689 ) Placement of mortgage loans (529,548 ) — — (529,548 ) Proceeds from sale of real estate investments 4,077 — — 4,077 Capital improvements to real estate investments (15,525 ) (2,392 ) — (17,917 ) Proceeds from other investments 13,589 — — 13,589 Investments in other investments (9,441 ) — — (9,441 ) Collection of mortgage principal 122,984 — — 122,984 Net cash used in investing activities (545,553 ) (2,392 ) — (547,945 ) Cash flows from financing activities Proceeds from credit facility borrowings 900,000 — — 900,000 Payments on credit facility borrowings (1,141,000 ) — — (1,141,000 ) Receipts of other long-term borrowings 842,148 — — 842,148 Payments of other long-term borrowings (241,369 ) (1,175 ) — (242,544 ) Payments of financing related costs (17,716 ) — — (17,716 ) Receipts from dividend reinvestment plan 71,487 — — 71,487 Payments for exercised options and restricted stock (3,577 ) — — (3,577 ) Net proceeds from issuance of common stock 61,981 — — 61,981 Dividends paid (258,501 ) — — (258,501 ) Net cash provided by (used in) financing activities 213,453 (1,175 ) — 212,278 Increase in cash and cash equivalents 1,873 — — 1,873 Cash and cash equivalents at beginning of period 2,616 — — 2,616 Cash and cash equivalents at end of period $ 4,489 $ — $ — $ 4,489

ORGANIZATION AND BASIS OF PRE50

ORGANIZATION AND BASIS OF PRESENTATION (Narrative) (Detail) - Segment	1 Months Ended	12 Months Ended
	Jun. 30, 2015	Dec. 31, 2016
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Number of reportable segments		1
Operating Partnership units
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Percentage of limited partnership interest owned	95.00%	96.00%
Other investors | Operating Partnership units
Organization Consolidation And Presentation Of Financial Statements [Line Items]
Percentage of limited partnership interest owned	5.00%	4.00%

SUMMARY OF SIGNIFICANT ACCOUN51

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Accounting Policies [Abstract]
Contractual receivables	$ 13,376	$ 8,452
Effective yield interest receivables	9,749	9,028
Straight-line rent receivables	208,874	175,709
Lease inducements	8,393	10,982
Allowance	(357)	(309)
Accounts receivable - net	$ 240,035	$ 203,862

SUMMARY OF SIGNIFICANT ACCOUN52

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Term Loans, net	$ 1,094,343	$ 745,693
Secured Borrowings, net	54,365	235,593
Unsecured Borrowings, net	3,028,146	2,328,727
Prior to change in accounting principle
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Term Loans, net	1,100,000	750,000
Secured Borrowings, net	54,954	236,204
Unsecured Borrowings, net	3,055,849	2,352,882
Impact of change in accounting principle
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Term Loans, net	(5,657)	(4,307)
Secured Borrowings, net	(589)	(611)
Unsecured Borrowings, net	$ (27,703)	$ (24,155)

SUMMARY OF SIGNIFICANT ACCOUN53

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Detail)	12 Months Ended
	Dec. 31, 2016
Property, Plant and Equipment [Line Items]
Depreciation method	straight-line basis
Building | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives	20 years
Building | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives	40 years
Site improvements | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives	8 years
Site improvements | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives	15 years
Furniture, fixtures and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives	3 years
Furniture, fixtures and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives	10 years

SUMMARY OF SIGNIFICANT ACCOUN54

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Detail 1) $ / shares in Units, $ in Thousands, shares in Millions	Feb. 01, 2016USD ($)Facility	Jun. 30, 2015shares	Dec. 31, 2016USD ($)FacilityHealthcare_facility	Dec. 31, 2015USD ($)Facility	Dec. 31, 2014USD ($)Facility	Apr. 01, 2015$ / sharesshares
Accounting Policies [Line Items]
Unamortized direct costs related to origination of direct financing leases			$ 3,300	$ 3,300
Recognized impairment losses			58,726	17,681	$ 3,660
Loan loss reserves			8,700	3,000
Straight line rent receivables wrote off			$ 4,300	3,200	800
Effective yield interest receivables wrote off				$ 1,500	$ 2,000
Number of facilities transitioned | Facility				4	2
Annual percentage increases over the rents of the prior year, minimum			2.00%
Annual percentage increases over the rents of the prior year, maximum			3.00%
Amortization of financing costs			$ 9,345	$ 6,990	$ 4,459
Number of leased real estate properties | Healthcare_facility			996
Rental income			$ 743,885	605,991	$ 388,443
SNF's
Accounting Policies [Line Items]
Number of leased real estate properties | Facility			809
ALFs
Accounting Policies [Line Items]
Number of leased real estate properties | Facility			101
Cash flow hedges
Accounting Policies [Line Items]
Cash flow hedges recorded at fair value in accrued expenses and other liabilities			$ 1,500	$ 700
Omega OP Units
Accounting Policies [Line Items]
Limited partnership interest owned | shares						138.8
Number of units settled in cash | shares		0.2
Percentage of limited partnership interest owned		95.00%	96.00%
Aviv Operating Partnership | Omega OP Units
Accounting Policies [Line Items]
Limited partnership interest owned | shares						52.9
Limited Partnership units, redeemable, par value per share | $ / shares						$ 0.10
Other investors | Omega OP Units
Accounting Policies [Line Items]
Percentage of limited partnership interest owned		5.00%	4.00%
Laurel Healthcare Holdings | SNF's
Accounting Policies [Line Items]
Number of leased real estate properties | Facility	10
Purchase price of buildings acquired paid in cash	$ 169,000
Laurel Healthcare Holdings | Directors
Accounting Policies [Line Items]
Percentage of ownership interest	34.00%

PROPERTIES (Detail)

PROPERTIES (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Property, Plant and Equipment [Line Items]
Total real estate investments	$ 7,566,358	$ 6,743,958
Less accumulated depreciation	(1,240,336)	(1,019,150)
Total	6,326,022	5,724,808
Buildings
Property, Plant and Equipment [Line Items]
Total real estate investments	5,954,771	5,320,482
Land
Property, Plant and Equipment [Line Items]
Total real estate investments	759,295	670,916
Furniture, fixtures and equipment
Property, Plant and Equipment [Line Items]
Total real estate investments	454,760	426,040
Site improvements
Property, Plant and Equipment [Line Items]
Total real estate investments	206,206	132,182
Construction in progress
Property, Plant and Equipment [Line Items]
Total real estate investments	$ 191,326	$ 194,338

PROPERTIES (Detail 1)

PROPERTIES (Detail 1) $ in Thousands	Dec. 31, 2016USD ($)
Real Estate [Abstract]
2,017	$ 718,999
2,018	711,714
2,019	689,641
2,020	701,543
2,021	705,418
Thereafter	3,732,920
Total	$ 7,260,235

PROPERTIES (Detail 2)

PROPERTIES (Detail 2) $ in Millions		5 Months Ended	12 Months Ended
		Jul. 24, 2015USD ($)	Dec. 31, 2016USD ($)FacilityHealthcare_facility	Dec. 31, 2015USD ($)Facility	Dec. 31, 2014USD ($)Facility
Real Estate Properties [Line Items]
Number of Facilities | Healthcare_facility			996
Initial Annual Cash Yield (%)		5.00%
SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility			809
ALFs
Real Estate Properties [Line Items]
Number of Facilities | Facility			101
2016 Acquisitions and Other
Real Estate Properties [Line Items]
Total Investment			$ 1,022.8
2016 Acquisitions and Other | Land
Real Estate Properties [Line Items]
Total Investment			100.4
2016 Acquisitions and Other | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment			876.6
2016 Acquisitions and Other | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment			$ 45.8
2016 Acquisitions and Other | SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility			70
2016 Acquisitions and Other | ALFs
Real Estate Properties [Line Items]
Number of Facilities | Facility			20
2016 Acquisitions and Other | Q1 | UK
Real Estate Properties [Line Items]
Total Investment			$ 8.3
Initial Annual Cash Yield (%)			7.00%
2016 Acquisitions and Other | Q1 | UK | Land
Real Estate Properties [Line Items]
Total Investment			$ 1.4
2016 Acquisitions and Other | Q1 | UK | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment			6.7
2016 Acquisitions and Other | Q1 | UK | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment			$ 0.2
2016 Acquisitions and Other | Q1 | UK | ALFs
Real Estate Properties [Line Items]
Number of Facilities | Facility			1
2016 Acquisitions and Other | Q1 | UK
Real Estate Properties [Line Items]
Total Investment			$ 6.1
Initial Annual Cash Yield (%)			7.00%
2016 Acquisitions and Other | Q1 | UK | Land
Real Estate Properties [Line Items]
Total Investment			$ 0.6
2016 Acquisitions and Other | Q1 | UK | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment			5.3
2016 Acquisitions and Other | Q1 | UK | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment			$ 0.2
2016 Acquisitions and Other | Q1 | UK | ALFs
Real Estate Properties [Line Items]
Number of Facilities | Facility			1
2016 Acquisitions and Other | Q1 | OH, VA, MI
Real Estate Properties [Line Items]
Total Investment	[1]		$ 169
Initial Annual Cash Yield (%)			8.50%
2016 Acquisitions and Other | Q1 | OH, VA, MI | Land
Real Estate Properties [Line Items]
Total Investment			$ 10.5
2016 Acquisitions and Other | Q1 | OH, VA, MI | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment			152.5
2016 Acquisitions and Other | Q1 | OH, VA, MI | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment			$ 6
2016 Acquisitions and Other | Q1 | OH, VA, MI | SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility			10
2016 Acquisitions and Other | Q1 | GA
Real Estate Properties [Line Items]
Total Investment			$ 20.2
Initial Annual Cash Yield (%)			7.50%
2016 Acquisitions and Other | Q1 | GA | Land
Real Estate Properties [Line Items]
Total Investment			$ 0.8
2016 Acquisitions and Other | Q1 | GA | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment			18.3
2016 Acquisitions and Other | Q1 | GA | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment			$ 1.1
2016 Acquisitions and Other | Q1 | GA | ALFs
Real Estate Properties [Line Items]
Number of Facilities | Facility			2
2016 Acquisitions and Other | Q1 | MD
Real Estate Properties [Line Items]
Total Investment			$ 25
Initial Annual Cash Yield (%)			8.50%
2016 Acquisitions and Other | Q1 | MD | Land
Real Estate Properties [Line Items]
Total Investment			$ 2.5
2016 Acquisitions and Other | Q1 | MD | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment			19.9
2016 Acquisitions and Other | Q1 | MD | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment			$ 2.6
2016 Acquisitions and Other | Q1 | MD | SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility			3
2016 Acquisitions and Other | Q1 | VA, NC
Real Estate Properties [Line Items]
Total Investment			$ 212.5
Initial Annual Cash Yield (%)			8.50%
2016 Acquisitions and Other | Q1 | VA, NC | Land
Real Estate Properties [Line Items]
Total Investment			$ 19.3
2016 Acquisitions and Other | Q1 | VA, NC | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment			181.1
2016 Acquisitions and Other | Q1 | VA, NC | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment			$ 12.1
2016 Acquisitions and Other | Q1 | VA, NC | SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility			21
2016 Acquisitions and Other | Q2 | UK
Real Estate Properties [Line Items]
Total Investment	[2]		$ 111.9
Initial Annual Cash Yield (%)			7.00%
2016 Acquisitions and Other | Q2 | UK | Land
Real Estate Properties [Line Items]
Total Investment			$ 24.8
2016 Acquisitions and Other | Q2 | UK | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment			83.9
2016 Acquisitions and Other | Q2 | UK | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment			$ 3.2
2016 Acquisitions and Other | Q2 | UK | ALFs
Real Estate Properties [Line Items]
Number of Facilities | Facility			10
2016 Acquisitions and Other | Q2 | TX
Real Estate Properties [Line Items]
Total Investment	[3]		$ 66
Initial Annual Cash Yield (%)			6.80%
2016 Acquisitions and Other | Q2 | TX | Land
Real Estate Properties [Line Items]
Total Investment			$ 5.8
2016 Acquisitions and Other | Q2 | TX | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment			58.6
2016 Acquisitions and Other | Q2 | TX | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment			$ 1.6
2016 Acquisitions and Other | Q2 | TX | ALFs
Real Estate Properties [Line Items]
Number of Facilities | Facility			3
2016 Acquisitions and Other | Q2 | CO, MO
Real Estate Properties [Line Items]
Total Investment			$ 31.8
Initial Annual Cash Yield (%)			9.00%
2016 Acquisitions and Other | Q2 | CO, MO | Land
Real Estate Properties [Line Items]
Total Investment			$ 3.1
2016 Acquisitions and Other | Q2 | CO, MO | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment			26.2
2016 Acquisitions and Other | Q2 | CO, MO | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment			$ 2.5
2016 Acquisitions and Other | Q2 | CO, MO | SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility			3
2016 Acquisitions and Other | Q3 | GA
Real Estate Properties [Line Items]
Total Investment			$ 2.5
Initial Annual Cash Yield (%)			8.00%
2016 Acquisitions and Other | Q3 | GA | Land
Real Estate Properties [Line Items]
Total Investment			$ 0.2
2016 Acquisitions and Other | Q3 | GA | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment			2.1
2016 Acquisitions and Other | Q3 | GA | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment			$ 0.2
2016 Acquisitions and Other | Q3 | GA | ALFs
Real Estate Properties [Line Items]
Number of Facilities | Facility			1
2016 Acquisitions and Other | Q3 | FL
Real Estate Properties [Line Items]
Total Investment			$ 4.3
Initial Annual Cash Yield (%)			8.00%
2016 Acquisitions and Other | Q3 | FL | Land
Real Estate Properties [Line Items]
Total Investment			$ 2.3
2016 Acquisitions and Other | Q3 | FL | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment			1.8
2016 Acquisitions and Other | Q3 | FL | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment			$ 0.2
2016 Acquisitions and Other | Q3 | FL | ALFs
Real Estate Properties [Line Items]
Number of Facilities | Facility			1
2016 Acquisitions and Other | Q3 | FL
Real Estate Properties [Line Items]
Total Investment			$ 16.5
Initial Annual Cash Yield (%)			8.00%
2016 Acquisitions and Other | Q3 | FL | Land
Real Estate Properties [Line Items]
Total Investment			$ 1.8
2016 Acquisitions and Other | Q3 | FL | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment			14.3
2016 Acquisitions and Other | Q3 | FL | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment			$ 0.4
2016 Acquisitions and Other | Q3 | FL | ALFs
Real Estate Properties [Line Items]
Number of Facilities | Facility			1
2016 Acquisitions and Other | Q3 | SC
Real Estate Properties [Line Items]
Total Investment			$ 10.1
Initial Annual Cash Yield (%)			9.00%
2016 Acquisitions and Other | Q3 | SC | Land
Real Estate Properties [Line Items]
Total Investment			$ 2.7
2016 Acquisitions and Other | Q3 | SC | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment			6.5
2016 Acquisitions and Other | Q3 | SC | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment			$ 0.9
2016 Acquisitions and Other | Q3 | SC | SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility			1
2016 Acquisitions and Other | Q3 | OH
Real Estate Properties [Line Items]
Total Investment	[4]		$ 9
Initial Annual Cash Yield (%)			9.00%
2016 Acquisitions and Other | Q3 | OH | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment			$ 8.6
2016 Acquisitions and Other | Q3 | OH | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment			$ 0.4
2016 Acquisitions and Other | Q3 | OH | SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility			1
2016 Acquisitions and Other | Q3 | FL, KY,TN
Real Estate Properties [Line Items]
Total Investment	[5],[6]		$ 329.6
Initial Annual Cash Yield (%)			9.00%
2016 Acquisitions and Other | Q3 | FL, KY,TN | Land
Real Estate Properties [Line Items]
Total Investment			$ 24.6
2016 Acquisitions and Other | Q3 | FL, KY,TN | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment			290.8
2016 Acquisitions and Other | Q3 | FL, KY,TN | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment			$ 14.2
2016 Acquisitions and Other | Q3 | FL, KY,TN | SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility			31
2015 Acquisitions and Other
Real Estate Properties [Line Items]
Total Investment				$ 228.7
2015 Acquisitions and Other | Land
Real Estate Properties [Line Items]
Total Investment				122
2015 Acquisitions and Other | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment				98.6
2015 Acquisitions and Other | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment				$ 8.1
2015 Acquisitions and Other | SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility				13
2015 Acquisitions and Other | ALFs
Real Estate Properties [Line Items]
Number of Facilities | Facility				4
2015 Acquisitions and Other | NY
Real Estate Properties [Line Items]
Total Investment		$ 111.7
2015 Acquisitions and Other | Q1 | TX
Real Estate Properties [Line Items]
Total Investment				$ 6.8
Initial Annual Cash Yield (%)				9.50%
2015 Acquisitions and Other | Q1 | TX | Land
Real Estate Properties [Line Items]
Total Investment				$ 0.1
2015 Acquisitions and Other | Q1 | TX | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment				6.1
2015 Acquisitions and Other | Q1 | TX | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment				$ 0.6
2015 Acquisitions and Other | Q1 | TX | SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility				1
2015 Acquisitions and Other | Q3 | GA
Real Estate Properties [Line Items]
Total Investment				$ 10.8
Initial Annual Cash Yield (%)				7.00%
2015 Acquisitions and Other | Q3 | GA | Land
Real Estate Properties [Line Items]
Total Investment				$ 1.2
2015 Acquisitions and Other | Q3 | GA | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment				9
2015 Acquisitions and Other | Q3 | GA | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment				$ 0.6
2015 Acquisitions and Other | Q3 | GA | ALFs
Real Estate Properties [Line Items]
Number of Facilities | Facility				2
2015 Acquisitions and Other | Q3 | FL
Real Estate Properties [Line Items]
Total Investment				$ 32
Initial Annual Cash Yield (%)				9.00%
2015 Acquisitions and Other | Q3 | FL | Land
Real Estate Properties [Line Items]
Total Investment				$ 1.4
2015 Acquisitions and Other | Q3 | FL | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment				29
2015 Acquisitions and Other | Q3 | FL | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment				$ 1.6
2015 Acquisitions and Other | Q3 | FL | SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility				2
2015 Acquisitions and Other | Q3 | NE
Real Estate Properties [Line Items]
Total Investment				$ 15
Initial Annual Cash Yield (%)				9.00%
2015 Acquisitions and Other | Q3 | NE | Land
Real Estate Properties [Line Items]
Total Investment				$ 1.4
2015 Acquisitions and Other | Q3 | NE | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment				12.1
2015 Acquisitions and Other | Q3 | NE | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment				$ 1.5
2015 Acquisitions and Other | Q3 | NE | SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility				6
2015 Acquisitions and Other | Q3 | WA
Real Estate Properties [Line Items]
Total Investment				$ 18
Initial Annual Cash Yield (%)				8.00%
2015 Acquisitions and Other | Q3 | WA | Land
Real Estate Properties [Line Items]
Total Investment				$ 2.2
2015 Acquisitions and Other | Q3 | WA | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment				14.9
2015 Acquisitions and Other | Q3 | WA | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment				$ 0.9
2015 Acquisitions and Other | Q3 | WA | SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility				1
2015 Acquisitions and Other | Q3 | WA | ALFs
Real Estate Properties [Line Items]
Number of Facilities | Facility				2
2015 Acquisitions and Other | Q3 | VA
Real Estate Properties [Line Items]
Total Investment	[7]			$ 28.5
Initial Annual Cash Yield (%)				9.25%
2015 Acquisitions and Other | Q3 | VA | Land
Real Estate Properties [Line Items]
Total Investment				$ 1.9
2015 Acquisitions and Other | Q3 | VA | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment				24.2
2015 Acquisitions and Other | Q3 | VA | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment				$ 2.4
2015 Acquisitions and Other | Q3 | VA | SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility				1
2015 Acquisitions and Other | Q3 | NY
Real Estate Properties [Line Items]
Total Investment	[8],[9]			$ 111.7
2015 Acquisitions and Other | Q3 | NY | Land
Real Estate Properties [Line Items]
Total Investment				111.7
2015 Acquisitions and Other | Q4 | TX
Real Estate Properties [Line Items]
Total Investment				$ 5.3
Initial Annual Cash Yield (%)				9.50%
2015 Acquisitions and Other | Q4 | TX | Land
Real Estate Properties [Line Items]
Total Investment				$ 1.8
2015 Acquisitions and Other | Q4 | TX | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment				3
2015 Acquisitions and Other | Q4 | TX | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment				$ 0.5
2015 Acquisitions and Other | Q4 | TX | SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility				1
2015 Acquisitions and Other | Q4 | AZ
Real Estate Properties [Line Items]
Total Investment	[8]			$ 0.6
Initial Annual Cash Yield (%)				9.00%
2015 Acquisitions and Other | Q4 | AZ | Land
Real Estate Properties [Line Items]
Total Investment				$ 0.3
2015 Acquisitions and Other | Q4 | AZ | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment				$ 0.3
2015 Acquisitions and Other | Q4 | AZ | SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility				1
2014 Acquisitions and Other
Real Estate Properties [Line Items]
Total Investment					$ 131.7
2014 Acquisitions and Other | Land
Real Estate Properties [Line Items]
Total Investment					6.8
2014 Acquisitions and Other | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment					120.1
2014 Acquisitions and Other | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment					$ 4.8
2014 Acquisitions and Other | SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility					4
2014 Acquisitions and Other | ALFs
Real Estate Properties [Line Items]
Number of Facilities | Facility					5
2014 Acquisitions and Other | Q1 | AZ
Real Estate Properties [Line Items]
Total Investment					$ 4.7
Initial Annual Cash Yield (%)					9.75%
2014 Acquisitions and Other | Q1 | AZ | Land
Real Estate Properties [Line Items]
Total Investment					$ 0.4
2014 Acquisitions and Other | Q1 | AZ | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment					3.9
2014 Acquisitions and Other | Q1 | AZ | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment					$ 0.4
2014 Acquisitions and Other | Q1 | AZ | ALFs
Real Estate Properties [Line Items]
Number of Facilities | Facility					1
2014 Acquisitions and Other | Q2/Q3 | GA, SC
Real Estate Properties [Line Items]
Total Investment					$ 34.6
Initial Annual Cash Yield (%)					9.50%
2014 Acquisitions and Other | Q2/Q3 | GA, SC | Land
Real Estate Properties [Line Items]
Total Investment					$ 0.9
2014 Acquisitions and Other | Q2/Q3 | GA, SC | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment					32.1
2014 Acquisitions and Other | Q2/Q3 | GA, SC | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment					$ 1.6
2014 Acquisitions and Other | Q2/Q3 | GA, SC | SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility					3
2014 Acquisitions and Other | Q3 | TX
Real Estate Properties [Line Items]
Total Investment					$ 8.2
Initial Annual Cash Yield (%)					9.75%
2014 Acquisitions and Other | Q3 | TX | Land
Real Estate Properties [Line Items]
Total Investment					$ 0.4
2014 Acquisitions and Other | Q3 | TX | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment					7.4
2014 Acquisitions and Other | Q3 | TX | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment					$ 0.4
2014 Acquisitions and Other | Q3 | TX | SNF's
Real Estate Properties [Line Items]
Number of Facilities | Facility					1
2014 Acquisitions and Other | Q4 | PA,OR, AR
Real Estate Properties [Line Items]
Total Investment					$ 84.2
Initial Annual Cash Yield (%)					6.00%
2014 Acquisitions and Other | Q4 | PA,OR, AR | Land
Real Estate Properties [Line Items]
Total Investment					$ 5.1
2014 Acquisitions and Other | Q4 | PA,OR, AR | Buildings and site improvements
Real Estate Properties [Line Items]
Total Investment					76.7
2014 Acquisitions and Other | Q4 | PA,OR, AR | Furniture and fixtures
Real Estate Properties [Line Items]
Total Investment					$ 2.4
2014 Acquisitions and Other | Q4 | PA,OR, AR | ALFs
Real Estate Properties [Line Items]
Number of Facilities | Facility					4
[1]	Acquired from a related party. Refer to Note - 2 Summary of Significant Accounting Policies - Related Party Transactions.
[2]	Omega also recorded a deferred tax asset of approximately $1.9 million in connection with the acquisition.
[3]	The Company paid $63.0 million in cash at closing to acquire the facilities. We have agreed to pay an additional $1.5 million in April 2017 and the remaining $1.5 million in April 2018. The additional consideration to be paid is contractually determined and not contingent on other factors. The $3.0 million liability is recorded in unsecured borrowings - net on our Consolidated Balance Sheet.
[4]	The Company paid approximately $3.5 million in cash to acquire the facility. The remainder of the purchase price (approximately $5.5 million) was funded with the redemption of an other investment note.
[5]	The Company estimated the fair value of the assets acquired on the acquisition date based on certain valuation analyses that have yet to be finalized, and accordingly, the assets acquired, as detailed, are subject to adjustment once the analysis is completed.
[6]	The Company's investment includes a purchase option buyout obligation with a fair value of approximately $29.6 million. The future buyout obligation is recorded in accrued expenses and other liabilities on our Consolidated Balance Sheet. The Company also acquired a term loan with a fair value of approximately $37.0 million which is recorded in other investments on our Consolidated Balance Sheet. Refer to Note - 6 Other Investments.
[7]	In July 2015, we leased the facility to a new operator with an initial lease term of 10 years.
[8]	Accounted for as an asset acquisition.
[9]	On July 24, 2015, we purchased five buildings located in New York City, New York for approximately $111.7 million. We and our operator plan to construct a 201,000 square-foot assisted living and memory care facility. The properties were added to the operator's existing master lease. The lease provides for a 5% annual cash yield on the land during the construction phase. Upon issuance of a certification of occupancy, the annual cash yield will increase to 7% in year one and 8% in year two with 2.5% annual escalators thereafter.

PROPERTIES (Parentheticals) (De

PROPERTIES (Parentheticals) (Detail 2) $ in Millions	1 Months Ended	5 Months Ended	12 Months Ended
	Jul. 31, 2015	Jul. 24, 2015USD ($)ft²Facility	Dec. 31, 2016USD ($)Healthcare_facility	Dec. 31, 2015USD ($)
Real Estate Properties [Line Items]
Number of leased real estate properties | Healthcare_facility			996
Area of land | ft²		201,000
Percentage of annual cash yield		5.00%
Percentage of annual cash yield increase in year one		7.00%
Percentage of annual cash yield increase in year two		8.00%
Percentage of annual cash yield increase in year thereafter		2.50%
2016 Acquisitions and Other
Real Estate Properties [Line Items]
Total Investment			$ 1,022.8
2016 Acquisitions and Other | FL, KY,TN
Real Estate Properties [Line Items]
Fair value of purchase option buyout obligation			29.6
Fair value of acquired term loan			37
2016 Acquisitions and Other | UK
Real Estate Properties [Line Items]
Deferred tax asset on acquisition of investment			1.9
2016 Acquisitions and Other | TX
Real Estate Properties [Line Items]
Cash payment to acquire facilities			63
Additional agreed payment due in April 2017			1.5
Remaining facilities payment due in April 2018			1.5
Unsecured borrowings			3
2016 Acquisitions and Other | OH
Real Estate Properties [Line Items]
Cash payment to acquire facilities			3.5
Remainder of purchase price funded by redemption of a note			$ 5.5
2015 Acquisitions and Other
Real Estate Properties [Line Items]
Total Investment				$ 228.7
2015 Acquisitions and Other | NY
Real Estate Properties [Line Items]
Total Investment		$ 111.7
2015 Acquisitions and Other | NY | Building
Real Estate Properties [Line Items]
Number of leased real estate properties | Facility		5
2015 Acquisitions and Other | VIRGINIA
Real Estate Properties [Line Items]
Lease term	10 years

PROPERTIES (Detail 3)

PROPERTIES (Detail 3) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Apr. 01, 2015
Fair value of net assets acquired:
Goodwill	$ 643,474	$ 645,683
Merger Agreement | Aviv REIT, Inc
Fair value of net assets acquired:
Land and buildings			$ 3,107,530
Investment in direct financing leases			26,823
Mortgages notes receivable			19,246
Other investments			23,619
Total investments			3,177,218
Goodwill			630,679
Accounts receivables and other assets			17,144
Cash acquired			84,858
Accrued expenses and other liabilities			(223,002)
Debt			(1,410,637)
Fair value of net assets acquired			$ 2,276,260

PROPERTIES (Detail 4)

PROPERTIES (Detail 4) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Earnings per share - diluted:
Net income - as reported	$ 0.63	$ 0.40	$ 0.57	$ 0.29	$ 0.32	$ 0.43	$ 0.22	$ 0.32	$ 1.90	$ 1.29	$ 1.74
Pro forma
Proforma Information [Line Items]
Pro forma revenues										$ 817,642	$ 789,270
Pro forma net income										$ 258,927	$ 318,271
Earnings per share - diluted:
Net income - as reported										$ 1.29	$ 1.74
Net income - pro forma										$ 1.33	$ 1.74

PROPERTIES - Leased Property (N

PROPERTIES - Leased Property (Narrative) (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2016USD ($)FacilityHealthcare_facility	Dec. 31, 2015USD ($)
Real Estate Properties [Line Items]
Number of leased real estate properties | Healthcare_facility	996
Project cost | $	$ 6.6
Capitalized interest | $		$ 3.7
Property available for operating lease | Minimum
Real Estate Properties [Line Items]
Lease term	5 years
Property available for operating lease | Maximum
Real Estate Properties [Line Items]
Lease term	15 years
SNF's
Real Estate Properties [Line Items]
Number of leased real estate properties	809
ALFs
Real Estate Properties [Line Items]
Number of leased real estate properties	101
Specialty facilities
Real Estate Properties [Line Items]
Number of leased real estate properties	16
Medical office building
Real Estate Properties [Line Items]
Number of leased real estate properties	1

PROPERTIES - 2016 and 2015 Acqu

PROPERTIES - 2016 and 2015 Acquisitions and Other (Narrative) (Detail 1) $ in Thousands, shares in Millions	May 01, 2015USD ($)BedCare_home	Apr. 01, 2015USD ($)FacilityPropertyLeaseMortgageshares	Dec. 31, 2016USD ($)	Sep. 30, 2016USD ($)	Jun. 30, 2016USD ($)	Mar. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Sep. 30, 2015USD ($)	Jun. 30, 2015USD ($)	Mar. 31, 2015USD ($)	Dec. 31, 2016USD ($)Parcel	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)
Real Estate Properties [Line Items]
Revenues			$ 234,486	$ 224,638	$ 228,824	$ 212,879	$ 210,512	$ 201,974	$ 197,711	$ 133,420	$ 900,827	$ 743,617	$ 504,787
Net income available to common stockholders			$ 124,259	$ 78,549	$ 108,052	$ 55,555	60,642	$ 79,402	$ 41,428	$ 43,052	366,415	224,524	221,349
Acquisition related expenses											9,582	57,525	3,948
Rental income											743,885	605,991	$ 388,443
Aviv REIT, Inc | Merger Agreement
Real Estate Properties [Line Items]
Revenues												188,400
Acquisition related expenses												52,100
Contingent liability assumed in accrued expenses and other liabilities							$ 67,300					67,300
Conversion ratio of shares		0.90
Number of shares and units issued | shares		43.7
Number of properties acquired | Property		342
Number of facilities subject to direct financing leases | Lease		2
Number of mortgage facilities | Mortgage		2
Fair value of consideration		$ 2,276,260
Aviv REIT, Inc | Merger Agreement | Medical office building
Real Estate Properties [Line Items]
Number of properties acquired | Facility		1
Care Homes
Real Estate Properties [Line Items]
Acquisition related expenses												3,200
Number of care homes located in the United Kingdom | Care_home	23
Number of registered beds | Bed	1,018
Master lease agreement term	12 years
Percentage of initial annual cash yield	7.00%
Percentage of annual escalators	2.50%
Purchase price of beds acquired paid in cash	$ 193,800
Rental income												9,500
Care Homes | Land
Real Estate Properties [Line Items]
Purchase price of beds acquired paid in cash	20,700
Care Homes | Buildings and site improvements
Real Estate Properties [Line Items]
Purchase price of beds acquired paid in cash	152,100
Care Homes | Furniture and fixtures
Real Estate Properties [Line Items]
Purchase price of beds acquired paid in cash	5,300
Care Homes | Goodwill
Real Estate Properties [Line Items]
Purchase price of beds acquired paid in cash	$ 15,700
2016 Acquisitions and Other
Real Estate Properties [Line Items]
Acquisition related expenses											9,600
Purchase price of beds acquired paid in cash											1,022,800
Rental income											58,100
2016 Acquisitions and Other | Land
Real Estate Properties [Line Items]
Purchase price of beds acquired paid in cash											$ 100,400
Number of properties acquired | Parcel											5
Cash payment to acquire facilities											$ 8,300
2016 Acquisitions and Other | Buildings and site improvements
Real Estate Properties [Line Items]
Purchase price of beds acquired paid in cash											876,600
2016 Acquisitions and Other | Furniture and fixtures
Real Estate Properties [Line Items]
Purchase price of beds acquired paid in cash											$ 45,800
2015 Acquisitions and Other
Real Estate Properties [Line Items]
Revenues												4,900
Acquisition related expenses												2,200
Purchase price of beds acquired paid in cash												228,700
2015 Acquisitions and Other | Land
Real Estate Properties [Line Items]
Purchase price of beds acquired paid in cash												122,000
2015 Acquisitions and Other | Buildings and site improvements
Real Estate Properties [Line Items]
Purchase price of beds acquired paid in cash												98,600
2015 Acquisitions and Other | Furniture and fixtures
Real Estate Properties [Line Items]
Purchase price of beds acquired paid in cash												$ 8,100

PROPERTIES - 2014 Acquisition (

PROPERTIES - 2014 Acquisition (Narrative) (Detail 2) $ in Millions	12 Months Ended
	Dec. 31, 2014USD ($)Facility	Dec. 31, 2015Facility	Jul. 01, 2014FacilityBed
Real Estate Properties [Line Items]
Revenue attributable to the acquisitions	$ 3.2
Acquisition related expenses	$ 3.9
Number of facilities transitioned | Facility	2	4
SNFs West Virginia Facility Bed
Real Estate Properties [Line Items]
Number of facilities transitioned | Facility			2
Number of beds | Bed			150
Provision for uncollectible straight-line rent receivable	$ 0.8
Period of master lease agreement	12 years

PROPERTIES - Asset Sales, Impai

PROPERTIES - Asset Sales, Impairments and Other (Narrative) (Detail 3) $ in Millions	12 Months Ended
	Dec. 31, 2016USD ($)Facility	Dec. 31, 2015USD ($)Facility	Dec. 31, 2014USD ($)Facility
Real Estate Properties [Line Items]
Number of facilities sold	38
Number of previously classified as held for sale	21
Number of facilities impaired	29
Total cash proceeds | $	$ 169.6
Amount of gain (loss) from sale of facilities | $		$ 6.4	$ 2.9
Provision for impairment | $	58.7
SNF's
Real Estate Properties [Line Items]
Number of facilities sold		7	4
Number of previously classified as held for sale		4	3
Number of facilities impaired		6	2
Number of facilities impaired and closed			2
Total cash proceeds | $		$ 41.5	$ 4.1
Amount of gain (loss) from sale of facilities | $	$ 50.2
Provision for impairment | $		$ 17.7	$ 3.7

DIRECT FINANCING LEASES (Detail

DIRECT FINANCING LEASES (Detail) $ in Thousands	Dec. 31, 2016USD ($)Lease	Dec. 31, 2015USD ($)Lease
Leases, Capital [Abstract]
Minimum lease payments receivable	$ 4,287,069	$ 4,320,876
Less unearned income	(3,685,131)	(3,733,175)
Investment in direct financing leases - net	$ 601,938	$ 587,701
Properties subject to direct financing leases | Lease	58	59

DIRECT FINANCING LEASES (Deta66

DIRECT FINANCING LEASES (Detail 1) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Capital Leased Assets [Line Items]
Investment in direct financing leases - net	$ 601,938	$ 587,701
New Ark
Capital Leased Assets [Line Items]
Investment in direct financing leases - net	574,581	560,308
Reliance Health Care Management, Inc
Capital Leased Assets [Line Items]
Investment in direct financing leases - net	15,498	15,509
Sun Mar Healthcare
Capital Leased Assets [Line Items]
Investment in direct financing leases - net	11,443	11,381
Markleysburg Healthcare Investors, LP
Capital Leased Assets [Line Items]
Investment in direct financing leases - net	$ 416	$ 503

DIRECT FINANCING LEASES (Deta67

DIRECT FINANCING LEASES (Detail 2) $ in Thousands	Dec. 31, 2016USD ($)
Leases, Capital [Abstract]
2,017	$ 50,772
2,018	52,098
2,019	53,377
2,020	54,677
2,021	$ 55,919

DIRECT FINANCING LEASES (Narrat

DIRECT FINANCING LEASES (Narrative) (Detail) $ in Millions	1 Months Ended
	Nov. 27, 2013USD ($)FacilityBedLeaseState	Dec. 31, 2016StateHealthcare_facility
Capital Leased Assets [Line Items]
Number of facilities | Healthcare_facility		996
Number of states | State		42
Ark Holding Company Inc
Capital Leased Assets [Line Items]
Purchase price of beds acquired paid in cash | $	$ 529
Number of lease | Lease	4
Lease term	50 years
Interest on lease per annum	10.60%
Number of facilities	56
Number of licensed beds | Bed	5,623
Number of states | State	12
Ark Holding Company Inc | Southeast
Capital Leased Assets [Line Items]
Number of additional facility owned	39
Ark Holding Company Inc | Northwest
Capital Leased Assets [Line Items]
Number of additional facility owned	7
Ark Holding Company Inc | Texas
Capital Leased Assets [Line Items]
Number of additional facility owned	9
Ark Holding Company Inc | Indiana
Capital Leased Assets [Line Items]
Number of additional facility owned	1
SNF's | Ark Holding Company Inc | Direct financing leases
Capital Leased Assets [Line Items]
Number of facilities	55
ALFs | Ark Holding Company Inc
Capital Leased Assets [Line Items]
Number of facilities	1

MORTGAGE NOTES RECEIVABLE (Deta

MORTGAGE NOTES RECEIVABLE (Detail) - USD ($) $ in Thousands		Dec. 31, 2016	Dec. 31, 2015
Mortgage Loans On Real Estate [Line Items]
Mortgage notes receivable, gross		$ 643,277	$ 679,795
Allowance for loss on mortgage notes receivable		(3,934)
Total mortgages - net		639,343	679,795
Mortgage note due 2024; interest at 9.79%
Mortgage Loans On Real Estate [Line Items]
Mortgage notes receivable, gross		112,500	112,500
Mortgage note due 2028; interest at 11.00%
Mortgage Loans On Real Estate [Line Items]
Mortgage notes receivable, gross		35,964	69,928
Mortgage note due 2029; interest at 9.45%
Mortgage Loans On Real Estate [Line Items]
Mortgage notes receivable, gross		412,140	413,399
Other mortgage notes outstanding
Mortgage Loans On Real Estate [Line Items]
Mortgage notes receivable, gross	[1]	$ 82,673	$ 83,968
[1]	Other mortgage notes outstanding have stated interest rates ranging from 8.35% to 12.0% per annum and maturity dates through 2029.

MORTGAGE NOTES RECEIVABLE (Pare

MORTGAGE NOTES RECEIVABLE (Parentheticals) (Detail) - Other mortgage notes outstanding	12 Months Ended
	Dec. 31, 2016
Minimum
Mortgage Loans On Real Estate [Line Items]
Mortgage loans on real estate, interest rate	8.35%
Maximum
Mortgage Loans On Real Estate [Line Items]
Maturity year	2,029
Mortgage loans on real estate, interest rate	12.00%

MORTGAGE NOTES RECEIVABLE (Narr

MORTGAGE NOTES RECEIVABLE (Narrative) (Detail) $ in Thousands	1 Months Ended		12 Months Ended
	Apr. 29, 2016USD ($)Facility	Jan. 31, 2016USD ($)Facility	Dec. 31, 2016USD ($)FacilityMortgageStateEntityHealthcare_facility	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Jun. 30, 2014USD ($)Facility	Jan. 17, 2014USD ($)Facility
Mortgage Loans on Real Estate [Line Items]
Number of states | State			42
Mortgage notes receivable			$ 639,343	$ 679,795
Number of leased real estate properties | Healthcare_facility			996
Collection of mortgage principal			$ 59,975	1,359	$ 122,984
Placement of mortgage loans			48,722	14,042	529,548
Effective yield interest receivables			$ 9,749	9,028
Effective yield interest receivables wrote off				1,500	$ 2,000
Mortgage Loans
Mortgage Loans on Real Estate [Line Items]
Number of fixed rate mortgage | Mortgage			25
Number of long term care facilities | Facility			47
Number of states | State			10
Number of mortgage notes receivable independent operating companies | Entity			7
SNF's
Mortgage Loans on Real Estate [Line Items]
Number of leased real estate properties | Facility			809
Number of facilities under fixed rate mortgage loan | Facility			44
ALFs
Mortgage Loans on Real Estate [Line Items]
Number of leased real estate properties | Facility			101
Number of facilities under fixed rate mortgage loan | Facility			2
Mortgage Notes due 2046 | Maryland
Mortgage Loans on Real Estate [Line Items]
Number of facility acquired | Facility		3
Fair value of facilities approximated		$ 25,000
Mortgage Notes Due 2024
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate, interest rate			9.79%
Mortgage Notes Due 2024 | Mortgage Loans
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable							$ 112,500
Mortgage Notes Due 2024 | SNF's | Mortgage Loans | Pennsylvania
Mortgage Loans on Real Estate [Line Items]
Number of leased real estate properties | Facility							7
Mortgage Notes Due 2024 | ALFs | Mortgage Loans | Ohio
Mortgage Loans on Real Estate [Line Items]
Number of leased real estate properties | Facility							2
Mortgage Notes due 2028 | Mortgage Loans
Mortgage Loans on Real Estate [Line Items]
Mortgage loans on real estate, interest rate	11.00%
Mortgage loan, initial annual cash interest rate increase in 2 year	13.75%
Collection of mortgage principal	$ 47,800
Net gain from repayment of a mortgage note	5,400
Mortgage Notes due 2028 | Mortgage Loans | Maryland
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable	$ 36,000
Number of facilities under fixed rate mortgage loan | Facility	3
Mortgage Notes Due 2029 | Retired Mortgage Loans Mortgage Facility | Mortgage Loans | Michigan
Mortgage Loans on Real Estate [Line Items]
Mortgage notes receivable						$ 117,000
Annual incremental interest rate			0.225%
Description of cash interest rate			The new loan bore an initial annual cash interest rate of 9.0% that increases by 0.225% per year (e.g., beginning in year 2 the annual cash interest rate will be 9.225%, in year 3 the annual cash interest rate will be 9.45%, etc.).
Mortgage loans on real estate, interest rate			9.00%
Mortgage loan, initial annual cash interest rate increase in 2 year			9.225%
Mortgage loan, initial annual cash interest rate increase in 3 year			9.45%
Number of additional facilities for mortgage financing | Facility						14
Number of leased real estate properties | Facility			31			17
Placement of mortgage loans				415,000
Effective yield interest receivables				2,000
Effective yield interest receivables wrote off				$ 2,000

OTHER INVESTMENTS (Detail)

OTHER INVESTMENTS (Detail) - USD ($) $ in Thousands		Dec. 31, 2016	Dec. 31, 2015
Schedule of Investments [Line Items]
Other investments, gross		$ 261,644	$ 92,259
Allowance for loss on other investments		(4,798)	(2,960)
Total other investments		256,846	89,299
Other investment note due 2019; interest at 10.50%
Schedule of Investments [Line Items]
Other investments, gross		$ 49,458
Interest rate		10.50%
Other investment note due 2020; interest at 10.00%
Schedule of Investments [Line Items]
Other investments, gross		$ 23,000	$ 23,000
Interest rate		10.00%	10.00%
Other investment note due 2020; interest at 14.00%
Schedule of Investments [Line Items]
Other investments, gross		$ 47,913
Interest rate		14.00%
Other investment note due 2022, interest at 9.00%
Schedule of Investments [Line Items]
Other investments, gross		$ 31,987
Interest rate		9.00%
Other investment note due 2030; interest at 6.66%
Schedule of Investments [Line Items]
Other investments, gross		$ 44,595	$ 26,966
Interest rate		6.66%	6.66%
Other investment notes outstanding
Schedule of Investments [Line Items]
Other investments, gross	[1]	$ 64,691	$ 42,293
[1]	Other investment notes have maturity dates through 2028 and interest rates ranging from 6.50% to 13.0% per annum.

OTHER INVESTMENTS (Parenthetica

OTHER INVESTMENTS (Parentheticals) (Detail) - Other investment note through 2028	12 Months Ended
	Dec. 31, 2016
Minimum
Schedule Of Investments [Line Items]
Interest rate	6.50%
Maturity year	2,016
Maximum
Schedule Of Investments [Line Items]
Interest rate	13.00%
Maturity year	2,028

OTHER INVESTMENTS (Narrative) (

OTHER INVESTMENTS (Narrative) (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Sep. 30, 2016USD ($)	Jul. 29, 2016USD ($)	Apr. 29, 2016USD ($)Note	Mar. 01, 2016USD ($)	Feb. 26, 2016USD ($)	Jun. 30, 2015USD ($)
Schedule Of Investments [Line Items]
Other investments, gross	$ 261,644	$ 92,259
Other investment note due 2022
Schedule Of Investments [Line Items]
Other investments, gross	$ 37,000
Fair value of term loan			$ 37,000
Other Investment Notes Due 2023 Payoff
Schedule Of Investments [Line Items]
Other investments, gross					$ 7,600
Number of working capital notes | Note					10
Other investment note due 2019; interest at 10.50%
Schedule Of Investments [Line Items]
Other Investment notes							$ 50,000
Interest rate	10.50%
Other investments, gross	$ 49,458
Discount on notes receivable							$ 750
Other investment note due 2020; interest at 10.00%
Schedule Of Investments [Line Items]
Interest rate	10.00%	10.00%
Other investments, gross	$ 23,000	$ 23,000
Maximum drawing capacity of loan		28,000
Amount of additional loan drawn		6,000
Amount of additional funding		$ 6,000
Remaining outstanding amount of loan	$ 23,000
Line of credit term		5 years
Other Investment Note Due 2020 Interest at 14.00%
Schedule Of Investments [Line Items]
Other Investment notes				$ 48,000
Interest rate	14.00%
Other investments, gross	$ 47,913
Description of variable rate basis	LIBOR
LIBOR with floor rate	1.00%
LIBOR plus an applicable percentage	13.00%
Other Investment Note Due 2020 Interest at 14.00% | Through July 2019
Schedule Of Investments [Line Items]
Monthly principal payments	$ 250
Frequency of periodic payment	monthly
Other Investment Note Due 2020 Interest at 14.00% | August 2019 through maturity
Schedule Of Investments [Line Items]
Monthly principal payments	$ 5,000
Frequency of periodic payment	monthly
Other investment note due 2019, interest at 13.00%, Tranche one
Schedule Of Investments [Line Items]
Interest rate	13.00%
Other investments, gross	$ 5,000
Other Investment Note Due 2022 Interest at 9.00%, Tranche two
Schedule Of Investments [Line Items]
Interest rate	9.00%
Other investments, gross	$ 31,987
Other Investment Note Due 2030 Interest At 6.6 Percent
Schedule Of Investments [Line Items]
Interest rate	6.66%	6.66%
Other investments, gross	$ 44,595	$ 26,966
Remaining outstanding amount of loan	$ 44,595
Other Investment Note Due 2030 Interest At 6.6 Percent | Revolving Credit Facility
Schedule Of Investments [Line Items]
Fair value of term loan								$ 50,000
Other Investment Note Due 2017 Interest At 8.5% payoff
Schedule Of Investments [Line Items]
Other Investment notes						$ 15,000
Interest rate	8.50%
Other Investment Note Due 2028 Interest At 8.5% payoff
Schedule Of Investments [Line Items]
Other Investment notes						$ 20,000
Interest rate	8.50%
Interest rate annual increase percentage						2.50%

INVESTMENT IN UNCONSOLIDATED 75

INVESTMENT IN UNCONSOLIDATED JOINT VENTURE (Narrative) (Detail) $ in Thousands	1 Months Ended	12 Months Ended
	Nov. 01, 2016USD ($)Facility	Dec. 31, 2016USD ($)
Schedule of Equity Method Investments [Line Items]
Investment in unconsolidated joint venture		$ 48,776
Second Spring Healthcare Investments
Schedule of Equity Method Investments [Line Items]
Investment in unconsolidated joint venture	$ 50,000
Percentage of ownership interest	15.00%
Assets management fees recognized		$ 300
Second Spring Healthcare Investments | Affiliates of Lindsey Goldberg LLC
Schedule of Equity Method Investments [Line Items]
Percentage of ownership interest	85.00%
Second Spring Healthcare Investments | Welltower Inc | SNF's
Schedule of Equity Method Investments [Line Items]
Number of properties acquired | Facility	64
Payments to acquire facilities	$ 1,100,000

ASSETS HELD FOR SALE (Detail)

ASSETS HELD FOR SALE (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2016USD ($)Property		Dec. 31, 2015USD ($)Property
Number Of Properties
Beginning Balance | Property	3		4
Properties sold/other | Property	(24)	[1]	(5)	[2]
Properties added | Property	41	[3]	4	[4]
Ending balance | Property	20		3
Net Book Value
Beginning Balance | $	$ 6,599		$ 12,792
Properties sold/other | $	(75,948)	[1]	(16,877)	[2]
Properties added | $	122,217	[3]	10,684	[4]
Ending Balance | $	$ 52,868		$ 6,599
[1]	In 2016, we sold 21SNFs for approximately $86.7 million in net proceeds recognizing gains on sales of approximately $16.5 million. We also recorded approximately $4.9 million of impairments on 16 facilities to reduce their net book values to their estimated fair value less costs to sell. Two SNFs and one ALF classified as assets held for sale in the second quarter were no longer considered held for sale and were reclassified in the third quarter back to leased properties at their fair values (approximately $7.0 million).
[2]	In 2015, a parcel of land was reclassified to closed facilities. In addition, we sold four facilities for approximately $25.5 million in net proceeds recognizing gains on sales of approximately $8.8 million.
[3]	In 2016, we reclassified ten ALFs and 31 SNFs to assets held for sale (including the two SNFs and one ALF mentioned above that were reclassified back to leased properties in the third quarter). We recorded approximately $49.4 million of impairment charges on 20 of these facilities to reduce their net book values to their estimated fair value less costs to sell.
[4]	In 2015, we recorded a $3.0 million impairment charge on a SNF in New Mexico to reduce its net book value to its estimated fair value less costs to sell.

ASSETS HELD FOR SALE (Parenthet

ASSETS HELD FOR SALE (Parentheticals) (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2016USD ($)FacilityProperty	Dec. 31, 2015USD ($)	Sep. 30, 2016USD ($)Lease
Real Estate Properties [Line Items]
Impairment charge	$ 49.4	$ 3
Number of property reclassified | Facility	20
SNF's
Real Estate Properties [Line Items]
Fair value of leased properties			$ 7
Number of facilities added to held for sale | Property	31
Number of facilities classified as held for sale sold | Property	21
Net proceeds from sale of facilities held for sale	$ 86.7	25.5
Gain from sale of facilities	16.5	$ 8.8
Impairment charge	$ 4.9
Number of property reclassified | Facility	16
Number of leased real estate properties | Lease			2
ALFs
Real Estate Properties [Line Items]
Number of facilities added to held for sale | Property	10
Number of leased real estate properties | Lease			1

INTANGIBLES - Summary of our in

INTANGIBLES - Summary of our intangibles (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Assets:
Goodwill	$ 643,474	$ 645,683
Accumulated amortization	(15,864)	(14,162)
Net intangible assets	6,779	8,125
Liabilities:
Below market lease	165,028	165,331
Accumulated amortization	(70,738)	(55,131)
Net intangible liabilities	94,290	110,200
Above market lease
Assets:
Gross intangible assets	22,476	21,901
In-place lease
Assets:
Gross intangible assets	$ 167	$ 386

INTANGIBLES - Reconciliation of

INTANGIBLES - Reconciliation of goodwill (Detail 1) $ in Thousands	12 Months Ended
	Dec. 31, 2016USD ($)
Goodwill [Roll Forward]
Balance as of December 31, 2015	$ 645,683
Add: additional valuation adjustments related to preliminary valuations	275
Less: foreign currency translation	(2,484)
Balance as of December 31, 2016	$ 643,474

INTANGIBLES (Narrative) (Detail

INTANGIBLES (Narrative) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Amortization of intangible assets	$ 13.9	$ 13.9	$ 5
2,017	12
2,018	10.6
2,019	9.5
2,020	9.3
2,021	8.7
Thereafter	$ 37.3
Above market lease assets
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period	8 years 1 month 6 days
Below market lease liabilities
Finite-Lived Intangible Assets [Line Items]
Weighted average remaining amortization period	9 years 6 months

CONCENTRATION OF RISK (Narrativ

CONCENTRATION OF RISK (Narrative) (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2016USD ($)FacilityStateOperatorHealthcare_facility	Dec. 31, 2015USD ($)
Concentration Risk [Line Items]
Number of facilities owned | Healthcare_facility	996
Number of states | State	42
Number of operators | Operator	79
Gross investment in facilities, net of impairments and before reserve for uncollectible loans | $	$ 8,900,000
Percentage share of real estate investments related to long-term care facilities	99.00%
Number of facilities held-for-sale/closed	23
Miscellaneous investments, net | $	$ 256,846	$ 89,299
Concentration risk, benchmark description	No single operator or manager generated more than 10% of our total revenues for the year ended December 31, 2016.
Florida
Concentration Risk [Line Items]
Concentration percent by state	9.00%
Ohio
Concentration Risk [Line Items]
Concentration percent by state	10.00%
Texas
Concentration Risk [Line Items]
Concentration percent by state	9.00%
SNF's
Concentration Risk [Line Items]
Number of facilities owned	809
Number of facilities under fixed rate mortgage loan	44
ALFs
Concentration Risk [Line Items]
Number of facilities owned	101
Number of facilities under fixed rate mortgage loan	2
Specialty facilities
Concentration Risk [Line Items]
Number of facilities owned	16
Medical office building
Concentration Risk [Line Items]
Number of facilities owned	1

LEASE AND MORTGAGE DEPOSITS (Na

LEASE AND MORTGAGE DEPOSITS (Narrative) (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2016USD ($)
Security Deposits And Letters Of Credit [Line Items]
Liquidity deposits	$ 5.7
Security Deposit	49.8
Letters of credit outstanding	$ 66.8
Minimum
Security Deposits And Letters Of Credit [Line Items]
Period specified for rental and mortgage interest	3 months
Maximum
Security Deposits And Letters Of Credit [Line Items]
Period specified for rental and mortgage interest	6 months

BORROWING ARRANGEMENTS - Long-t

BORROWING ARRANGEMENTS - Long-term borrowings (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Jul. 12, 2016	Dec. 31, 2015	Dec. 16, 2015	Sep. 23, 2015	Mar. 18, 2015	Sep. 11, 2014	Mar. 11, 2014	Mar. 19, 2012
Secured borrowings:
Secured borrowings - net		$ 54,365		$ 235,593
Unsecured borrowings:
Revolving line of credit		190,000		230,000
Term loans - net		1,094,343		745,693
Other		256,846		89,299
Secured borrowings
Secured borrowings:
Secured borrowings - net		54,365		235,593
Secured borrowings | Mortgage term loan
Secured borrowings:
Mortgage term loan				180,000
Secured borrowings | HUD mortgages assumed December 2011
Debt Instrument [Line Items]
Maturity	[1]	2,044
Rate	[1]	3.06%
Secured borrowings:
Secured borrowings - net	[1]	$ 54,954		56,204
Secured borrowings | Deferred financing costs - net
Secured borrowings:
Deferred financing costs - net		(589)		(611)
Unsecured borrowings
Unsecured borrowings:
Term loans - net		1,094,343		745,693
Discount - net		(17,151)		(17,118)
Total unsecured borrowings		3,028,146		2,328,727
Total secured and unsecured borrowings - net		4,366,854		3,540,013
Unsecured borrowings | Deferred financing costs - net
Unsecured borrowings:
Deferred financing costs - net		(5,657)		(4,307)
Deferred financing costs - net		$ (27,703)		(24,155)
Unsecured borrowings | Revolving line of credit
Debt Instrument [Line Items]
Maturity		2,018
Rate		2.06%
Unsecured borrowings:
Revolving line of credit		$ 190,000		230,000
Unsecured borrowings | Tranche A-1 term loan
Debt Instrument [Line Items]
Maturity		2,019
Rate		2.27%
Unsecured borrowings:
Term loans - net		$ 200,000		200,000
Unsecured borrowings | Tranche A-2 term loan
Debt Instrument [Line Items]
Maturity		2,017
Rate		2.19%
Unsecured borrowings:
Term loans - net		$ 200,000		200,000
Unsecured borrowings | Tranche A-3 term loan
Debt Instrument [Line Items]
Maturity		2,021
Rate		2.27%
Unsecured borrowings:
Term loans - net		$ 350,000
Unsecured borrowings | Omega OP Term loan
Debt Instrument [Line Items]
Maturity		2,017
Rate		2.19%
Unsecured borrowings:
Term loans - net		$ 100,000		100,000
Unsecured borrowings | 2015 term loan
Debt Instrument [Line Items]
Maturity		2,022
Rate		3.80%
Unsecured borrowings:
Term loans - net		$ 250,000		250,000	$ 250,000
Unsecured borrowings | 2023 notes
Debt Instrument [Line Items]
Maturity		2,023
Rate		4.375%	99.739%
Unsecured borrowings:
Senior notes outstanding		$ 700,000	$ 700,000
Unsecured borrowings | 2024 notes
Debt Instrument [Line Items]
Maturity		2,024
Rate		5.875%							4.95%
Unsecured borrowings:
Senior notes outstanding		$ 400,000		400,000					$ 400,000
Unsecured borrowings | 2024 Notes
Debt Instrument [Line Items]
Maturity		2,024
Rate		4.95%								5.875%
Unsecured borrowings:
Senior notes outstanding		$ 400,000		400,000						$ 400,000
Unsecured borrowings | 2025 notes
Debt Instrument [Line Items]
Maturity		2,025
Rate		4.50%						4.50%
Unsecured borrowings:
Senior notes outstanding		$ 250,000		250,000				$ 250,000
Unsecured borrowings | 2026 Notes
Debt Instrument [Line Items]
Maturity		2,026
Rate		5.25%				5.25%
Unsecured borrowings:
Senior notes outstanding		$ 600,000		600,000		$ 600,000
Unsecured borrowings | 2027 Notes
Debt Instrument [Line Items]
Maturity		2,027
Rate		4.50%					4.50%
Unsecured borrowings:
Senior notes outstanding		$ 700,000		700,000			$ 700,000
Unsecured borrowings | Other
Debt Instrument [Line Items]
Maturity		2,018
Unsecured borrowings:
Other		$ 3,000
Unsecured borrowings | Subordinated debt
Debt Instrument [Line Items]
Maturity		2,021
Rate		9.00%
Unsecured borrowings:
Subordinated debt - net		$ 20,000		$ 20,000
[1]	Reflects the weighted average annual contractual interest rate on the mortgages at December 31, 2016 excluding a third-party administration fee of approximately 0.5%. Secured by real estate assets with a net carrying value of $65.7 million as of December 31, 2016.

BORROWING ARRANGEMENTS - Long84

BORROWING ARRANGEMENTS - Long-term borrowings (Parentheticals) (Detail) - Secured Borrowings - HUD mortgages assumed December 2011 $ in Millions	Dec. 31, 2016USD ($)
Debt Instrument [Line Items]
Percentage of third-party administration fee	0.50%
Real estate assets with a net carrying value	$ 65.7

BORROWING ARRANGEMENTS - Princi

BORROWING ARRANGEMENTS - Principal payments (Detail 1) - Senior notes $ in Thousands	Dec. 31, 2016USD ($)
Borrowing Arrangements [Line Items]
2,017	$ 302,788
2,018	192,828
2,019	201,369
2,020	1,412
2,021	371,456
Thereafter	3,348,101
Totals	$ 4,417,954

BORROWING ARRANGEMENTS - Refina

BORROWING ARRANGEMENTS - Refinancing related costs (Detail 2) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Debt Disclosure [Abstract]
Write off of deferred financing cost and unamortized premiums due to refinancing	[1],[2],[3]	$ 301	$ (7,134)	$ 1,180
Prepayment and other costs associated with refinancing	[4]	1,812	35,971	1,861
Total debt extinguishment costs		$ 2,113	$ 28,837	$ 3,041
[1]	In 2014, we recorded: (a) $2.6 million write-off of deferred financing costs associated with the termination of the $700 million 2012 credit facilities, (b) $2.0 million write-off of deferred financing costs associated with the termination of our $200 million 2013 term loan facility offset by (c) $3.5 million gain related to the early extinguishment of debt from the write off of unamortized premium on the HUD debt paid off in September and December 2014.
[2]	In 2015, we recorded: (a) $4.2 million of write-offs of unamortized deferred financing costs and discount associated with the early redemption of our 2020 Notes, (b) $1.9 million in net write-offs associated with unamortized deferred financing costs and original issuance premiums/discounts associated with the early redemption of our 2022 Notes, offset by (c) $13.2 million gain related to the early extinguishment of debt from the write off of unamortized premium on the HUD debt paid off in March, April and December 2015.
[3]	In 2016, we recorded $0.3 million of write-offs of unamortized deferred financing costs associated with three facilities that were acquired via a deed-in-lieu foreclosure.
[4]	In 2016, we purchased a $180 million mortgage term loan and paid a 1% premium of approximately $1.8 million to purchase the debt. In 2015, we made: (a) $7.5 million of prepayment penalties associated with the early redemption of our 2020 Notes, (b) $19.4 million of prepayment penalties associated with the early redemption of our 2022 Notes and (c) $9.1 million of prepayment penalties associated with 24 HUD mortgage loans that we paid off in March, April and December 2015. In 2014, we made prepayment penalties of $1.9 million associated with five HUD mortgage loans that we paid off in September and October 2014.

BORROWING ARRANGEMENTS - Refi87

BORROWING ARRANGEMENTS - Refinancing related costs (Parentheticals) (Detail 2) $ in Thousands		1 Months Ended		12 Months Ended
		Apr. 30, 2015USD ($)	Mar. 31, 2015USD ($)	Dec. 31, 2016USD ($)Facility	Dec. 31, 2015USD ($)HUD	Dec. 31, 2014USD ($)HUD
Financing Activities and Borrowing Arrangements [Line Items]
Write off of deferred financing cost and unamortized premiums due to refinancing	[1],[2],[3]			$ 301	$ (7,134)	$ 1,180
Prepayment and other costs associated with refinancing	[4]			$ 1,812	35,971	1,861
Number of facilities acquired via a deed-in-lieu foreclosure | Facility				3
2020 Notes
Financing Activities and Borrowing Arrangements [Line Items]
Write off of deferred financing cost and unamortized premiums due to refinancing					4,200
Prepayment and other costs associated with refinancing					7,500
2022 Notes
Financing Activities and Borrowing Arrangements [Line Items]
Write off of deferred financing cost and unamortized premiums due to refinancing					1,900
Prepayment and other costs associated with refinancing					19,400
HUD Mortgage
Financing Activities and Borrowing Arrangements [Line Items]
Write off of deferred financing cost and unamortized premiums due to refinancing		$ 1,500	$ 9,700		2,100
Prepayment and other costs associated with refinancing					9,100	1,900
Gain from write-off of unamortized premium on the HUD loans					$ 13,200	$ 3,500
Number of HUD loans paid off | HUD					24	5
2012 Credit Facility
Financing Activities and Borrowing Arrangements [Line Items]
Write off of deferred financing cost and unamortized premiums due to refinancing						$ 2,600
Termination of 2012 Credit Facility and 2013 Term Loan Facility						700,000
Term Loan Facility 2013
Financing Activities and Borrowing Arrangements [Line Items]
Write off of deferred financing cost and unamortized premiums due to refinancing						2,000
Termination of 2012 Credit Facility and 2013 Term Loan Facility						$ 200,000
Mortgage term loan
Financing Activities and Borrowing Arrangements [Line Items]
Prepayment and other costs associated with refinancing				$ 1,800
Purchased of loan				$ 180,000
Percentage of premium paid to purchase debt				1.00%
[1]	In 2014, we recorded: (a) $2.6 million write-off of deferred financing costs associated with the termination of the $700 million 2012 credit facilities, (b) $2.0 million write-off of deferred financing costs associated with the termination of our $200 million 2013 term loan facility offset by (c) $3.5 million gain related to the early extinguishment of debt from the write off of unamortized premium on the HUD debt paid off in September and December 2014.
[2]	In 2015, we recorded: (a) $4.2 million of write-offs of unamortized deferred financing costs and discount associated with the early redemption of our 2020 Notes, (b) $1.9 million in net write-offs associated with unamortized deferred financing costs and original issuance premiums/discounts associated with the early redemption of our 2022 Notes, offset by (c) $13.2 million gain related to the early extinguishment of debt from the write off of unamortized premium on the HUD debt paid off in March, April and December 2015.
[3]	In 2016, we recorded $0.3 million of write-offs of unamortized deferred financing costs associated with three facilities that were acquired via a deed-in-lieu foreclosure.
[4]	In 2016, we purchased a $180 million mortgage term loan and paid a 1% premium of approximately $1.8 million to purchase the debt. In 2015, we made: (a) $7.5 million of prepayment penalties associated with the early redemption of our 2020 Notes, (b) $19.4 million of prepayment penalties associated with the early redemption of our 2022 Notes and (c) $9.1 million of prepayment penalties associated with 24 HUD mortgage loans that we paid off in March, April and December 2015. In 2014, we made prepayment penalties of $1.9 million associated with five HUD mortgage loans that we paid off in September and October 2014.

BORROWING ARRANGEMENTS (Narrati

BORROWING ARRANGEMENTS (Narrative) (Detail) $ in Millions	1 Months Ended	12 Months Ended
	Jun. 30, 2016USD ($)	Dec. 31, 2016USD ($)SubsidiaryHealthcare_facility	Jul. 25, 2016USD ($)
Mortgage term loan
Debt Instrument [Line Items]
Purchased of loan		$ 180
Debt Instrument Purchase Premium Percentage		1.00%
Secured Borrowings | Aviv
Debt Instrument [Line Items]
Number of subsidiary | Subsidiary		2
Number of facilities owned | Healthcare_facility		28
Secured Borrowings | Mortgage term loan
Debt Instrument [Line Items]
Purchased of loan		$ 180	$ 180
Net carrying value	$ 290.5
Description of variable rate basis	LIBOR
LIBOR plus an applicable percentage	0.50%
Basis spread percentage of floor rate plus margin	3.50%
Interest rate	4.13%
Debt Instrument Purchase Premium Percentage		1.00%

BORROWING ARRANGEMENTS (Narra89

BORROWING ARRANGEMENTS (Narrative) (Detail 1) $ in Thousands		1 Months Ended		12 Months Ended
		Apr. 30, 2015USD ($)Mortgage	Mar. 31, 2015USD ($)Mortgage	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)Mortgage	Dec. 31, 2014USD ($)
Debt Instrument [Line Items]
Write off of deferred financing cost and unamortized premiums due to refinancing	[1],[2],[3]			$ 301	$ (7,134)	$ 1,180
HUD Mortgage
Debt Instrument [Line Items]
Payment to retire HUD mortgages		$ 9,100	$ 154,300		$ 25,100
Number of HUD mortgages | Mortgage		1	21		2
Total HUD mortgage loans principal payoff			$ 146,900
Notes issued, interest rate					5.50%
Lease expiration period					March 1 and April 1, 2036
Gain on extinguishment of the debt		$ 1,000	2,300		$ 900
Write off of deferred financing cost and unamortized premiums due to refinancing		1,500	9,700		2,100
Prepayment fees		$ 500	$ 7,400		$ 1,200
HUD Mortgage | Hud interest rate 5.35%
Debt Instrument [Line Items]
Number of mortgage loans | Mortgage			18
Notes issued, interest rate			5.35%
Lease expiration period			January 2040 and January 2045
HUD Mortgage | Hud interest rate 5.23%
Debt Instrument [Line Items]
Number of mortgage loans | Mortgage			3
Notes issued, interest rate			5.23%
Lease expiration period			February 2040 and February 2045
HUD Mortgage | Hud interest rate 4.35%
Debt Instrument [Line Items]
Notes issued, interest rate		4.35%
Lease expiration period		March 1, 2041
[1]	In 2014, we recorded: (a) $2.6 million write-off of deferred financing costs associated with the termination of the $700 million 2012 credit facilities, (b) $2.0 million write-off of deferred financing costs associated with the termination of our $200 million 2013 term loan facility offset by (c) $3.5 million gain related to the early extinguishment of debt from the write off of unamortized premium on the HUD debt paid off in September and December 2014.
[2]	In 2015, we recorded: (a) $4.2 million of write-offs of unamortized deferred financing costs and discount associated with the early redemption of our 2020 Notes, (b) $1.9 million in net write-offs associated with unamortized deferred financing costs and original issuance premiums/discounts associated with the early redemption of our 2022 Notes, offset by (c) $13.2 million gain related to the early extinguishment of debt from the write off of unamortized premium on the HUD debt paid off in March, April and December 2015.
[3]	In 2016, we recorded $0.3 million of write-offs of unamortized deferred financing costs associated with three facilities that were acquired via a deed-in-lieu foreclosure.

BORROWING ARRANGEMENTS (Narra90

BORROWING ARRANGEMENTS (Narrative) (Detail 2) - USD ($) $ in Thousands

Jul. 12, 2016

Apr. 01, 2015

Sep. 11, 2014

Mar. 11, 2014

Dec. 16, 2015

Sep. 23, 2015

Mar. 18, 2015

Mar. 19, 2012

Dec. 31, 2016

Jan. 29, 2016

Dec. 31, 2015

Oct. 26, 2015

Borrowing Arrangements [Line Items]

Term loan

$ 1,094,343

$ 745,693

Long-term Line of Credit

190,000

230,000

Omega OP Term Loan Facility

Borrowing Arrangements [Line Items]

Term loan

$ 100,000

Pricing of credit facility at LIBOR plus an applicable percentage

1.50%

Credit facility, description of variable rate basis

LIBOR plus an applicable percentage (beginning at 150 basis points, with a range of 100 to 195 basis points)

Debt maturity date

Jun. 27, 2017

Minimum | Omega OP Term Loan Facility

Borrowing Arrangements [Line Items]

Pricing of credit facility at LIBOR plus an applicable percentage

1.00%

Maximum | Omega OP Term Loan Facility

Borrowing Arrangements [Line Items]

Pricing of credit facility at LIBOR plus an applicable percentage

1.95%

Mortgage term loan

Borrowing Arrangements [Line Items]

Purchased of loan

$ 180,000

Senior unsecured revolving credit facility | Tranche A-3 Term Loan Facility

Borrowing Arrangements [Line Items]

Term loan, borrowing capacity

$ 350,000

Senior unsecured revolving credit facility | Omega Credit Agreement

Borrowing Arrangements [Line Items]

Credit facility, borrowing capacity

1,250,000

Senior unsecured revolving credit facility | First Amendment to Omega Credit Agreement | Tranche A-2 Term Loan Facility

Borrowing Arrangements [Line Items]

Term loan, borrowing capacity

200,000

2023 notes

Borrowing Arrangements [Line Items]

Interest rate

4.375%

2026 Notes

Borrowing Arrangements [Line Items]

Interest rate

5.25%

2027 Notes

Borrowing Arrangements [Line Items]

Interest rate

4.50%

4.50% notes due 2025

Borrowing Arrangements [Line Items]

Interest rate

4.50%

5.875% Notes due 2024

Borrowing Arrangements [Line Items]

Interest rate

5.875%

Unsecured borrowings

Borrowing Arrangements [Line Items]

Term loan

$ 1,094,343

745,693

Unsecured borrowings | Tranche A-2 Term Loan Facility

Borrowing Arrangements [Line Items]

Pricing of credit facility at LIBOR plus an applicable percentage

1.50%

Credit facility, description of variable rate basis

LIBOR plus an applicable percentage (beginning at 150 basis points, with a range of 100 to 195 basis points)

Debt maturity date

Jun. 27, 2017

Unsecured borrowings | Tranche A-3 Term Loan Facility

Borrowing Arrangements [Line Items]

Pricing of credit facility at LIBOR plus an applicable percentage

1.50%

Credit facility, description of variable rate basis

LIBOR plus an applicable percentage (beginning at 150 basis points, with a range of 100 to 195 basis points)

Debt maturity date

Jan. 29, 2021

Unsecured borrowings | Minimum | Tranche A-2 Term Loan Facility

Borrowing Arrangements [Line Items]

Pricing of credit facility at LIBOR plus an applicable percentage

1.00%

Unsecured borrowings | Minimum | Tranche A-3 Term Loan Facility

Borrowing Arrangements [Line Items]

Pricing of credit facility at LIBOR plus an applicable percentage

1.00%

Unsecured borrowings | Maximum | Tranche A-2 Term Loan Facility

Borrowing Arrangements [Line Items]

Pricing of credit facility at LIBOR plus an applicable percentage

1.95%

Unsecured borrowings | Maximum | Tranche A-3 Term Loan Facility

Borrowing Arrangements [Line Items]

Pricing of credit facility at LIBOR plus an applicable percentage

1.95%

Unsecured borrowings | 2015 term loan

Borrowing Arrangements [Line Items]

Rate

3.80%

Term loan

$ 250,000

$ 250,000

250,000

Pricing of credit facility at LIBOR plus an applicable percentage

1.80%

Credit facility, description of variable rate basis

LIBOR plus an applicable percentage (beginning at 180 basis points, with a range of 140 to 235 basis points) based on our ratings from Standard & Poor's, Moody's and/or Fitch Ratings

Debt maturity date

Dec. 16, 2022

Term loan, borrowing capacity

$ 400,000

Unsecured borrowings | 2015 term loan | Interest rate swaps

Borrowing Arrangements [Line Items]

Rate

3.8005%

Credit facility, description of variable rate basis

One-month LIBOR

Debt maturity date

Dec. 15, 2022

Unsecured borrowings | 2015 term loan | Minimum

Borrowing Arrangements [Line Items]

Pricing of credit facility at LIBOR plus an applicable percentage

1.40%

Unsecured borrowings | 2015 term loan | Minimum | Interest rate swaps

Borrowing Arrangements [Line Items]

Pricing of credit facility at LIBOR plus an applicable percentage

0.40%

Unsecured borrowings | 2015 term loan | Maximum

Borrowing Arrangements [Line Items]

Pricing of credit facility at LIBOR plus an applicable percentage

2.35%

Unsecured borrowings | 2015 term loan | Maximum | Interest rate swaps

Borrowing Arrangements [Line Items]

Pricing of credit facility at LIBOR plus an applicable percentage

0.55%

Unsecured borrowings | Senior unsecured revolving credit facility

Borrowing Arrangements [Line Items]

Pricing of credit facility at LIBOR plus an applicable percentage

1.30%

Credit facility, description of variable rate basis

LIBOR plus an applicable percentage (beginning at 130 basis points, with a range of 92.5 to 170 basis points) based on our ratings from Standard & Poor's, Moody's and/or Fitch Ratings

Facility fee, basis spread on variable rate

0.25%

Facility fee, description of variable rate basis

Facility fee based on the same ratings (initially 25 basis points, with a range of 12.5 to 30 basis points)

Debt maturity date

Jun. 27, 2018

Unsecured borrowings | Senior unsecured revolving credit facility | Minimum

Borrowing Arrangements [Line Items]

Pricing of credit facility at LIBOR plus an applicable percentage

0.925%

Facility fee, basis spread on variable rate

0.125%

Unsecured borrowings | Senior unsecured revolving credit facility | Maximum

Borrowing Arrangements [Line Items]

Pricing of credit facility at LIBOR plus an applicable percentage

1.70%

Facility fee, basis spread on variable rate

0.30%

Unsecured borrowings | Tranche A-1

Borrowing Arrangements [Line Items]

Rate

2.27%

Term loan

$ 200,000

200,000

Pricing of credit facility at LIBOR plus an applicable percentage

1.50%

Credit facility, description of variable rate basis

LIBOR plus an applicable percentage (beginning at 150 basis points, with a range of 100 to 195 basis points)

Debt maturity date

Jun. 27, 2019

Term loan, borrowing capacity

$ 200,000

Unsecured borrowings | Tranche A-1 | Minimum

Borrowing Arrangements [Line Items]

Pricing of credit facility at LIBOR plus an applicable percentage

1.00%

Unsecured borrowings | Tranche A-1 | Maximum

Borrowing Arrangements [Line Items]

Pricing of credit facility at LIBOR plus an applicable percentage

1.95%

Unsecured borrowings | Initial 2022 Notes

Borrowing Arrangements [Line Items]

Rate

6.75%

6.75%

Senior notes outstanding

$ 575,000

Unsecured borrowings | 2023 notes

Borrowing Arrangements [Line Items]

Rate

99.739%

4.375%

Purchased of loan

$ 180,000

Interest rate

4.375%

4.375%

Senior notes outstanding

$ 700,000

$ 700,000

Gross proceeds from issuance of debt

$ 692,000

Unsecured borrowings | 2026 Notes

Borrowing Arrangements [Line Items]

Rate

5.25%

5.25%

Interest rate

5.25%

Senior notes outstanding

$ 600,000

$ 600,000

600,000

Debt maturity date

Jan. 15, 2026

Debt instrument, issuance price, percentage of principal amount issued

99.717%

Net proceeds from issuance of debt, after deducting initial purchasers' discounts

$ 594,400

Unsecured borrowings | 2027 Notes

Borrowing Arrangements [Line Items]

Rate

4.50%

4.50%

Interest rate

4.50%

Senior notes outstanding

$ 700,000

$ 700,000

700,000

Debt maturity date

Apr. 1, 2027

Debt instrument, issuance price, percentage of principal amount issued

98.546%

Net proceeds from issuance of debt, after deducting initial purchasers' discounts

$ 683,000

Unsecured borrowings | 4.50% notes due 2025

Borrowing Arrangements [Line Items]

Rate

4.50%

4.50%

Interest rate

4.50%

Senior notes outstanding

$ 250,000

$ 250,000

250,000

Debt maturity date

Jan. 15, 2025

Debt instrument, issuance price, percentage of principal amount issued

99.131%

Gross proceeds from issuance of debt

$ 247,800

Unsecured borrowings | 4.95% Notes due 2024

Borrowing Arrangements [Line Items]

Rate

4.95%

5.875%

Interest rate

4.95%

Senior notes outstanding

$ 400,000

$ 400,000

400,000

Debt maturity date

Apr. 1, 2024

Debt instrument, issuance price, percentage of principal amount issued

98.58%

Gross proceeds from issuance of debt

$ 394,300

Unsecured borrowings | 5.875% Notes due 2024

Borrowing Arrangements [Line Items]

Rate

5.875%

4.95%

Interest rate

5.875%

Senior notes outstanding

$ 400,000

$ 400,000

$ 400,000

Debt maturity date

Mar. 15, 2024

BORROWING ARRANGEMENTS (Narra91

BORROWING ARRANGEMENTS (Narrative) (Detail 3) - USD ($) shares in Thousands, $ in Thousands		Mar. 13, 2015	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Oct. 26, 2015	Sep. 23, 2015
Debt Instrument [Line Items]
Write off deferred financing and discount costs	[1],[2],[3]			$ 301	$ (7,134)	$ 1,180
Issuance of common stock (in shares)					10,925
7.50% Notes due 2020
Debt Instrument [Line Items]
Write off deferred financing and discount costs					$ 4,200
6.75% Notes due 2022
Debt Instrument [Line Items]
Write off deferred financing and discount costs					$ 1,900
Unsecured borrowings | 7.50% Notes due 2020
Debt Instrument [Line Items]
Rate		7.50%
Senior notes outstanding		$ 200,000
Redemption price, percentage		103.75%
Redemption price		$ 208,700
Redemption related costs and write-offs		11,700
Redemption prepayment fee		7,500
Write off deferred financing and discount costs		$ 4,200
Issuance of common stock (in shares)		10,925
Unsecured borrowings | 6.75% Notes due 2022
Debt Instrument [Line Items]
Rate							6.75%	6.75%
Senior notes outstanding								$ 575,000
Redemption related costs and write-offs			$ 21,300
Redemption prepayment fee			19,400
Write off deferred financing and discount costs			$ 1,900
[1]	In 2014, we recorded: (a) $2.6 million write-off of deferred financing costs associated with the termination of the $700 million 2012 credit facilities, (b) $2.0 million write-off of deferred financing costs associated with the termination of our $200 million 2013 term loan facility offset by (c) $3.5 million gain related to the early extinguishment of debt from the write off of unamortized premium on the HUD debt paid off in September and December 2014.
[2]	In 2015, we recorded: (a) $4.2 million of write-offs of unamortized deferred financing costs and discount associated with the early redemption of our 2020 Notes, (b) $1.9 million in net write-offs associated with unamortized deferred financing costs and original issuance premiums/discounts associated with the early redemption of our 2022 Notes, offset by (c) $13.2 million gain related to the early extinguishment of debt from the write off of unamortized premium on the HUD debt paid off in March, April and December 2015.
[3]	In 2016, we recorded $0.3 million of write-offs of unamortized deferred financing costs associated with three facilities that were acquired via a deed-in-lieu foreclosure.

BORROWING ARRANGEMENTS (Narra92

BORROWING ARRANGEMENTS (Narrative) (Detail 4) - USD ($) $ in Thousands	Apr. 01, 2015	Dec. 31, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Long-term Line of Credit		$ 190,000	$ 230,000
Aviv REIT, Inc | Note Payable
Debt Instrument [Line Items]
Loan amount	$ 650,000
Early repayment of debt	705,600
Aviv REIT, Inc | Revolving line of credit
Debt Instrument [Line Items]
Long-term Line of Credit	525,000
Early repayment of debt	$ 525,000

FINANCIAL INSTRUMENTS (Detail)

FINANCIAL INSTRUMENTS (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Assets:
Cash and cash equivalents	$ 93,687	$ 5,424	$ 4,489	$ 2,616
Restricted cash	13,589	14,607
Investments in direct financing leases - net	601,938	587,701
Mortgage notes receivable - net	639,343	679,795
Other investments - net	256,846	89,299
Liabilities:
Revolving line of credit	190,000	230,000
Term loans - net	1,094,343	745,693
HUD debt - net	54,365	235,593
Carrying Amount
Assets:
Cash and cash equivalents	93,687	5,424
Restricted cash	13,589	14,607
Investments in direct financing leases - net	601,938	587,701
Mortgage notes receivable - net	639,343	679,795
Other investments - net	256,846	89,299
Total	1,605,403	1,376,826
Liabilities:
Revolving line of credit	190,000	230,000
Tranche A-1 term loan	198,830	197,699
Tranche A-2 term loan	200,000	200,000
Tranche A-3 term loan	347,449
Omega OP term loan	100,000	100,000
Term loans - net	248,064	247,994
Mortgage term loan due 2019		180,000
HUD debt - net	54,365	55,593
Subordinated debt - net	20,490	20,613
Other	3,000
Totals	4,366,854	3,540,013
Carrying Amount | 4.375% notes due 2023
Liabilities:
Notes Payable	692,305
Carrying Amount | 5.875% notes due 2024 - net
Liabilities:
Notes Payable	395,065	394,382
Carrying Amount | 4.95% notes due 2024 - net
Liabilities:
Notes Payable	392,669	391,658
Carrying Amount | 4.50% notes due 2025 - net
Liabilities:
Notes Payable	245,949	245,446
Carrying Amount | 5.25% notes due 2026 - net
Liabilities:
Notes Payable	593,616	593,032
Carrying Amount | 4.50% notes due 2027 - net
Liabilities:
Notes Payable	685,052	683,596
Fair Value
Assets:
Cash and cash equivalents	93,687	5,424
Restricted cash	13,589	14,607
Investments in direct financing leases - net	598,665	584,358
Mortgage notes receivable - net	644,961	687,130
Other investments - net	253,385	90,745
Total	1,604,287	1,382,264
Liabilities:
Revolving line of credit	190,000	230,000
Tranche A-1 term loan	200,000	200,000
Tranche A-2 term loan	200,000	200,000
Tranche A-3 term loan	350,000
Omega OP term loan	100,000	100,000
2015 term loan	250,000	250,000
Mortgage term loan due 2019		180,000
HUD debt - net	52,510	52,678
Subordinated debt - net	23,944	24,366
Other	3,000
Totals	4,444,772	3,593,007
Fair Value | 4.375% notes due 2023
Liabilities:
Notes Payable	693,505
Fair Value | 5.875% notes due 2024 - net
Liabilities:
Notes Payable	432,938	429,956
Fair Value | 4.95% notes due 2024 - net
Liabilities:
Notes Payable	406,361	403,064
Fair Value | 4.50% notes due 2025 - net
Liabilities:
Notes Payable	249,075	242,532
Fair Value | 5.25% notes due 2026 - net
Liabilities:
Notes Payable	611,461	612,760
Fair Value | 4.50% notes due 2027 - net
Liabilities:
Notes Payable	$ 681,978	$ 667,651

FINANCIAL INSTRUMENTS (Parenthe

FINANCIAL INSTRUMENTS (Parentheticals) (Detail)	Dec. 31, 2016
4.375% notes due 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate	4.375%
5.875% Notes due 2024
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate	5.875%
4.95% notes due 2024
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate	4.95%
4.50% notes due 2025
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate	4.50%
5.25% notes due 2026 - net
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate	5.25%
4.50% notes due 2027 - net
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest rate	4.50%

TAXES (Narrative) (Detail)

TAXES (Narrative) (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2016USD ($)FacilityEntityShareholderSubsidiary
Income Tax Disclosure [Abstract]
Required dividend distribution as a percent of REIT taxable income	90.00%
Required dividend distribution by a REIT as a percent of net income from foreclosure property	90.00%
Required 75% of gross income test from qualifying sources	75.00%
Required 95% of gross income test from qualifying sources	95.00%
Required percentage of REIT qualifying assets	75.00%
Maximum ownership percentage of voting or value of any one security by REIT	10.00%
Maximum ownership percentage by REIT of either debt or equity securities of another company	5.00%
Maximum percentage of assets invested in one or more taxable REIT subsidiaries	25.00%
Maximum percentage of assets invested in one or more taxable REIT subsidiaries after December 31, 2017	20.00%
Minimum number of stockholders who own shares or interest in the REIT | Shareholder	100
Maximum percentage of interest in REIT that five or fewer individuals own directly or indirectly	50.00%
Minimum number of subsequent years the company may not be able to qualify as a REIT	4 years
Percentage of income subject to federal taxation	100.00%
Permitted ownership of a taxable REIT subsidiary ("TRS"), maximum percentage	100.00%
Number of subsidiary created REITs as per qualification rules | Subsidiary	5
Number of taxable REIT subsidiaries | Subsidiary	1
Number of subsidiary elected for treated as TRSs | Subsidiary	2
Net operating loss carry-forward	$ 0.8
Number of legal entities | Entity	10
Number of facilities | Facility	23
Tax basis in legal entities acquired for United Kingdom taxes	$ 82
Deferred tax liability	15
State and local income tax provision	3.3
Provision (benefit) for foreign income taxes	$ (1.9)

RETIREMENT ARRANGEMENTS (Narrat

RETIREMENT ARRANGEMENTS (Narrative) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Compensation Related Costs [Abstract]
Amounts charged to operations with respect to retirement arrangements	$ 0.5	$ 0.4	$ 0.3
Deferred stock units outstanding	384,107	400,814

STOCKHOLDERS' EQUITY (Detail)

STOCKHOLDERS' EQUITY (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Stockholders' Equity Note [Abstract]
Foreign currency translation adjustments	$ (52,495)	$ (8,027)
Cash flow hedge adjustments	(1,332)	(685)
Total accumulated other comprehensive loss	$ (53,827)	$ (8,712)

STOCKHOLDERS' EQUITY (Narrative

STOCKHOLDERS' EQUITY (Narrative) (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	Sep. 03, 2015	Feb. 09, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Jun. 30, 2015	Mar. 27, 2015	Mar. 26, 2015
Stockholders Equity Note [Line Items]
Issuance of common stock (in shares)				10,925
Stock issued			656		1,848
Aggregate gross sales price of common stock sold			$ 19,651		$ 61,981
Gross proceeds from issuance of common stock			$ 19,651	$ 439,322	$ 61,981
Dividend reinvestment plan (in shares)			7,215	4,184	2,084
Capital stock, shares authorized							370,000	220,000
Common stock, shares authorized			350,000	350,000			350,000	200,000
500 Million Equity Shelf Program
Stockholders Equity Note [Line Items]
Stock issued			700
Issuance of common stock, average price per share			$ 29.97
Gross proceeds from issuance of common stock			$ 20,400
Sales price, equity distribution agreement	$ 500,000
Compensation percentage for sale of shares	2.00%
Commissions on sale of common stock			700
250 Million Equity Shelf Program
Stockholders Equity Note [Line Items]
Stock issued	7,400				1,800
Issuance of common stock, average price per share					$ 34.33
Gross proceeds from issuance of common stock	$ 233,800				$ 63,500
Sales price, equity distribution agreement	250,000					$ 250,000
Commissions on sale of common stock	$ 4,700				1,500
Dividend Reinvestment and Common Stock Purchase Plan
Stockholders Equity Note [Line Items]
Gross proceeds from issuance of common stock			$ 240,000	$ 150,800	$ 71,500
Dividend reinvestment plan (in shares)			7,200	4,200	2,100
10.925 Million Common Stock Offering
Stockholders Equity Note [Line Items]
Stock issued		10,925
Issuance of common stock, average price per share		$ 42
Aggregate gross sales price of common stock sold		$ 440,000

STOCK-BASED COMPENSATION (Detai

STOCK-BASED COMPENSATION (Detail) - USD ($) $ / shares in Units, $ in Millions		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Number of Shares/Units
Non-vested		1,622,871
Weighted - Average Grant-Date Fair Value per Share
Non-vested		$ 19.20
Compensation Cost	[1]	$ 31.2
Restricted stock and RSUs
Number of Shares/Units
Non-vested		413,628	309,934	257,198
Granted		158,506	233,483	143,637
Assumed in Aviv Merger	[2]		38,268
Cancelled		(905)	(61,911)
Vested		(235,176)	(106,146)	(90,901)
Non-vested		336,053	413,628	309,934
Weighted - Average Grant-Date Fair Value per Share
Non-vested		$ 34.45	$ 30.08	$ 29.32
Granted		34.49	39.25	30.70
Assumed in Aviv Merger	[2]		23.50
Cancelled		24.92	33.77
Vested		30.41	28.72	28.87
Non-vested		$ 37.32	$ 34.45	$ 30.08
Compensation Cost	[3]	$ 5.5	$ 9.2	$ 4.4
Compensation Cost - Assumed in Aviv Merger	[3]		$ 0.9
[1]	Total compensation costs are net of shares cancelled.
[2]	Omega stock price on April 1, 2015 was $40.74. The weighted average stock price indicated in the table above represents the expense per unit that we will record related to the assumed Aviv RSUs.
[3]	Total compensation cost to be recognized on the awards based on grant date fair value, which is based on the market price of the Company's common stock on the date of grant.

STOCK-BASED COMPENSATION (Paren

STOCK-BASED COMPENSATION (Parentheticals) (Detail)	Dec. 31, 2016$ / shares
Restricted stock and RSUs | Award granted in April 1, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Closing stock price	$ 40.74

STOCK-BASED COMPENSATION (De101

STOCK-BASED COMPENSATION (Detail 1) - PRSUs and LTIP Units	12 Months Ended
	Dec. 31, 2016$ / shares
Award granted in January 1, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Closing price on date of grant	$ 23.85
Dividend yield	4.24%
Risk free interest rate at time of grant, minimum	0.05%
Risk free interest rate at time of grant, maximum	0.43%
Expected volatility, minimum	15.56%
Expected volatility, maximum	23.83%
Awards granted in December 31, 2013 and January 1, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Closing price on date of grant	$ 29.80
Dividend yield	6.44%
Risk free interest rate at time of grant, minimum	0.04%
Risk free interest rate at time of grant, maximum	0.86%
Expected volatility, minimum	24.16%
Expected volatility, maximum	25.86%
Award granted in March 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Closing price on date of grant	$ 40.57
Dividend yield	5.23%
Risk free interest rate at time of grant, minimum	0.10%
Risk free interest rate at time of grant, maximum	0.94%
Expected volatility, minimum	20.06%
Expected volatility, maximum	21.09%
Award granted in April 1, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Closing price on date of grant	$ 40.74
Dividend yield	5.20%
Risk free interest rate at time of grant, minimum	0.09%
Risk free interest rate at time of grant, maximum	0.91%
Expected volatility, minimum	20.06%
Expected volatility, maximum	21.08%
Awards granted in July 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Closing price on date of grant	$ 36.26
Dividend yield	6.07%
Risk free interest rate at time of grant, minimum	0.13%
Risk free interest rate at time of grant, maximum	1.08%
Expected volatility, minimum	20.06%
Expected volatility, maximum	20.21%
Awards granted in March 17, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Closing price on date of grant	$ 34.78
Dividend yield	6.56%
Risk free interest rate at time of grant, minimum	0.05%
Risk free interest rate at time of grant, maximum	1.14%
Expected volatility, minimum	23.92%
Expected volatility, maximum	24.88%

STOCK-BASED COMPENSATION (De102

STOCK-BASED COMPENSATION (Detail 2) - USD ($) $ / shares in Units, $ in Millions		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015		Dec. 31, 2014
Number of Shares/Units
Non-vested		1,622,871
Weighted - Average Grant-Date Fair Value per Share
Non-vested		$ 19.20
Compensation Cost	[1]	$ 31.2
PRSUs and LTIP Units
Number of Shares/Units
Non-vested		913,087	850,213		1,038,024
Granted		679,549	537,923		309,168
Cancelled			(165,570)
Forfeited		(518,638)	(128,073)
Vested			(181,406)	[2]	(496,979)	[2]
Non-vested		1,073,998	913,087		850,213
Weighted - Average Grant-Date Fair Value per Share
Non-vested		$ 14.87	$ 10.97		$ 10.72
Granted		14.67	18.51		11.46
Cancelled			14.11
Forfeited		12.10	12.04
Vested			10.10	[2]	10.75	[2]
Non-vested		$ 16.08	$ 14.87		$ 10.97
Compensation Cost	[3]	$ 10	$ 10		$ 3.5
[1]	Total compensation costs are net of shares cancelled.
[2]	PRSUs are shown as vesting in the year that the Compensation Committee determines the level of achievement of the applicable performance measures.
[3]	Total compensation cost to be recognized on the awards was based on the grant date fair value or the modification date fair value.

STOCK-BASED COMPENSATION (De103

STOCK-BASED COMPENSATION (Detail 3) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2016USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares/Units | shares	1,622,871
Grant Date Average Fair Value Per Unit/ Share | $ / shares	$ 19.20
Total Compensation Cost	$ 31.2	[1]
Unrecognized Compensation Cost	$ 18.1
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares/Units | shares	289,254
Grant Date Average Fair Value Per Unit/ Share | $ / shares	$ 37.82
Total Compensation Cost	$ 11	[1]
Unrecognized Compensation Cost	$ 5.6
RSUs | 3/31/15 RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2,015
Shares/Units | shares	109,985
Grant Date Average Fair Value Per Unit/ Share | $ / shares	$ 40.57
Total Compensation Cost	$ 4.5	[1]
Weighted Average Period of Expense Recognition	33 months
Unrecognized Compensation Cost	$ 1.6
Vesting Dates	12/31/2017
RSUs | 4/1/15 RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2,015
Shares/Units | shares	40,464
Grant Date Average Fair Value Per Unit/ Share | $ / shares	$ 40.74
Total Compensation Cost	$ 1.6	[1]
Weighted Average Period of Expense Recognition	33 months
Unrecognized Compensation Cost	$ 0.6
Vesting Dates	12/31/2017
RSUs | Assumed Aviv RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2,015
Shares/Units | shares	7,799
Grant Date Average Fair Value Per Unit/ Share | $ / shares	$ 35.08
Total Compensation Cost	$ 0.3	[1]
Weighted Average Period of Expense Recognition	33 months
Unrecognized Compensation Cost	$ 0.1
Vesting Dates	11/1/2017
RSUs | 3/17/16 RSU
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2,016
Shares/Units | shares	131,006
Grant Date Average Fair Value Per Unit/ Share | $ / shares	$ 34.78
Total Compensation Cost	$ 4.6	[1]
Weighted Average Period of Expense Recognition	33 months
Unrecognized Compensation Cost	$ 3.3
Vesting Dates	12/31/2018
TSR PRSUs and LTIP Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares/Units | shares	699,103
Grant Date Average Fair Value Per Unit/ Share | $ / shares	$ 12.74
Total Compensation Cost	$ 8.9	[1]
Unrecognized Compensation Cost	$ 5.7
TSR PRSUs and LTIP Units | 2016 TSR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2,014
Shares/Units | shares	135,634
Grant Date Average Fair Value Per Unit/ Share | $ / shares	$ 8.67
Total Compensation Cost	$ 1.2	[1]
Weighted Average Period of Expense Recognition	48 months
Unrecognized Compensation Cost	$ 0.3
Performance Period	1/1/2014-12/31/2016
Vesting Dates	Quarterly in 2017
TSR PRSUs and LTIP Units | 3/31/15 2017 LTIP Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2,015
Shares/Units | shares	137,249
Grant Date Average Fair Value Per Unit/ Share | $ / shares	$ 14.66
Total Compensation Cost	$ 2	[1]
Weighted Average Period of Expense Recognition	45 months
Unrecognized Compensation Cost	$ 1.1
Performance Period	1/1/2015-12/31/2017
Vesting Dates	Quarterly in 2018
TSR PRSUs and LTIP Units | 4/1/2015 2017 LTIP Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2,015
Shares/Units | shares	54,151
Grant Date Average Fair Value Per Unit/ Share | $ / shares	$ 14.80
Total Compensation Cost	$ 0.8	[1]
Weighted Average Period of Expense Recognition	45 months
Unrecognized Compensation Cost	$ 0.4
Performance Period	1/1/2015-12/31/2017
Vesting Dates	Quarterly in 2018
TSR PRSUs and LTIP Units | 3/17/2016 2018 LTIP Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2,016
Shares/Units | shares	372,069
Grant Date Average Fair Value Per Unit/ Share | $ / shares	$ 13.21
Total Compensation Cost	$ 4.9	[1]
Weighted Average Period of Expense Recognition	45 months
Unrecognized Compensation Cost	$ 3.9
Performance Period	1/1/2016-12/31/2018
Vesting Dates	Quarterly in 2019
Relative TSR PRSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares/Units | shares	634,514
Grant Date Average Fair Value Per Unit/ Share | $ / shares	$ 17.84
Total Compensation Cost	$ 11.3	[1]
Unrecognized Compensation Cost	$ 6.8
Relative TSR PRSUs | 2016 Relative TSR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2,014
Shares/Units | shares	135,634
Grant Date Average Fair Value Per Unit/ Share | $ / shares	$ 14.24
Total Compensation Cost	$ 1.9	[1]
Weighted Average Period of Expense Recognition	48 months
Unrecognized Compensation Cost	$ 0.5
Performance Period	1/1/2014-12/31/2016
Vesting Dates	Quarterly in 2017
Relative TSR PRSUs | 3/31/15 2017 Relative TSR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2,015
Shares/Units | shares	137,249
Grant Date Average Fair Value Per Unit/ Share | $ / shares	$ 22.50
Total Compensation Cost	$ 3.1	[1]
Weighted Average Period of Expense Recognition	45 months
Unrecognized Compensation Cost	$ 1.6
Performance Period	1/1/2015-12/31/2017
Vesting Dates	Quarterly in 2018
Relative TSR PRSUs | 4/1/2015 2017 Relative TSR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2,015
Shares/Units | shares	54,151
Grant Date Average Fair Value Per Unit/ Share | $ / shares	$ 22.91
Total Compensation Cost	$ 1.2	[1]
Weighted Average Period of Expense Recognition	45 months
Unrecognized Compensation Cost	$ 0.7
Performance Period	1/1/2015-12/31/2017
Vesting Dates	Quarterly in 2018
Relative TSR PRSUs | 3/17/2016 2018 Relative TSR
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant Year	2,016
Shares/Units | shares	307,480
Grant Date Average Fair Value Per Unit/ Share | $ / shares	$ 16.45
Total Compensation Cost	$ 5.1	[1]
Weighted Average Period of Expense Recognition	45 months
Unrecognized Compensation Cost	$ 4
Performance Period	1/1/2016-12/31/2018
Vesting Dates	Quarterly in 2019
[1]	Total compensation costs are net of shares cancelled.

STOCK-BASED COMPENSATION (Narra

STOCK-BASED COMPENSATION (Narrative) (Detail) - USD ($) $ / shares in Units, $ in Millions		Apr. 01, 2015	Jun. 06, 2013	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of operating partnership units distributions				10.00%
Value of shares issued net of tax withholdings				$ 23.4	$ 26.7	$ 3.6
Shares of restricted stock outstanding/shares				1,622,871
Compensation Cost	[1]			$ 31.2
Aviv
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Closing stock price				$ 31.26
Number of employee stock options assumed		5,700,000
Conversion ratio of assumed employee stock options		0.9
Number of stock options issued		5,100,000
Intrinsic value of stock option assumed		$ 99.2
Number of stock options exercised				2,500,000	2,600,000
Weighted average rate of stock options exercised				$ 19.38	$ 19.38
Number of stock options remain outstanding and exercisable				26,000
Weighted average exercise price of stock options outstanding				$ 18.97
Aggregate intrinsic value of outstanding stock options				$ 0.3
2013 Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Increase in number of shares reserved for issuance			3,000,000
Number of common shares reserved for future issuance				2,000,000
Restricted stock | Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of restricted stock issued				27,500	30,500	21,500
Fair value of restricted stock award				$ 0.9	$ 1.1	$ 0.8
Shares of restricted stock outstanding/shares				51,999
Vesting period, years				3 years
Compensation Cost				$ 1.4
[1]	Total compensation costs are net of shares cancelled.

DIVIDENDS (Detail)

DIVIDENDS (Detail) - $ / shares	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Dividends [Line Items]
Common dividends (in dollars per share)	$ 0.61	$ 0.60	$ 0.58	$ 0.57	$ 0.56	$ 0.55	$ 0.54	$ 0.53	$ 2.36	$ 2.18	$ 2.02
Ordinary income
Dividends [Line Items]
Common dividends (in dollars per share)									1.968	1.133	1.834
Return of capital
Dividends [Line Items]
Common dividends (in dollars per share)									0.322	$ 1.047	$ 0.186
Capital gains
Dividends [Line Items]
Common dividends (in dollars per share)									$ 0.070

DIVIDENDS (Narrative) (Detail)

DIVIDENDS (Narrative) (Detail) - $ / shares	Jan. 12, 2017	Oct. 13, 2016	Jul. 14, 2016	Apr. 14, 2016	Jan. 14, 2016
Dividends [Line Items]
Common stock dividend declared, per share		$ 0.61	$ 0.60	$ 0.58	$ 0.57
Nature of common stock dividend payable		Quarterly	Quarterly	Quarterly	Quarterly
Increase in quarterly common dividend, per share		$ 0.01	$ 0.02	$ 0.01	$ 0.01
Dividends declared, date of declaration		Oct. 13, 2016	Jul. 14, 2016	Apr. 14, 2016	Jan. 14, 2016
Dividends declared, date of payment		Nov. 15, 2016	Aug. 15, 2016	May 16, 2016	Feb. 16, 2016
Dividends declared, date of record		Oct. 31, 2016	Aug. 1, 2016	May 2, 2016	Feb. 2, 2016
Subsequent event
Dividends [Line Items]
Common stock dividend declared, per share	$ 0.62
Nature of common stock dividend payable	Quarterly
Increase in quarterly common dividend, per share	$ 0.01
Dividends declared, date of declaration	Jan. 12, 2017
Dividends declared, date of payment	Feb. 15, 2017
Dividends declared, date of record	Jan. 31, 2017

SUMMARY OF QUARTERLY RESULTS107

SUMMARY OF QUARTERLY RESULTS (UNAUDITED) (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
Revenues	$ 234,486	$ 224,638	$ 228,824	$ 212,879	$ 210,512	$ 201,974	$ 197,711	$ 133,420	$ 900,827	$ 743,617	$ 504,787
Net income	129,883	82,134	113,154	58,196	63,543	83,254	43,466	43,052	383,367	233,315	221,349
Net income available to common stockholders	$ 124,259	$ 78,549	$ 108,052	$ 55,555	$ 60,642	$ 79,402	$ 41,428	$ 43,052	$ 366,415	$ 224,524	$ 221,349
Net income available to common per share:
Basic (in dollars per share)	$ 0.63	$ 0.40	$ 0.57	$ 0.30	$ 0.32	$ 0.43	$ 0.23	$ 0.32	$ 1.91	$ 1.30	$ 1.75
Net income per share:
Diluted (in dollars per share)	0.63	0.40	0.57	0.29	0.32	0.43	0.22	0.32	1.90	1.29	1.74
Cash dividends paid on common stock	$ 0.61	$ 0.60	$ 0.58	$ 0.57	$ 0.56	$ 0.55	$ 0.54	$ 0.53	$ 2.36	$ 2.18	$ 2.02

EARNINGS PER SHARE (Detail)

EARNINGS PER SHARE (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Numerator:
Net income	$ 129,883	$ 82,134	$ 113,154	$ 58,196	$ 63,543	$ 83,254	$ 43,466	$ 43,052	$ 383,367	$ 233,315	$ 221,349
Less: Net income attributable to noncontrolling interests									(16,952)	(8,791)
Net income available to common stockholders	$ 124,259	$ 78,549	$ 108,052	$ 55,555	$ 60,642	$ 79,402	$ 41,428	$ 43,052	$ 366,415	$ 224,524	$ 221,349
Denominator:
Denominator for basic earnings per share									191,781	172,242	126,550
Effect of dilutive securities:
Common stock equivalents									956	1,539	744
Noncontrolling interest - OP units									8,898	6,727
Denominator for diluted earnings per share									201,635	180,508	127,294
Earnings per share - basic:
Net income available to common stockholders (in dollars per share)	$ 0.63	$ 0.40	$ 0.57	$ 0.30	$ 0.32	$ 0.43	$ 0.23	$ 0.32	$ 1.91	$ 1.30	$ 1.75
Earnings per share - diluted:
Net income (in dollars per share)	$ 0.63	$ 0.40	$ 0.57	$ 0.29	$ 0.32	$ 0.43	$ 0.22	$ 0.32	$ 1.90	$ 1.29	$ 1.74

CONSOLIDATING FINANCIAL STAT109

CONSOLIDATING FINANCIAL STATEMENTS - CONSOLIDATING BALANCE SHEET (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Real estate properties
Real estate investments	$ 7,566,358	$ 6,743,958
Less accumulated depreciation	(1,240,336)	(1,019,150)
Real estate investments - net	6,326,022	5,724,808
Investments in direct financing leases - net	601,938	587,701
Mortgage notes receivable - net	639,343	679,795
Real estate properties, total	7,567,303	6,992,304
Other investments - net	256,846	89,299
Investment in unconsolidated joint venture	48,776
Assets held for sale - net	52,868	6,599
Total investments	7,925,793	7,088,202
Cash and cash equivalents	93,687	5,424	$ 4,489	$ 2,616
Restricted cash	13,589	14,607
Accounts receivable - net	240,035	203,862
Goodwill	643,474	645,683
Other assets	32,682	32,158
Total assets	8,949,260	7,989,936
LIABILITIES AND EQUITY
Revolving line of credit	190,000	230,000
Term loans - net	1,094,343	745,693
Secured borrowings - net	54,365	235,593
Unsecured borrowings - net	3,028,146	2,328,727
Accrued expenses and other liabilities	360,514	333,706
Deferred income taxes	9,906	15,352
Total liabilities	4,737,274	3,889,071
Equity:
Common stock	19,614	18,740
Common stock - additional paid-in capital	4,861,408	4,609,474
Cumulative net earnings	1,738,937	1,372,522
Cumulative dividends paid	(2,707,387)	(2,254,038)
Accumulated other comprehensive loss	(53,827)	(8,712)
Total stockholders' equity	3,858,745	3,737,986
Noncontrolling interest	353,241	362,879
Total equity	4,211,986	4,100,865	1,401,327	1,300,103
Total liabilities and equity	8,949,260	7,989,936
Issuer & Subsidiary Guarantors
Real estate properties
Real estate investments	6,923,469	6,184,507
Less accumulated depreciation	(1,191,117)	(991,314)
Real estate investments - net	5,732,352	5,193,193
Investments in direct financing leases - net	601,938	587,701
Mortgage notes receivable - net	639,343	679,795
Real estate properties, total	6,973,633	6,460,689
Other investments - net	256,846	89,299
Investment in unconsolidated joint venture	48,776
Assets held for sale - net	52,868	6,599
Total investments	7,332,123	6,556,587
Cash and cash equivalents	87,098	1,592	$ 4,489	$ 2,616
Restricted cash	6,915	8,058
Accounts receivable - net	230,097	196,107
Goodwill	630,679	630,404
Investments in and advances to affiliates	569,194	300,409
Other assets	21,293	25,270
Total assets	8,877,399	7,718,427
LIABILITIES AND EQUITY
Revolving line of credit	190,000	230,000
Term loans - net	1,094,343	745,693
Unsecured borrowings - net	3,028,146	2,328,727
Accrued expenses and other liabilities	352,924	326,815
Intercompany payable		(13,673)
Total liabilities	4,665,413	3,617,562
Equity:
Common stock	19,614	18,740
Common stock - additional paid-in capital	4,861,408	4,609,474
Cumulative net earnings	1,738,937	1,372,522
Cumulative dividends paid	(2,707,387)	(2,254,038)
Accumulated other comprehensive loss	(53,827)	(8,712)
Total stockholders' equity	3,858,745	3,737,986
Noncontrolling interest	353,241	362,879
Total equity	4,211,986	4,100,865
Total liabilities and equity	8,877,399	7,718,427
Non - Guarantor Subsidiaries
Real estate properties
Real estate investments	642,889	559,451
Less accumulated depreciation	(49,219)	(27,836)
Real estate investments - net	593,670	531,615
Real estate properties, total	593,670	531,615
Total investments	593,670	531,615
Cash and cash equivalents	6,589	3,832
Restricted cash	6,674	6,549
Accounts receivable - net	9,938	7,755
Goodwill	12,795	15,279
Other assets	11,389	6,888
Total assets	641,055	571,918
LIABILITIES AND EQUITY
Secured borrowings - net	429,214	360,849
Accrued expenses and other liabilities	7,590	6,891
Deferred income taxes	9,906	15,352
Intercompany payable	7,890	13,673
Total liabilities	454,600	396,765
Equity:
Equity investment from affiliates	156,446	156,830
Common stock - additional paid-in capital
Cumulative net earnings	29,479	18,246
Accumulated other comprehensive loss	530	77
Total stockholders' equity	186,455	175,153
Total equity	186,455	175,153
Total liabilities and equity	641,055	571,918
Elimination Company
Real estate properties
Investments in and advances to affiliates	(569,194)	(300,409)
Total assets	(569,194)	(300,409)
LIABILITIES AND EQUITY
Secured borrowings - net	(374,849)	(125,256)
Intercompany payable	(7,890)
Total liabilities	(382,739)	(125,256)
Equity:
Equity investment from affiliates	(156,446)	(156,830)
Common stock - additional paid-in capital
Cumulative net earnings	(29,479)	(18,246)
Accumulated other comprehensive loss	(530)	(77)
Total stockholders' equity	(186,455)	(175,153)
Total equity	(186,455)	(175,153)
Total liabilities and equity	$ (569,194)	$ (300,409)

CONSOLIDATING FINANCIAL STAT110

CONSOLIDATING FINANCIAL STATEMENTS - CONSOLIDATING STATEMENT OF OPERATIONS (Detail 1) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Revenues
Rental income									$ 743,885	$ 605,991	$ 388,443
Income from direct financing leases									62,298	59,936	56,719
Mortgage interest income									69,811	68,910	53,007
Other investment income - net									21,852	7,534	6,369
Miscellaneous income - net									2,981	1,246	249
Total operating revenues	$ 234,486	$ 224,638	$ 228,824	$ 212,879	$ 210,512	$ 201,974	$ 197,711	$ 133,420	900,827	743,617	504,787
Expenses
Depreciation and amortization									267,062	210,703	123,257
General and administrative									45,867	38,568	25,888
Acquisition and merger related costs									9,582	57,525	3,948
Impairment loss on real estate properties									58,726	17,681	3,660
Provision for uncollectible mortgages, notes and accounts receivable									9,845	7,871	2,723
Total operating expenses									391,082	332,348	159,476
Income before other income and expense									509,745	411,269	345,311
Other income (expense):
Interest income									173	285	44
Interest expense									(164,103)	(147,381)	(119,369)
Interest - amortization of deferred financing costs									(9,345)	(6,990)	(4,459)
Interest - refinancing costs									(2,113)	(28,837)	(3,041)
Realized loss on foreign exchange									(232)	(173)
Total other expense									(175,620)	(183,096)	(126,825)
Income before gain on assets sold									334,125	228,173	218,486
Gain on assets sold - net									50,208	6,353	2,863
Income from continuing operations									384,333	234,526	221,349
Income tax expense									(1,405)	(1,211)
Income from unconsolidated joint venture									439
Net income	129,883	82,134	113,154	58,196	63,543	83,254	43,466	43,052	383,367	233,315	221,349
Net income attributable to noncontrolling interest									(16,952)	(8,791)
Net income available to common stockholders	$ 124,259	$ 78,549	$ 108,052	$ 55,555	$ 60,642	$ 79,402	$ 41,428	$ 43,052	366,415	224,524	221,349
Issuer & Subsidiary Guarantors
Revenues
Rental income									684,771	564,112	379,180
Income from direct financing leases									62,298	59,936	56,719
Mortgage interest income									69,811	68,910	53,007
Other investment income - net									25,056	7,534	6,369
Miscellaneous income - net									2,981	1,246	249
Total operating revenues									844,917	701,738	495,524
Expenses
Depreciation and amortization									244,290	194,328	119,367
General and administrative									45,413	38,140	25,778
Acquisition and merger related costs									5,777	55,012	3,948
Impairment loss on real estate properties									58,508	17,681	3,660
Provision for uncollectible mortgages, notes and accounts receivable									6,583	7,871	2,723
Total operating expenses									360,571	313,032	155,476
Income before other income and expense									484,346	388,706	340,048
Other income (expense):
Interest income									161	272	32
Interest expense									(148,092)	(135,631)	(117,258)
Interest - amortization of deferred financing costs									(9,302)	(6,969)	(4,438)
Interest - refinancing costs									(2,113)	(28,837)	(3,041)
Realized loss on foreign exchange									(232)	(173)
Equity in earnings									11,233	10,610	3,143
Total other expense									(148,345)	(160,728)	(121,562)
Income before gain on assets sold									336,001	227,978	218,486
Gain on assets sold - net									50,208	6,353	2,863
Income from continuing operations									386,209	234,331
Income tax expense									(3,281)	(1,016)
Income from unconsolidated joint venture									439
Net income									383,367	233,315	221,349
Net income attributable to noncontrolling interest									(16,952)	(8,791)
Net income available to common stockholders									366,415	224,524	221,349
Non - Guarantor Subsidiaries
Revenues
Rental income									59,114	41,879	9,263
Other investment income - net									56
Total operating revenues									59,170	41,879	9,263
Expenses
Depreciation and amortization									22,772	16,375	3,890
General and administrative									454	428	110
Acquisition and merger related costs									3,805	2,513
Impairment loss on real estate properties									218
Provision for uncollectible mortgages, notes and accounts receivable									3,262
Total operating expenses									30,511	19,316	4,000
Income before other income and expense									28,659	22,563	5,263
Other income (expense):
Interest income									12	13	12
Interest expense									(19,271)	(11,750)	(2,111)
Interest - amortization of deferred financing costs									(43)	(21)	(21)
Total other expense									(19,302)	(11,758)	(2,120)
Income before gain on assets sold									9,357	10,805	3,143
Income from continuing operations									9,357	10,805
Income tax expense									1,876	(195)
Net income									11,233	10,610	3,143
Net income available to common stockholders									11,233	10,610	3,143
Elimination Company
Revenues
Other investment income - net									(3,260)
Total operating revenues									(3,260)
Expenses
Income before other income and expense									(3,260)
Other income (expense):
Interest expense									3,260
Equity in earnings									(11,233)	(10,610)	(3,143)
Total other expense									(7,973)	(10,610)	(3,143)
Income before gain on assets sold									(11,233)	(10,610)	(3,143)
Income from continuing operations									(11,233)	(10,610)
Net income									(11,233)	(10,610)	(3,143)
Net income available to common stockholders									$ (11,233)	$ (10,610)	$ (3,143)

CONSOLIDATING FINANCIAL STAT111

CONSOLIDATING FINANCIAL STATEMENTS - CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (Detail 2) - USD ($) $ in Thousands		3 Months Ended								12 Months Ended
		Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Condensed Financial Statements, Captions [Line Items]
Net income		$ 129,883	$ 82,134	$ 113,154	$ 58,196	$ 63,543	$ 83,254	$ 43,466	$ 43,052	$ 383,367	$ 233,315	$ 221,349
Other comprehensive income (loss)
Foreign currency translation										(46,535)	(8,413)
Cash flow hedges										(702)	(718)
Total other comprehensive income (loss)										(47,237)	(9,131)
Comprehensive income										336,130	224,184	221,349
Comprehensive income attributable to noncontrolling interest	[1]									(14,830)	(8,373)
Comprehensive income attributable to common stockholders	[1]									321,300	215,811	221,349
Issuer & Subsidiary Guarantors
Condensed Financial Statements, Captions [Line Items]
Net income										383,367	233,315	221,349
Other comprehensive income (loss)
Foreign currency translation										(46,535)	(8,413)
Cash flow hedges										(702)	(718)
Total other comprehensive income (loss)										(47,237)	(9,131)
Comprehensive income										336,130	224,184
Comprehensive income attributable to noncontrolling interest										(14,830)	(8,373)
Comprehensive income attributable to common stockholders										321,300	215,811
Non - Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Net income										11,233	10,610	3,143
Other comprehensive income (loss)
Comprehensive income										11,233	10,610
Comprehensive income attributable to common stockholders										11,233	10,610
Elimination Company
Condensed Financial Statements, Captions [Line Items]
Net income										(11,233)	(10,610)	$ (3,143)
Other comprehensive income (loss)
Comprehensive income										(11,233)	(10,610)
Comprehensive income attributable to common stockholders										$ (11,233)	$ (10,610)
[1]	The 2015 amount has been adjusted to increase the comprehensive income attributable to the noncontrolling interest and decrease the comprehensive income attributable to common stockholders by $8.8 million.

CONSOLIDATING FINANCIAL STAT112

CONSOLIDATING FINANCIAL STATEMENTS - CONSOLIDATED STATEMENTS OF CASH FLOWS (Detail 3) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities
Net income	$ 129,883	$ 82,134	$ 113,154	$ 58,196	$ 63,543	$ 83,254	$ 43,466	$ 43,052	$ 383,367	$ 233,315	$ 221,349
Adjustment to reconcile net income to net cash provided by operating activities:
Depreciation and amortization									267,062	210,703	123,257
Impairment loss on real estate properties									58,726	17,681	3,660
Provision for uncollectible mortgages, notes and accounts receivable									9,845	7,871	2,723
Refinancing costs and amortization of deferred financing costs									11,458	35,827	7,500
Accretion of direct financing leases									(12,157)	(11,007)	(9,787)
Stock-based compensation expense									13,790	11,133	8,592
Gain on assets sold - net									(50,208)	(6,353)	(2,863)
Amortization of acquired in-place leases - net									(13,991)	(13,846)	(4,986)
Change in operating assets and liabilities - net of amounts assumed/acquired:
Accounts receivable, net									(4,876)	248	(2,264)
Straight-line rent receivables									(42,091)	(36,057)	(20,956)
Lease inducements									2,589	994	2,656
Effective yield receivable on mortgage notes									(721)	(4,065)	(2,878)
Other operating assets and liabilities									2,998	17,441	11,537
Net cash provided by operating activities									625,791	463,885	337,540
Cash flows from investing activities
Acquisition of real estate - net of liabilities assumed and escrows acquired									(959,748)	(294,182)	(131,689)
Cash acquired in merger										84,858
Investments in construction in progress									(68,983)	(164,226)
Investments in direct financing leases									(2,080)	(6,793)
Placement of mortgage loans									(48,722)	(14,042)	(529,548)
Investments in unconsolidated joint venture									(50,032)
Distributions from unconsolidated joint venture									1,318
Proceeds from sale of real estate investments									169,603	41,543	4,077
Capital improvements to real estate investments									(40,471)	(26,397)	(17,917)
Proceeds from other investments									96,789	45,871	13,589
Investments in other investments									(271,557)	(65,402)	(9,441)
Collection of mortgage principal									59,975	1,359	122,984
Net cash used in investing activities									(1,113,908)	(397,411)	(547,945)
Cash flows from financing activities
Proceeds from credit facility borrowings									1,304,000	1,826,000	900,000
Payments on credit facility borrowings									(1,344,000)	(1,681,000)	(1,141,000)
Receipts of other long-term borrowings									1,048,173	1,838,124	842,148
Payments of other long-term borrowings									(181,249)	(2,187,314)	(242,544)
Payments of financing related costs									(11,830)	(54,721)	(17,716)
Receipts from dividend reinvestment plan									240,041	150,847	71,487
Payments for exercised options and restricted stock									(23,426)	(26,706)	(3,577)
Net proceeds from issuance of common stock									19,651	439,322	61,981
Dividends paid									(453,152)	(358,232)	(258,501)
Redemption of OP Units									(733)
Distributions to OP Unit Holders									(21,179)	(11,636)
Net cash provided by (used in) financing activities									576,296	(65,316)	212,278
Effect of foreign currency translation on cash and cash equivalents									84	(223)
Increase in cash and cash equivalents									88,263	935	1,873
Cash and cash equivalents at beginning of year				5,424				4,489	5,424	4,489	2,616
Cash and cash equivalents at end of year	93,687				5,424				93,687	5,424	4,489
Issuer & Subsidiary Guarantors
Cash flows from operating activities
Net income									383,367	233,315	221,349
Adjustment to reconcile net income to net cash provided by operating activities:
Depreciation and amortization									244,290	194,328	119,367
Impairment loss on real estate properties									58,508	17,681	3,660
Provision for uncollectible mortgages, notes and accounts receivable									6,583	7,871	2,723
Refinancing costs and amortization of deferred financing costs									11,415	35,806	7,479
Accretion of direct financing leases									(12,157)	(11,007)	(9,787)
Stock-based compensation expense									13,790	11,133	8,592
Gain on assets sold - net									(50,208)	(6,353)	(2,863)
Amortization of acquired in-place leases - net									(13,991)	(13,846)	(4,986)
Equity in earnings									(11,233)
Change in operating assets and liabilities - net of amounts assumed/acquired:
Accounts receivable, net									(4,876)	248	(2,264)
Straight-line rent receivables									(36,263)	(31,237)	(20,164)
Lease inducements									2,589	994	2,656
Effective yield receivable on mortgage notes									(721)	(4,065)	(2,878)
Other operating assets and liabilities									18,661	10,550	11,089
Net cash provided by operating activities									609,754	445,418	333,973
Cash flows from investing activities
Acquisition of real estate - net of liabilities assumed and escrows acquired									(833,390)	(116,698)	(131,689)
Cash acquired in merger										84,858
Investments in construction in progress									(68,983)	(164,226)
Investment in U.K. subsidiary									(116,099)	(166,082)
Investments in direct financing leases									(2,080)	(6,793)
Placement of mortgage loans									(48,722)	(14,042)	(529,548)
Investments in unconsolidated joint venture									(50,032)
Distributions from unconsolidated joint venture									1,318
Proceeds from sale of real estate investments									169,603	41,543	4,077
Capital improvements to real estate investments									(38,824)	(24,599)	(15,525)
Proceeds from other investments									94,840	45,871	13,589
Investments in other investments									(269,423)	(65,402)	(9,441)
Collection of mortgage principal									59,975	1,359	122,984
Net cash used in investing activities									(1,101,817)	(384,211)	(545,553)
Cash flows from financing activities
Proceeds from credit facility borrowings									1,304,000	1,826,000	900,000
Payments on credit facility borrowings									(1,344,000)	(1,681,000)	(1,141,000)
Receipts of other long-term borrowings									1,048,173	1,838,124	842,148
Payments of other long-term borrowings									(180,000)	(2,186,102)	(241,369)
Payments of financing related costs									(11,806)	(54,721)	(17,716)
Receipts from dividend reinvestment plan									240,041	150,847	71,487
Payments for exercised options and restricted stock									(23,426)	(26,706)	(3,577)
Net proceeds from issuance of common stock									19,651	439,322	61,981
Dividends paid									(453,152)	(358,232)	(258,501)
Redemption of OP Units									(733)
Distributions to OP Unit Holders									(21,179)	(11,636)
Net cash provided by (used in) financing activities									577,569	(64,104)	213,453
Increase in cash and cash equivalents									85,506	(2,897)	1,873
Cash and cash equivalents at beginning of year				1,592				$ 4,489	1,592	4,489	2,616
Cash and cash equivalents at end of year	87,098				1,592				87,098	1,592	4,489
Non - Guarantor Subsidiaries
Cash flows from operating activities
Net income									11,233	10,610	3,143
Adjustment to reconcile net income to net cash provided by operating activities:
Depreciation and amortization									22,772	16,375	3,890
Impairment loss on real estate properties									218
Provision for uncollectible mortgages, notes and accounts receivable									3,262
Refinancing costs and amortization of deferred financing costs									43	21	21
Change in operating assets and liabilities - net of amounts assumed/acquired:
Straight-line rent receivables									(5,828)	(4,820)	(792)
Other operating assets and liabilities									(15,663)	(3,719)	(2,695)
Net cash provided by operating activities									16,037	18,467	3,567
Cash flows from investing activities
Acquisition of real estate - net of liabilities assumed and escrows acquired									(126,358)	(177,484)
Investment in U.K. subsidiary										166,082
Capital improvements to real estate investments									(1,647)	(1,798)	(2,392)
Proceeds from other investments									1,949
Investments in other investments									(2,134)
Net cash used in investing activities									(128,190)	(13,200)	(2,392)
Cash flows from financing activities
Payments of other long-term borrowings									(1,249)	(1,212)	(1,175)
Payments of financing related costs									(24)
Contributions from affiliates									116,099
Net cash provided by (used in) financing activities									114,826	(1,212)	(1,175)
Effect of foreign currency translation on cash and cash equivalents									84	(223)
Increase in cash and cash equivalents									2,757	3,832
Cash and cash equivalents at beginning of year				$ 3,832					3,832
Cash and cash equivalents at end of year	$ 6,589				$ 3,832				6,589	3,832
Elimination Company
Cash flows from operating activities
Net income									(11,233)	(10,610)	(3,143)
Adjustment to reconcile net income to net cash provided by operating activities:
Equity in earnings									11,233
Change in operating assets and liabilities - net of amounts assumed/acquired:
Other operating assets and liabilities										$ 10,610	$ 3,143
Cash flows from investing activities
Investment in U.K. subsidiary									116,099
Net cash used in investing activities									116,099
Cash flows from financing activities
Contributions from affiliates									(116,099)
Net cash provided by (used in) financing activities									$ (116,099)

CONSOLIDATING FINANCIAL STAT113

CONSOLIDATING FINANCIAL STATEMENTS (Narrative) (Detail) - USD ($) $ in Thousands	Dec. 31, 2016	Jul. 12, 2016	Dec. 31, 2015	Sep. 23, 2015	Mar. 18, 2015	Sep. 11, 2014	Mar. 11, 2014	Mar. 19, 2012
4.375% notes due 2023
Condensed Financial Statements, Captions [Line Items]
Interest rate	4.375%
5.875% Notes due 2024
Condensed Financial Statements, Captions [Line Items]
Interest rate	5.875%
4.50% notes due 2025
Condensed Financial Statements, Captions [Line Items]
Interest rate	4.50%
5.25% notes due 2026 - net
Condensed Financial Statements, Captions [Line Items]
Interest rate	5.25%
4.50% notes due 2027 - net
Condensed Financial Statements, Captions [Line Items]
Interest rate	4.50%
Unsecured borrowings | 4.375% notes due 2023
Condensed Financial Statements, Captions [Line Items]
Senior notes outstanding	$ 700,000	$ 700,000
Interest rate	4.375%	4.375%
Unsecured borrowings | 5.875% Notes due 2024
Condensed Financial Statements, Captions [Line Items]
Senior notes outstanding	$ 400,000		$ 400,000					$ 400,000
Interest rate	5.875%
Unsecured borrowings | 4.95% Notes due 2024
Condensed Financial Statements, Captions [Line Items]
Senior notes outstanding	$ 400,000		400,000				$ 400,000
Interest rate	4.95%
Unsecured borrowings | 4.50% notes due 2025
Condensed Financial Statements, Captions [Line Items]
Senior notes outstanding	$ 250,000		250,000			$ 250,000
Interest rate	4.50%
Unsecured borrowings | 5.25% notes due 2026 - net
Condensed Financial Statements, Captions [Line Items]
Senior notes outstanding	$ 600,000		600,000	$ 600,000
Interest rate	5.25%
Unsecured borrowings | 4.50% notes due 2027 - net
Condensed Financial Statements, Captions [Line Items]
Senior notes outstanding	$ 700,000		$ 700,000		$ 700,000
Interest rate	4.50%

SCHEDULE III REAL ESTATE AND114

SCHEDULE III REAL ESTATE AND ACCUMULATED DEPRECIATION (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 767,018,940
Initial Cost to Company Buildings and Improvements	[1]	6,549,820,611
Cost Capitalized Subsequent to Acquisition Improvements	[1]	312,976,028
Cost Capitalized Subsequent to Acquisition Carrying Cost	[1]	8,718,627
Cost Capitalized Subsequent to Acquisition Other	[1],[2]	(72,175,923)
Gross Amount at Which Carried at Close of Period Land	[1]	759,294,503
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	6,807,063,780
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total		7,566,358,283	$ 6,743,957,698	$ 3,223,785,295	$ 3,099,547,182
Accumulated Depreciation		1,240,335,945	$ 1,019,149,678	$ 821,711,991	$ 707,409,888
Signature Holdings II
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	44,388,713
Initial Cost to Company Buildings and Improvements	[1]	490,665,754
Cost Capitalized Subsequent to Acquisition Improvements	[1]	22,910,980
Cost Capitalized Subsequent to Acquisition Carrying Cost	[1]	20,238
Gross Amount at Which Carried at Close of Period Land	[1]	44,388,713
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	513,596,972
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	557,985,685
Accumulated Depreciation	[1],[4]	85,901,618
Signature Holdings II | Florida
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	14,926,960
Initial Cost to Company Buildings and Improvements	[1]	184,977,257
Cost Capitalized Subsequent to Acquisition Improvements	[1]	10,162,810
Cost Capitalized Subsequent to Acquisition Carrying Cost	[1]	20,238
Gross Amount at Which Carried at Close of Period Land	[1]	14,926,960
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	195,160,305
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	210,087,265
Accumulated Depreciation	[1],[4]	$ 47,922,023
Date Of Construction	[1]	1940-1997
Date Acquired	[1]	1996-2016
Signature Holdings II | Florida | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	3 years
Signature Holdings II | Florida | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	39 years
Signature Holdings II | Georgia
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 3,832,748
Initial Cost to Company Buildings and Improvements	[1]	10,846,566
Cost Capitalized Subsequent to Acquisition Improvements	[1]	3,950,028
Gross Amount at Which Carried at Close of Period Land	[1]	3,832,748
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	14,796,594
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	18,629,342
Accumulated Depreciation	[1],[4]	$ 8,654,672
Date Of Construction	[1]	1970-1964
Date Acquired	[1]	2,007
Life on Which Depreciation in Latest Income Statements is Computed	[1]	20 years
Signature Holdings II | Kentucky
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 13,335,341
Initial Cost to Company Buildings and Improvements	[1]	87,790,543
Cost Capitalized Subsequent to Acquisition Improvements	[1]	4,174,496
Gross Amount at Which Carried at Close of Period Land	[1]	13,335,341
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	91,965,039
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	105,300,380
Accumulated Depreciation	[1],[4]	$ 19,646,496
Date Of Construction	[1]	1964-1980
Date Acquired	[1]	1999-2016
Signature Holdings II | Kentucky | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	20 years
Signature Holdings II | Kentucky | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Signature Holdings II | Maryland
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 1,480,000
Initial Cost to Company Buildings and Improvements	[1]	19,662,571
Cost Capitalized Subsequent to Acquisition Improvements	[1]	1,183,051
Gross Amount at Which Carried at Close of Period Land	[1]	1,480,000
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	20,845,622
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	22,325,622
Accumulated Depreciation	[1],[4]	$ 6,981,961
Date Of Construction	[1]	1977-1959
Date Acquired	[1]	2,010
Signature Holdings II | Maryland | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	29 years
Signature Holdings II | Maryland | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	30 years
Signature Holdings II | Tennessee
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 10,813,664
Initial Cost to Company Buildings and Improvements	[1]	187,388,817
Cost Capitalized Subsequent to Acquisition Improvements	[1]	3,440,595
Gross Amount at Which Carried at Close of Period Land	[1]	10,813,664
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	190,829,412
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	201,643,076
Accumulated Depreciation	[1],[4]	$ 2,696,466
Date Of Construction	[1]	1966-2016
Date Acquired	[1]	2014-2016
Signature Holdings II | Tennessee | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	25 years
Signature Holdings II | Tennessee | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	30 years
Maplewood Real Estate Holdings
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 160,860,541
Initial Cost to Company Buildings and Improvements	[1]	294,127,986
Cost Capitalized Subsequent to Acquisition Improvements	[1]	67,661,467
Cost Capitalized Subsequent to Acquisition Carrying Cost	[1]	7,435,164
Cost Capitalized Subsequent to Acquisition Other	[1],[2]	(680,345)
Gross Amount at Which Carried at Close of Period Land	[1]	160,860,541
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	368,544,272
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	529,404,813
Accumulated Depreciation	[1],[4]	19,662,877
Maplewood Real Estate Holdings | New York
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	118,604,252
Cost Capitalized Subsequent to Acquisition Improvements	[1]	6,655,755
Cost Capitalized Subsequent to Acquisition Carrying Cost	[1]	7,092,469
Gross Amount at Which Carried at Close of Period Land	[1]	118,604,252
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	13,748,224
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	$ 132,352,476
Date Acquired	[1]	2,015
Maplewood Real Estate Holdings | Connecticut
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 19,531,583
Initial Cost to Company Buildings and Improvements	[1]	216,537,730
Cost Capitalized Subsequent to Acquisition Improvements	[1]	2,241,593
Gross Amount at Which Carried at Close of Period Land	[1]	19,531,583
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	218,779,323
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	238,310,906
Accumulated Depreciation	[1],[4]	$ 12,740,033
Date Of Construction	[1]	1968-2015
Date Acquired	[1]	2,015
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Maplewood Real Estate Holdings | Massachusetts
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 19,041,468
Initial Cost to Company Buildings and Improvements	[1]	69,409,856
Cost Capitalized Subsequent to Acquisition Improvements	[1]	39,267,802
Cost Capitalized Subsequent to Acquisition Carrying Cost	[1]	342,695
Cost Capitalized Subsequent to Acquisition Other	[1],[2]	(680,345)
Gross Amount at Which Carried at Close of Period Land	[1]	19,041,468
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	108,340,008
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	127,381,476
Accumulated Depreciation	[1],[4]	$ 5,826,713
Date Of Construction	[1]	1988-2016
Date Acquired	[1]	2,015
Maplewood Real Estate Holdings | Massachusetts | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	30 years
Maplewood Real Estate Holdings | Massachusetts | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Maplewood Real Estate Holdings | Ohio
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 3,683,238
Initial Cost to Company Buildings and Improvements	[1]	8,180,400
Cost Capitalized Subsequent to Acquisition Improvements	[1]	19,496,317
Gross Amount at Which Carried at Close of Period Land	[1]	3,683,238
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	27,676,717
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	31,359,955
Accumulated Depreciation	[1],[4]	$ 1,096,131
Date Of Construction	[1]	1999-2016
Date Acquired	[1]	2,015
Maplewood Real Estate Holdings | Ohio | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	30 years
Maplewood Real Estate Holdings | Ohio | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Saber Health Group
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 32,106,466
Initial Cost to Company Buildings and Improvements	[1]	430,577,757
Cost Capitalized Subsequent to Acquisition Improvements	[1]	6,577,173
Cost Capitalized Subsequent to Acquisition Carrying Cost	[1]	47,891
Cost Capitalized Subsequent to Acquisition Other	[1],[2]	(268,000)
Gross Amount at Which Carried at Close of Period Land	[1]	32,106,466
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	436,934,821
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	469,041,287
Accumulated Depreciation	[1],[4]	23,321,261
Saber Health Group | Florida
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	422,935
Initial Cost to Company Buildings and Improvements	[1]	4,422,325
Gross Amount at Which Carried at Close of Period Land	[1]	422,935
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	4,422,325
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	4,845,260
Accumulated Depreciation	[1],[4]	$ 337,550
Date Of Construction	[1]	2,009
Date Acquired	[1]	2,015
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Saber Health Group | North Carolina
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 10,780,000
Initial Cost to Company Buildings and Improvements	[1]	106,694,700
Cost Capitalized Subsequent to Acquisition Improvements	[1]	2,312,955
Cost Capitalized Subsequent to Acquisition Carrying Cost	[1]	47,891
Gross Amount at Which Carried at Close of Period Land	[1]	10,780,000
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	109,055,546
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	119,835,546
Accumulated Depreciation	[1],[4]	$ 4,660,696
Date Of Construction	[1]	1965-2013
Date Acquired	[1]	2,016
Saber Health Group | North Carolina | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	20 years
Saber Health Group | North Carolina | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	30 years
Saber Health Group | Ohio
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 5,269,177
Initial Cost to Company Buildings and Improvements	[1]	109,002,482
Cost Capitalized Subsequent to Acquisition Improvements	[1]	2,438,309
Cost Capitalized Subsequent to Acquisition Other	[1],[2]	(268,000)
Gross Amount at Which Carried at Close of Period Land	[1]	5,269,177
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	111,172,791
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	116,441,968
Accumulated Depreciation	[1],[4]	$ 6,862,544
Date Of Construction	[1]	1968-2000
Date Acquired	[1]	2015-2016
Saber Health Group | Ohio | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	30 years
Saber Health Group | Ohio | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Saber Health Group | Pennsylvania
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 7,134,354
Initial Cost to Company Buildings and Improvements	[1]	124,475,985
Cost Capitalized Subsequent to Acquisition Improvements	[1]	1,825,909
Gross Amount at Which Carried at Close of Period Land	[1]	7,134,354
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	126,301,894
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	133,436,248
Accumulated Depreciation	[1],[4]	$ 8,140,340
Date Of Construction	[1]	1873-2002
Date Acquired	[1]	2,015
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Saber Health Group | Virginia
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 8,500,000
Initial Cost to Company Buildings and Improvements	[1]	85,982,265
Gross Amount at Which Carried at Close of Period Land	[1]	8,500,000
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	85,982,265
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	94,482,265
Accumulated Depreciation	[1],[4]	$ 3,320,131
Date Of Construction	[1]	1964-2013
Date Acquired	[1]	2,016
Life on Which Depreciation in Latest Income Statements is Computed	[1]	30 years
Ciena Healthcare
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 25,381,109
Initial Cost to Company Buildings and Improvements	[1]	435,896,017
Gross Amount at Which Carried at Close of Period Land	[1]	25,381,109
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	435,896,017
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	461,277,126
Accumulated Depreciation	[1],[4]	26,403,073
Ciena Healthcare | Indiana
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	321,066
Initial Cost to Company Buildings and Improvements	[1]	7,703,262
Gross Amount at Which Carried at Close of Period Land	[1]	321,066
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	7,703,262
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	8,024,328
Accumulated Depreciation	[1],[4]	$ 574,610
Date Of Construction	[1]	1,973
Date Acquired	[1]	2,015
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Ciena Healthcare | Michigan
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 4,086,842
Initial Cost to Company Buildings and Improvements	[1]	115,546,920
Gross Amount at Which Carried at Close of Period Land	[1]	4,086,842
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	115,546,920
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	119,633,762
Accumulated Depreciation	[1],[4]	$ 7,812,153
Date Of Construction	[1]	1964-1997
Date Acquired	[1]	2,015
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Ciena Healthcare | North Carolina
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 4,330,580
Initial Cost to Company Buildings and Improvements	[1]	65,027,000
Gross Amount at Which Carried at Close of Period Land	[1]	4,330,580
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	65,027,000
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	69,357,580
Accumulated Depreciation	[1],[4]	$ 4,446,154
Date Of Construction	[1]	1927-1997
Date Acquired	[1]	2,015
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Ciena Healthcare | Ohio
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 10,342,621
Initial Cost to Company Buildings and Improvements	[1]	159,846,959
Gross Amount at Which Carried at Close of Period Land	[1]	10,342,621
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	159,846,959
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	170,189,580
Accumulated Depreciation	[1],[4]	$ 10,349,693
Date Of Construction	[1]	1960-2007
Date Acquired	[1]	2010-2016
Ciena Healthcare | Ohio | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	20 years
Ciena Healthcare | Ohio | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Ciena Healthcare | Virginia
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 6,300,000
Initial Cost to Company Buildings and Improvements	[1]	87,771,876
Gross Amount at Which Carried at Close of Period Land	[1]	6,300,000
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	87,771,876
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	94,071,876
Accumulated Depreciation	[1],[4]	$ 3,220,463
Date Of Construction	[1]	1979-2007
Date Acquired	[1]	2,016
Life on Which Depreciation in Latest Income Statements is Computed	[1]	30 years
Other
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 504,282,111
Initial Cost to Company Buildings and Improvements	[1]	4,898,553,097
Cost Capitalized Subsequent to Acquisition Improvements	[1]	215,826,408
Cost Capitalized Subsequent to Acquisition Carrying Cost	[1]	1,215,334
Cost Capitalized Subsequent to Acquisition Other	[1],[2]	(71,227,578)
Gross Amount at Which Carried at Close of Period Land	[1]	496,557,674
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	5,052,091,698
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	5,548,649,372
Accumulated Depreciation	[1],[4]	1,085,047,116
Other | Alabama
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	1,817,320
Initial Cost to Company Buildings and Improvements	[1]	33,356,170
Cost Capitalized Subsequent to Acquisition Improvements	[1]	12,915,787
Gross Amount at Which Carried at Close of Period Land	[1]	1,817,320
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	46,271,957
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	48,089,277
Accumulated Depreciation	[1],[4]	$ 30,926,414
Date Of Construction	[1]	1960-1982
Date Acquired	[1]	1992-1997
Other | Alabama | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	31 years 6 months
Other | Alabama | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Other | Arizona
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1],[5]	$ 10,995,190
Initial Cost to Company Buildings and Improvements	[1],[5]	86,868,402
Gross Amount at Which Carried at Close of Period Land	[1],[5]	10,995,190
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1],[5]	86,868,402
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3],[5]	97,863,592
Accumulated Depreciation	[1],[4],[5]	$ 10,017,581
Date Of Construction	[1],[5]	1949-1999
Date Acquired	[1],[5]	2012-2015
Other | Arizona | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1],[5]	33 years
Other | Arizona | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1],[5]	40 years
Other | Arkansas
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1],[5]	$ 9,057,536
Initial Cost to Company Buildings and Improvements	[1],[5]	161,016,248
Cost Capitalized Subsequent to Acquisition Improvements	[1],[5]	13,045,870
Cost Capitalized Subsequent to Acquisition Other	[1],[2],[5]	(36,350)
Gross Amount at Which Carried at Close of Period Land	[1],[5]	9,057,536
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1],[5]	174,025,768
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3],[5]	183,083,304
Accumulated Depreciation	[1],[4],[5]	$ 55,208,651
Date Of Construction	[1],[5]	1960-2009
Date Acquired	[1],[5]	1992-2015
Other | Arkansas | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1],[5]	20 years
Other | Arkansas | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1],[5]	38 years
Other | California
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 78,596,505
Initial Cost to Company Buildings and Improvements	[1]	423,131,800
Cost Capitalized Subsequent to Acquisition Improvements	[1]	2,823,085
Cost Capitalized Subsequent to Acquisition Carrying Cost	[1]	63,156
Gross Amount at Which Carried at Close of Period Land	[1]	78,596,505
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	426,018,041
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	504,614,546
Accumulated Depreciation	[1],[4]	$ 55,083,670
Date Of Construction	[1]	1927-2013
Date Acquired	[1]	1997-2015
Other | California | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	5 years
Other | California | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	35 years
Other | Colorado
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 11,279,262
Initial Cost to Company Buildings and Improvements	[1]	88,830,136
Cost Capitalized Subsequent to Acquisition Improvements	[1]	7,790,478
Gross Amount at Which Carried at Close of Period Land	[1]	11,279,262
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	96,620,614
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	107,899,876
Accumulated Depreciation	[1],[4]	$ 29,232,095
Date Of Construction	[1]	1925-1975
Date Acquired	[1]	1998-2016
Other | Colorado | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	20 years
Other | Colorado | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	39 years
Other | Connecticut
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 878,937
Initial Cost to Company Buildings and Improvements	[1]	4,445,263
Cost Capitalized Subsequent to Acquisition Improvements	[1]	980,393
Cost Capitalized Subsequent to Acquisition Other	[1],[2]	(5,425,656)
Gross Amount at Which Carried at Close of Period Land	[1]	878,937
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	$ 878,937
Date Acquired	[1]	1,999
Other | Florida
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 61,806,778
Initial Cost to Company Buildings and Improvements	[1]	481,225,245
Cost Capitalized Subsequent to Acquisition Improvements	[1]	36,333,087
Cost Capitalized Subsequent to Acquisition Carrying Cost	[1]	948,913
Cost Capitalized Subsequent to Acquisition Other	[1],[2]	(9,736,615)
Gross Amount at Which Carried at Close of Period Land	[1]	61,806,778
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	508,770,630
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	570,577,408
Accumulated Depreciation	[1],[4]	$ 150,266,763
Date Of Construction	[1]	1933-2007
Date Acquired	[1]	1992-2016
Other | Florida | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	2 years
Other | Florida | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	40 years
Other | Georgia
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 3,730,000
Initial Cost to Company Buildings and Improvements	[1]	47,387,507
Gross Amount at Which Carried at Close of Period Land	[1]	3,730,000
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	47,387,507
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	51,117,507
Accumulated Depreciation	[1],[4]	$ 5,230,371
Date Of Construction	[1]	1967-1998
Date Acquired	[1]	1998-2016
Other | Georgia | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	30 years
Other | Georgia | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	40 years
Other | Idaho
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 6,705,560
Initial Cost to Company Buildings and Improvements	[1]	62,572,804
Cost Capitalized Subsequent to Acquisition Improvements	[1]	1,321,587
Gross Amount at Which Carried at Close of Period Land	[1]	6,705,560
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	63,894,391
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	70,599,951
Accumulated Depreciation	[1],[4]	$ 12,106,038
Date Of Construction	[1]	1911-2008
Date Acquired	[1]	1997-2015
Other | Idaho | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	25 years
Other | Idaho | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	39 years
Other | Illinois
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 5,809,737
Initial Cost to Company Buildings and Improvements	[1]	111,441,468
Cost Capitalized Subsequent to Acquisition Improvements	[1]	510,576
Gross Amount at Which Carried at Close of Period Land	[1]	5,809,737
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	111,952,044
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	117,761,781
Accumulated Depreciation	[1],[4]	$ 15,117,035
Date Of Construction	[1]	1926-1990
Date Acquired	[1]	1996-2015
Other | Illinois | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	30 years
Other | Illinois | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Other | Indiana
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 28,245,140
Initial Cost to Company Buildings and Improvements	[1]	366,055,214
Cost Capitalized Subsequent to Acquisition Improvements	[1]	2,332,364
Cost Capitalized Subsequent to Acquisition Other	[1],[2]	(1,828,124)
Gross Amount at Which Carried at Close of Period Land	[1]	28,237,640
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	366,566,954
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	394,804,594
Accumulated Depreciation	[1],[4]	$ 77,812,713
Date Of Construction	[1]	1923-2008
Date Acquired	[1]	1992-2015
Other | Indiana | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	20 years
Other | Indiana | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	40 years
Other | Iowa
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 2,923,947
Initial Cost to Company Buildings and Improvements	[1]	68,736,698
Cost Capitalized Subsequent to Acquisition Improvements	[1]	2,084,807
Gross Amount at Which Carried at Close of Period Land	[1]	2,923,947
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	70,821,505
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	73,745,452
Accumulated Depreciation	[1],[4]	$ 13,120,583
Date Of Construction	[1]	1961-1998
Date Acquired	[1]	1997-2015
Other | Iowa | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	23 years
Other | Iowa | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Other | Kansas
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 4,799,714
Initial Cost to Company Buildings and Improvements	[1]	47,680,306
Cost Capitalized Subsequent to Acquisition Improvements	[1]	9,250,851
Gross Amount at Which Carried at Close of Period Land	[1]	4,799,714
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	56,931,157
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	61,730,871
Accumulated Depreciation	[1],[4]	$ 6,164,491
Date Of Construction	[1]	1957-1985
Date Acquired	[1]	2010-2015
Other | Kansas | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	20 years
Other | Kansas | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Other | Kentucky
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 6,279,163
Initial Cost to Company Buildings and Improvements	[1]	123,327,734
Cost Capitalized Subsequent to Acquisition Improvements	[1]	8,677,102
Gross Amount at Which Carried at Close of Period Land	[1]	6,279,163
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	132,004,836
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	138,283,999
Accumulated Depreciation	[1],[4]	$ 20,157,352
Date Of Construction	[1]	1917-2002
Date Acquired	[1]	1994-2015
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Other | Louisiana
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 2,177,542
Initial Cost to Company Buildings and Improvements	[1]	52,869,373
Cost Capitalized Subsequent to Acquisition Improvements	[1]	1,749,991
Gross Amount at Which Carried at Close of Period Land	[1]	2,177,542
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	54,619,364
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	56,796,906
Accumulated Depreciation	[1],[4]	$ 17,883,426
Date Of Construction	[1]	1957-1983
Date Acquired	[1]	1997-2006
Other | Louisiana | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Other | Louisiana | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	39 years
Other | Maryland
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 7,190,000
Initial Cost to Company Buildings and Improvements	[1]	74,028,613
Cost Capitalized Subsequent to Acquisition Improvements	[1]	2,518,228
Gross Amount at Which Carried at Close of Period Land	[1]	7,190,000
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	76,546,841
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	83,736,841
Accumulated Depreciation	[1],[4]	$ 14,350,237
Date Of Construction	[1]	1921-1985
Date Acquired	[1]	2010-2011
Other | Maryland | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	25 years
Other | Maryland | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	30 years
Other | Massachusetts
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 5,898,952
Initial Cost to Company Buildings and Improvements	[1]	41,120,152
Cost Capitalized Subsequent to Acquisition Improvements	[1]	2,160,034
Gross Amount at Which Carried at Close of Period Land	[1]	5,898,952
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	43,280,186
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	49,179,138
Accumulated Depreciation	[1],[4]	$ 20,605,218
Date Of Construction	[1]	1964-1993
Date Acquired	[1]	1997-2010
Other | Massachusetts | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	20 years
Other | Massachusetts | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	39 years
Other | Michigan
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 829,621
Initial Cost to Company Buildings and Improvements	[1]	30,921,159
Gross Amount at Which Carried at Close of Period Land	[1]	829,621
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	30,921,159
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	31,750,780
Accumulated Depreciation	[1],[4]	$ 4,655,127
Date Of Construction	[1]	1964-1975
Date Acquired	[1]	2011-2015
Other | Michigan | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	25 years
Other | Michigan | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Other | Minnesota
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 10,571,691
Initial Cost to Company Buildings and Improvements	[1]	52,399,655
Cost Capitalized Subsequent to Acquisition Improvements	[1]	653,399
Gross Amount at Which Carried at Close of Period Land	[1]	10,571,691
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	53,053,054
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	63,624,745
Accumulated Depreciation	[1],[4]	$ 3,949,866
Date Of Construction	[1]	1958-1983
Date Acquired	[1]	2,015
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Other | Mississippi
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 2,910,000
Initial Cost to Company Buildings and Improvements	[1]	49,506,905
Cost Capitalized Subsequent to Acquisition Improvements	[1]	826,654
Gross Amount at Which Carried at Close of Period Land	[1]	2,910,000
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	50,333,559
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	53,243,559
Accumulated Depreciation	[1],[4]	$ 14,274,382
Date Of Construction	[1]	1962-1988
Date Acquired	[1]	2009-2010
Other | Mississippi | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	20 years
Other | Mississippi | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	40 years
Other | Missouri
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 7,333,114
Initial Cost to Company Buildings and Improvements	[1]	121,480,904
Cost Capitalized Subsequent to Acquisition Improvements	[1]	692,135
Cost Capitalized Subsequent to Acquisition Other	[1],[2]	(152,575)
Gross Amount at Which Carried at Close of Period Land	[1]	7,333,114
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	122,020,464
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	129,353,578
Accumulated Depreciation	[1],[4]	$ 14,794,489
Date Of Construction	[1]	1955-1994
Date Acquired	[1]	1999-2016
Other | Missouri | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	30 years
Other | Missouri | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Other | Montana
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 1,319,454
Initial Cost to Company Buildings and Improvements	[1]	11,698,411
Gross Amount at Which Carried at Close of Period Land	[1]	1,319,454
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	11,698,411
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	13,017,865
Accumulated Depreciation	[1],[4]	$ 811,679
Date Of Construction	[1]	1963-1971
Date Acquired	[1]	2,015
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Other | Nebraska
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 1,599,631
Initial Cost to Company Buildings and Improvements	[1]	23,142,177
Gross Amount at Which Carried at Close of Period Land	[1]	1,599,631
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	23,142,177
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	24,741,808
Accumulated Depreciation	[1],[4]	$ 2,256,512
Date Of Construction	[1]	1963-1969
Date Acquired	[1]	2,015
Other | Nebraska | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	20 years
Other | Nebraska | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Other | Nevada
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 5,501,308
Initial Cost to Company Buildings and Improvements	[1]	50,472,213
Cost Capitalized Subsequent to Acquisition Improvements	[1]	8,350,000
Gross Amount at Which Carried at Close of Period Land	[1]	5,501,308
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	58,822,213
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	64,323,521
Accumulated Depreciation	[1],[4]	$ 10,013,989
Date Of Construction	[1]	1972-2004
Date Acquired	[1]	2009-2015
Other | Nevada | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	26 years
Other | Nevada | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Other | New Hampshire
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 1,782,067
Initial Cost to Company Buildings and Improvements	[1]	19,837,436
Cost Capitalized Subsequent to Acquisition Improvements	[1]	1,462,797
Gross Amount at Which Carried at Close of Period Land	[1]	1,782,067
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	21,300,233
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	23,082,300
Accumulated Depreciation	[1],[4]	$ 8,439,787
Date Of Construction	[1]	1963-1999
Date Acquired	[1]	1998-2006
Other | New Hampshire | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Other | New Hampshire | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	39 years
Other | New Mexico
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 9,002,270
Initial Cost to Company Buildings and Improvements	[1]	68,658,130
Cost Capitalized Subsequent to Acquisition Improvements	[1]	130,323
Gross Amount at Which Carried at Close of Period Land	[1]	9,002,270
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	68,788,453
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	77,790,723
Accumulated Depreciation	[1],[4]	$ 7,348,628
Date Of Construction	[1]	1960-1989
Date Acquired	[1]	2008-2015
Other | New Mexico | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	20 years
Other | New Mexico | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Other | North Carolina
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 3,069,856
Initial Cost to Company Buildings and Improvements	[1]	52,675,612
Cost Capitalized Subsequent to Acquisition Improvements	[1]	3,550,986
Gross Amount at Which Carried at Close of Period Land	[1]	3,069,856
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	56,226,598
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	59,296,454
Accumulated Depreciation	[1],[4]	$ 26,436,775
Date Of Construction	[1]	1964-1987
Date Acquired	[1]	1994-2010
Other | North Carolina | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	25 years
Other | North Carolina | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	36 years
Other | Ohio
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 35,367,198
Initial Cost to Company Buildings and Improvements	[1]	439,998,943
Cost Capitalized Subsequent to Acquisition Improvements	[1]	30,731,141
Cost Capitalized Subsequent to Acquisition Other	[1],[2]	(1,166,009)
Gross Amount at Which Carried at Close of Period Land	[1]	35,367,198
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	469,564,075
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	504,931,273
Accumulated Depreciation	[1],[4]	$ 133,969,181
Date Of Construction	[1]	1920-2008
Date Acquired	[1]	1994-2015
Other | Ohio | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	20 years
Other | Ohio | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	39 years
Other | Oklahoma
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 4,650,087
Initial Cost to Company Buildings and Improvements	[1]	36,246,616
Gross Amount at Which Carried at Close of Period Land	[1]	4,650,087
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	36,246,616
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	40,896,703
Accumulated Depreciation	[1],[4]	$ 7,883,686
Date Of Construction	[1]	1965-2013
Date Acquired	[1]	2010-2015
Other | Oklahoma | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	20 years
Other | Oklahoma | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Other | Oregon
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 3,640,572
Initial Cost to Company Buildings and Improvements	[1]	45,217,827
Cost Capitalized Subsequent to Acquisition Improvements	[1]	2,610,185
Gross Amount at Which Carried at Close of Period Land	[1]	3,640,572
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	47,828,012
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	51,468,584
Accumulated Depreciation	[1],[4]	$ 3,179,897
Date Of Construction	[1]	1959-2004
Date Acquired	[1]	2014-2015
Other | Oregon | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	25 years
Other | Oregon | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Other | Pennsylvania
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 11,733,450
Initial Cost to Company Buildings and Improvements	[1]	206,264,434
Cost Capitalized Subsequent to Acquisition Improvements	[1]	11,281,116
Gross Amount at Which Carried at Close of Period Land	[1]	11,733,450
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	217,545,550
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	229,279,000
Accumulated Depreciation	[1],[4]	$ 66,127,725
Date Of Construction	[1]	1942-2012
Date Acquired	[1]	1998-2015
Other | Pennsylvania | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	16 years
Other | Pennsylvania | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	39 years
Other | Rhode Island
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 3,658,261
Initial Cost to Company Buildings and Improvements	[1]	35,082,551
Cost Capitalized Subsequent to Acquisition Improvements	[1]	4,792,882
Gross Amount at Which Carried at Close of Period Land	[1]	3,658,261
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	39,875,433
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	43,533,694
Accumulated Depreciation	[1],[4]	$ 16,190,347
Date Of Construction	[1]	1965-1981
Date Acquired	[1]	2,006
Life on Which Depreciation in Latest Income Statements is Computed	[1]	39 years
Other | South Carolina
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 7,800,000
Initial Cost to Company Buildings and Improvements	[1]	59,782,493
Gross Amount at Which Carried at Close of Period Land	[1]	7,800,000
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	59,782,493
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	67,582,493
Accumulated Depreciation	[1],[4]	$ 5,718,501
Date Of Construction	[1]	1959-2007
Date Acquired	[1]	2014-2016
Other | South Carolina | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	20 years
Other | South Carolina | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	30 years
Other | Tennessee
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 5,932,773
Initial Cost to Company Buildings and Improvements	[1]	99,743,478
Cost Capitalized Subsequent to Acquisition Improvements	[1]	4,897,458
Cost Capitalized Subsequent to Acquisition Other	[1],[2]	(527,491)
Gross Amount at Which Carried at Close of Period Land	[1]	5,827,316
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	104,218,902
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	110,046,218
Accumulated Depreciation	[1],[4]	$ 46,714,574
Date Of Construction	[1]	1958-1985
Date Acquired	[1]	1992-2015
Other | Tennessee | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	20 years
Other | Tennessee | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	31 years
Other | Texas
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 67,370,202
Initial Cost to Company Buildings and Improvements	[1]	667,695,852
Cost Capitalized Subsequent to Acquisition Improvements	[1]	24,223,887
Cost Capitalized Subsequent to Acquisition Carrying Cost	[1]	203,265
Cost Capitalized Subsequent to Acquisition Other	[1],[2]	(1,000)
Gross Amount at Which Carried at Close of Period Land	[1]	67,370,202
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	692,122,004
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	759,492,206
Accumulated Depreciation	[1],[4]	$ 97,331,606
Date Of Construction	[1]	1952-2015
Date Acquired	[1]	1997-2016
Other | Texas | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	2 years
Other | Texas | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	40 years
Other | United Kingdom
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 47,432,242
Initial Cost to Company Buildings and Improvements	[1]	256,409,736
Cost Capitalized Subsequent to Acquisition Improvements	[1]	1,646,761
Cost Capitalized Subsequent to Acquisition Other	[1],[2]	(52,350,758)
Gross Amount at Which Carried at Close of Period Land	[1]	39,822,262
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	213,315,719
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	253,137,981
Accumulated Depreciation	[1],[4]	$ 10,141,108
Date Of Construction	[1]	1750-2011
Date Acquired	[1]	2015-2016
Life on Which Depreciation in Latest Income Statements is Computed		30 years
Other | Utah
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 633,938
Initial Cost to Company Buildings and Improvements	[1]	2,986,062
Gross Amount at Which Carried at Close of Period Land	[1]	633,938
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	2,986,062
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	3,620,000
Accumulated Depreciation	[1],[4]	$ 247,001
Date Of Construction	[1]	1,977
Date Acquired	[1]	2,015
Life on Which Depreciation in Latest Income Statements is Computed	[1]	24 years
Other | Vermont
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 317,500
Initial Cost to Company Buildings and Improvements	[1]	6,005,388
Cost Capitalized Subsequent to Acquisition Improvements	[1]	602,296
Gross Amount at Which Carried at Close of Period Land	[1]	317,500
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	6,607,684
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	6,925,184
Accumulated Depreciation	[1],[4]	$ 2,416,363
Date Of Construction	[1]	1,971
Date Acquired	[1]	2,004
Life on Which Depreciation in Latest Income Statements is Computed	[1]	39 years
Other | Virginia
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 2,566,363
Initial Cost to Company Buildings and Improvements	[1]	30,009,385
Gross Amount at Which Carried at Close of Period Land	[1]	2,566,363
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	30,009,385
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	32,575,748
Accumulated Depreciation	[1],[4]	$ 1,582,827
Date Of Construction	[1]	1989-1995
Date Acquired	[1]	2,015
Other | Virginia | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Other | Virginia | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	40 years
Other | Washington
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 11,719,119
Initial Cost to Company Buildings and Improvements	[1]	138,054,574
Cost Capitalized Subsequent to Acquisition Improvements	[1]	2,626,926
Cost Capitalized Subsequent to Acquisition Other	[1],[2]	(1,500)
Gross Amount at Which Carried at Close of Period Land	[1]	11,717,619
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	140,681,500
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	152,399,119
Accumulated Depreciation	[1],[4]	$ 22,271,862
Date Of Construction	[1]	1930-2004
Date Acquired	[1]	1995-2015
Other | Washington | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	20 years
Other | Washington | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
Other | West Virginia
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 1,972,682
Initial Cost to Company Buildings and Improvements	[1]	66,945,947
Cost Capitalized Subsequent to Acquisition Improvements	[1]	7,000,345
Gross Amount at Which Carried at Close of Period Land	[1]	1,972,682
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	73,946,292
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	75,918,974
Accumulated Depreciation	[1],[4]	$ 32,588,074
Date Of Construction	[1]	1961-1996
Date Acquired	[1]	1994-2011
Other | West Virginia | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	25 years
Other | West Virginia | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	39 years
Other | Wisconsin
Real Estate and Accumulated Depreciation [Line Items]
Initial Cost to Company Land	[1]	$ 7,377,429
Initial Cost to Company Buildings and Improvements	[1]	53,224,076
Cost Capitalized Subsequent to Acquisition Improvements	[1]	5,252,877
Cost Capitalized Subsequent to Acquisition Other	[1],[2]	(1,500)
Gross Amount at Which Carried at Close of Period Land	[1]	7,377,429
Gross Amount at Which Carried at Close of Period Buildings and Improvements	[1]	58,475,453
Gross Amount at Which Carried at Close of Period Land and Buildings and Improvements Total	[1],[3]	65,852,882
Accumulated Depreciation	[1],[4]	$ 12,420,492
Date Of Construction	[1]	1930-1994
Date Acquired	[1]	2009-2015
Other | Wisconsin | Minimum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	20 years
Other | Wisconsin | Maximum
Real Estate and Accumulated Depreciation [Line Items]
Life on Which Depreciation in Latest Income Statements is Computed	[1]	33 years
[1]	The real estate included in this schedule is being used in either the operation of skilled nursing facilities (SNF), assisted living facilities (AL), independent living facilities (ILF), tramatic brain injury (TBI), medical office building (MOB) or specialty hospitals (SH) located in the states or country indicated.
[2]	Reflects bed sales, land easements and impacts from foreign currency exchange rates.
[3]	Year Ended December 31, 2014 2015 2016 Balance at beginning of period $ 3,099,547,182 $ 3,223,785,295 $ 6,743,957,698 Acquisitions through foreclosure - - 25,000,000 Acquisitions 131,689,483 3,371,233,860 1,017,760,963 Impairment (3,660,381 ) (12,916,233 ) (53,716,724 ) Improvements 17,916,855 220,272,401 95,806,618 Disposals/other (21,707,844 ) (58,417,625 ) (262,450,272 ) Balance at close of period $ 3,223,785,295 $ 6,743,957,698 $ 7,566,358,283
[4]	Year Ended December 31, 2014 2015 2016 Balance at beginning of period $ 707,409,888 $ 821,711,991 $ 1,019,149,678 Provisions for depreciation 123,141,880 210,554,569 266,904,418 Dispositions/other (8,839,777 ) (13,116,882 ) (45,718,151 ) Balance at close of period $ 821,711,991 $ 1,019,149,678 $ 1,240,335,945
[5]	Certain of the real estate indicated are security for the HUD loan borrowings totaling $54,954,695 at December 31, 2016

SCHEDULE III REAL ESTATE AND115

SCHEDULE III REAL ESTATE AND ACCUMULATED DEPRECIATION (Detail 2) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
SEC Schedule III, Reconciliation of Carrying Amount of Real Estate Investments [Roll Forward]
Balance at beginning of period	$ 6,743,957,698	$ 3,223,785,295	$ 3,099,547,182
Acquisitions through foreclosure	25,000,000
Acquisitions	1,017,760,963	3,371,233,860	131,689,483
Impairment	(53,716,724)	(12,916,233)	(3,660,381)
Improvements	95,806,618	220,272,401	17,916,855
Disposals/other	(262,450,272)	(58,417,625)	(21,707,844)
Balance at close of period	7,566,358,283	6,743,957,698	3,223,785,295
Reconciliation of real estate accumulated depreciation
Balance at beginning of period	1,019,149,678	821,711,991	707,409,888
Provisions for depreciation	266,904,418	210,554,569	123,141,880
Dispositions/other	(45,718,151)	(13,116,882)	(8,839,777)
Balance at close of period	$ 1,240,335,945	$ 1,019,149,678	$ 821,711,991

SCHEDULE III REAL ESTATE AND116

SCHEDULE III REAL ESTATE AND ACCUMULATED DEPRECIATION (Detail 3) $ in Billions	Dec. 31, 2016USD ($)
Real Estate and Accumulated Depreciation Disclosure [Abstract]
Reported amount of real estate in excess of the tax basis	$ 1.1

SCHEDULE IV MORTGAGE LOANS O117

SCHEDULE IV MORTGAGE LOANS ON REAL ESTATE (Detail)	12 Months Ended
	Dec. 31, 2016USD ($)	[1]
Mortgage Loans on Real Estate [Line Items]
Face Amount of Mortgages	$ 685,283,732
Carrying Amount of Mortgages	$ 639,343,243	[2],[3]
Louisiana | Group 1
Mortgage Loans on Real Estate [Line Items]
Interest Rate	8.75%
Final Maturity Date	2,018
Periodic Payment Terms	Interest accrues monthly
Prior Liens	$ 0
Face Amount of Mortgages	9,870,626
Carrying Amount of Mortgages	9,870,626	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Maryland | Group 1
Mortgage Loans on Real Estate [Line Items]
Interest Rate	11.00%
Final Maturity Date	2,028
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	74,927,751
Carrying Amount of Mortgages	35,963,840	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Michigan | Group 1
Mortgage Loans on Real Estate [Line Items]
Interest Rate	9.45%
Final Maturity Date	2,029
Periodic Payment Terms	Interest plus $105,000 of principal payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	415,000,000
Carrying Amount of Mortgages	412,140,060	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Michigan | Group 2
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10.77%
Final Maturity Date	2,021
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	3,917,030
Carrying Amount of Mortgages	3,917,030	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Michigan | Group 3
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10.51%
Final Maturity Date	2,021
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	4,111,387
Carrying Amount of Mortgages	4,111,387	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Michigan | Group 4
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10.25%
Final Maturity Date	2,029
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	2,214,376
Carrying Amount of Mortgages	2,214,376	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Michigan | Group 5
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10.25%
Final Maturity Date	2,029
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	560,601
Carrying Amount of Mortgages	560,601	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Michigan | Group 6
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10.25%
Final Maturity Date	2,029
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	267,170
Carrying Amount of Mortgages	267,170	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Michigan | Group 7
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10.25%
Final Maturity Date	2,029
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	100,000
Carrying Amount of Mortgages	100,000	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Michigan | Group 8
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10.25%
Final Maturity Date	2,029
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	252,241
Carrying Amount of Mortgages	252,241	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Michigan | Group 9
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10.25%
Final Maturity Date	2,029
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	269,740
Carrying Amount of Mortgages	269,740	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Michigan | Group 10
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10.25%
Final Maturity Date	2,029
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	4,036,982
Carrying Amount of Mortgages	4,036,982	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Michigan | Group 11
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10.25%
Final Maturity Date	2,029
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	4,089,039
Carrying Amount of Mortgages	4,089,039	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Michigan | Group 12
Mortgage Loans on Real Estate [Line Items]
Interest Rate	9.50%
Final Maturity Date	2,029
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	597,022
Carrying Amount of Mortgages	597,022	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Michigan | Group 13
Mortgage Loans on Real Estate [Line Items]
Interest Rate	9.50%
Final Maturity Date	2,029
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	125,930
Carrying Amount of Mortgages	125,930	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Michigan | Group 14
Mortgage Loans on Real Estate [Line Items]
Interest Rate	9.50%
Final Maturity Date	2,029
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	1,803,905
Carrying Amount of Mortgages	1,803,905	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Michigan | Group 15
Mortgage Loans on Real Estate [Line Items]
Interest Rate	9.50%
Final Maturity Date	2,029
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	432,754
Carrying Amount of Mortgages	432,754	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Michigan | Group 16
Mortgage Loans on Real Estate [Line Items]
Interest Rate	9.50%
Final Maturity Date	2,029
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	190,842
Carrying Amount of Mortgages	190,842	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Michigan | Group 17
Mortgage Loans on Real Estate [Line Items]
Interest Rate	8.50%
Final Maturity Date	2,029
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	14,044,762
Carrying Amount of Mortgages	14,044,762	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Missouri and Tennessee | Group 1
Mortgage Loans on Real Estate [Line Items]
Interest Rate	8.35%
Final Maturity Date	2,015
Periodic Payment Terms	Interest plus $0 of principal payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	6,997,610
Carrying Amount of Mortgages	2,500,000	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
New Jersey | Group 1
Mortgage Loans on Real Estate [Line Items]
Interest Rate	10.00%
Final Maturity Date	2,017
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	3,195,000
Carrying Amount of Mortgages	3,195,000	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Ohio and Pennsylvania | Group 1
Mortgage Loans on Real Estate [Line Items]
Interest Rate	9.79%
Final Maturity Date	2,024
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	112,500,000
Carrying Amount of Mortgages	112,500,000	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Ohio | Group 1
Mortgage Loans on Real Estate [Line Items]
Interest Rate	11.67%
Final Maturity Date	2,018
Periodic Payment Terms	Interest payable monthly
Prior Liens	$ 0
Face Amount of Mortgages	11,874,013
Carrying Amount of Mortgages	12,254,985	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
South Carolina | Group 1
Mortgage Loans on Real Estate [Line Items]
Interest Rate	8.75%
Final Maturity Date	2,018
Periodic Payment Terms	Interest accrues monthly
Prior Liens	$ 0
Face Amount of Mortgages	8,762,943
Carrying Amount of Mortgages	8,762,943	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
Virginia | Group 1
Mortgage Loans on Real Estate [Line Items]
Interest Rate	8.75%
Final Maturity Date	2,018
Periodic Payment Terms	Interest accrues monthly
Prior Liens	$ 0
Face Amount of Mortgages	5,142,008
Carrying Amount of Mortgages	5,142,008	[2],[3]
Principal Amount of Loans Subject to Delinquent Principal or Interest	$ 0
[1]	Mortgage loans included in this schedule represent first mortgages on facilities used in the delivery of long-term healthcare of which such facilities are located in the states indicated.
[2]	The aggregate cost for federal income tax purposes is equal to the carrying amount.
[3]	Year Ended December 31,2014 2015 2016 Balance at beginning of period $ 241,514,812, $ 648,078,550, $ 679,795,236 Additions during period Placements $ 529,547,836, $ 33,288,320, $ 48,721,953 Deductions during period - collection of principal/other(122,984,098)( 1,571,634)( 89,173,946) Balance at close of period $ 648,078,550 $ 679,795,236 $ 639,343,243

SCHEDULE IV MORTGAGE LOANS O118

SCHEDULE IV MORTGAGE LOANS ON REAL ESTATE (Detail 1) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Movement in Mortgage Loans on Real Estate [Roll Forward]
Balance at beginning of period	$ 679,795,236	$ 648,078,550	$ 241,514,812
Additions during period - Placements	48,721,953	33,288,320	529,547,836
Deductions during period - collection of principal/other	(89,173,946)	(1,571,634)	(122,984,098)
Balance at close of period	$ 639,343,243	$ 679,795,236	$ 648,078,550